EurekaMag PDF full texts Chapter 54,209

Berwick, M.; MacArthur, J.; Orlow, I.; Kanetsky, P.; Begg, C.B.; Luo, L.; Reiner, A.; Sharma, A.; Armstrong, B.K.; Kricker, A.; Cust, A.E.; Marrett, L.D.; Gruber, S.B.; Anton-Culver, H.; Zanetti, R.; Rosso, S.; Gallagher, R.P.; Dwyer, T.; Venn, A.; Busam, K.; From, L.; White, K.; Thomas, N.E.; Berwick, M.; Begg, C.B.; Orlow, I.; Busam, K.J.; Reiner, A.S.; Roy, P.; Sharma, A.; Berwick, M.; White, K.; Paine, S.; Armstrong, B.K.; Phil, D.; Kricker, A.; Cust, A.; Venn, A.; Dwyer, T.; Tucker, P.; Gallagher, R.P.; Kan, D.; Marrett, L.D.; Theis, E.; From, L.; Zanetti, R.; Rosso, S.; Anton-Culver, H.; Gruber, S.B.; Johnson, T.; Huang, S.-C.; Klotz, J.; Wilcox, H.; Paddock, L.; Thomas, N.E.; Millikan, R.C.; Ollila, D.W.; Conway, K.; Groben, P.A.; Ed 2014: MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors. Pigment Cell and Melanoma Research 27(3): 485-488

Nybakken, G.E.; Sargen, M.; Abraham, R.; Zhang, P.J.; Ming, M.; Xu, X. 2013: MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations. American Journal of dermatopathology 35(1): 25-29

Eccles, M.R.; He, S.; Ahn, A.; Slobbe, L.J.; Jeffs, A.R.; Yoon, H.-S.; Baguley, B.C. 2013: MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a "Genetic Switch" Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma. Frontiers in Oncology 3: 229

Lister, J.A. 2013: MITF from missense to malady. Pigment Cell and Melanoma Research 26(6): 790-791

Grill, C.; Bergsteinsdóttir, K.ín.; Ogmundsdóttir, M.ét.H.; Pogenberg, V.; Schepsky, A.; Wilmanns, M.; Pingault, V.; Steingrímsson, E.ík. 2013: MITF mutations associated with pigment deficiency syndromes and melanoma have different effects on protein function. Human Molecular Genetics 22(21): 4357-4367

Yokoyama, S.; Salma, N.; Fisher, D.E. 2009: MITF pathway mutations in melanoma. Pigment Cell and Melanoma Research 22(4): 376-377

Tallon, B.; Beer, T.W.; Beer, T.M. 2014: MITF positivity in atypical fibroxanthoma: a diagnostic pitfall. American Journal of Dermatopathology 36(11): 888-891

Koludrovic, D.; Davidson, I. 2013: MITF, the Janus transcription factor of melanoma. Future Oncology 9(2): 235-244

Ronai, Z.'e. 2010: MITF--past, present and future. Pigment Cell and Melanoma Research 23(6): 723

Shiohara, M.; Shigemura, T.; Suzuki, T.; Tanaka, M.; Morii, E.; Ohtsu, H.; Shibahara, S.; Koike, K. 2009: MITF-CM, a newly identified isoform of microphthalmia-associated transcription factor, is expressed in cultured mast cells. International Journal of Laboratory Hematology 31(2): 215-226

Ondrušová, L.; Vachtenheim, J.; Réda, J.; Záková, P.; Benková, K. 2013: MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells. Plos one 8(1): E54110

Bertolotto, C.; Lesueur, F.; Bressac de Paillerets, B. 2012: MITF: a genetic key to melanoma and renal cell carcinoma?. Medecine Sciences: M/S 28(3): 258-261

Hoek, K.S. 2011: MITF: the power and the glory. Pigment Cell and Melanoma Research 24(2): 262-263

Normile, D. 1994: MITi Ecoprojects Target the Desert--and the Home Front. Science 266(5188): 1188

Dunkin, B.J. 2009: MITIE--an educational home for health care professionals. Methodist Debakey Cardiovascular Journal 5(2): 9-12

Behr, J.; Kahles, A.é; Zhong, Y.; Sreedharan, V.T.; Drewe, P.; Rätsch, G. 2013: MITIE: Simultaneous RNA-Seq-based transcript identification and quantification in multiple samples. Bioinformatics 29(20): 2529-2538

Fritzsche, K.H.; Neher, P.F.; Reicht, I.; van Bruggen, T.; Goch, C.; Reisert, M.; Nolden, M.; Zelzer, S.; Meinzer, H-P.; Stieltjes, B. 2012: MITK diffusion imaging. Methods of Information in Medicine 51(5): 441-448

März, K.; Franz, A.M.; Seitel, A.; Winterstein, A.; Bendl, R.; Zelzer, S.; Nolden, M.; Meinzer, H.-P.; Maier-Hein, L. 2014: MITK-US: real-time ultrasound support within MITK. International Journal of Computer Assisted Radiology and Surgery 9(3): 411-420

Furukawa, R.; Yamada, Y.; Harashima, H. 2012: MITO-Porter; a cutting-edge technology for mitochondrial gene therapy. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 132(12): 1389-1398

Subramaniam, V.; Golik, P.; Murdock, D.G.; Levy, S.; Kerstann, K.W.; Coskun, P.E.; Melkonian, G.A.; Wallace, D.C. 2008: MITOCHIP assessment of differential gene expression in the skeletal muscle of Ant1 knockout mice: coordinate regulation of OXPHOS, antioxidant, and apoptotic genes. Biochimica et Biophysica Acta 1777(7-8): 666-675

Prompers, J.J.; Wessels, B.; Kemp, G.J.; Nicolay, K. 2014: MITOCHONDRIA: investigation of in vivo muscle mitochondrial function by 31P magnetic resonance spectroscopy. International Journal of Biochemistry and Cell Biology 50: 67-72

Sugiura, A.; Nagashima, S.; Tokuyama, T.; Amo, T.; Matsuki, Y.; Ishido, S.; Kudo, Y.; McBride, H.M.; Fukuda, T.; Matsushita, N.; Inatome, R.; Yanagi, S. 2013: MITOL regulates endoplasmic reticulum-mitochondria contacts via Mitofusin2. Molecular Cell 51(1): 20-34

Rockel, S.; Geertz, M.; Maerkl, S.J. 2012: MITOMI: a microfluidic platform for in vitro characterization of transcription factor-DNA interaction. Methods in Molecular Biology 786: 97-114

Watanabe, T.; Chuma, S.; Yamamoto, Y.; Kuramochi-Miyagawa, S.; Totoki, Y.; Toyoda, A.; Hoki, Y.; Fujiyama, A.; Shibata, T.; Sado, T.; Noce, T.; Nakano, T.; Nakatsuji, N.; Lin, H.; Sasaki, H. 2011: MITOPLD is a mitochondrial protein essential for nuage formation and piRNA biogenesis in the mouse germline. Developmental Cell 20(3): 364-375

Bernt, M.; Donath, A.; Jühling, F.; Externbrink, F.; Florentz, C.; Fritzsch, G.; Pütz, J.; Middendorf, M.; Stadler, P.F. 2013: MITOS: improved de novo metazoan mitochondrial genome annotation. Molecular Phylogenetics and Evolution 69(2): 313-319

Mick, D.U.; Dennerlein, S.; Wiese, H.; Reinhold, R.; Pacheu-Grau, D.; Lorenzi, I.; Sasarman, F.; Weraarpachai, W.; Shoubridge, E.A.; Warscheid, B.; Rehling, P. 2012: MITRAC links mitochondrial protein translocation to respiratory-chain assembly and translational regulation. Cell 151(7): 1528-1541

Clark, C.; Aberdeen, J.; Coarr, M.; Tresner-Kirsch, D.; Wellner, B.; Yeh, A.; Hirschman, L. 2011: MITRE system for clinical assertion status classification. Journal of the American Medical Informatics Association: Jamia 18(5): 563-567

Ouattara, L.A.; Barnable, P.; Mawson, P.; Seidor, S.; Zydowsky, T.M.; Kizima, L.; Rodriguez, A.; Fernández-Romero, J.é A.; Cooney, M.L.; Roberts, K.D.; Gettie, A.; Blanchard, J.; Robbiani, M.; Teleshova, N. 2014: MIV-150-containing intravaginal rings protect macaque vaginal explants against SHIV-RT infection. Antimicrobial Agents and ChemoTherapy 58(5): 2841-2848

Takasugi, W.; Wakaisami, M.; Sasaki, N.; Sakuma, T.; Yamamoto, M.; Kitagawa, A.; Muramatsu, M. 2010: MIVOC method with temperature control. Review of Scientific Instruments 81(2): 02a329

Xu, M.; Medvedev, S.; Yang, J.; Hecht, N.B. 2009: MIWI-independent small RNAs (MSY-RNAs) bind to the RNA-binding protein, MSY2, in male germ cells. Proceedings of the National Academy of Sciences of the United States of America 106(30): 12371-12376

Anonymous 1946: MIXED bacterial infections in dogs. Veterinary Medicine 41: 227

Hedeker, D.; Nordgren, R. 2013: MIXREGLS: A Program for Mixed-Effects Location Scale Analysis. Journal of Statistical Software 52(12): 1-38

Yamazaki, T.; Miyazawa, Y.; Kobayashi, A.; Moriwaki, T.; Fujii, N.; Takahashi, H. 2012: MIZ1, an essential protein for root hydrotropism, is associated with the cytoplasmic face of the endoplasmic reticulum membrane in Arabidopsis root cells. Febs Letters 586(4): 398-402

Iwata, S.; Miyazawa, Y.; Fujii, N.; Takahashi, H. 2013: MIZ1-regulated hydrotropism functions in the growth and survival of Arabidopsis thaliana under natural conditions. Annals of Botany 112(1): 103-114

Lawson, L.; Bunyan, C. 2013: MIdwives: the next generation. Midwives 16(4): 46-47

Pepino, A.; Sicignano, G.; Rovani, M.; D'Addio, G. 2012: MInD: moving in the dark. Studies in Health Technology and Informatics 180: 1212-1214

Miller, M.J. 2010: MJ Miller's introduction for the Seminars in Immunopathology special issue on two-photon imaging immunity. Seminars in immunopathology 32(3): 211-213

Yang, J.-S.; Hour, M.-J.; Huang, W.-W.; Lin, K.-L.; Kuo, S.-C.; Chung, J.-G. 2010: MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells. Journal of Pharmacology and Experimental Therapeutics 334(2): 477-488

Liu, W.-T.; Chen, C.; Lu, I.-C.; Kuo, S.-C.; Lee, K.-H.; Chen, T.-L.; Song, T.-S.; Lu, Y.-L.; Gean, P.-W.; Hour, M.-J. 2014: MJ-66 induces malignant glioma cells G2/M phase arrest and mitotic catastrophe through regulation of cyclin B1/Cdk1 complex. Neuropharmacology 86: 219-227

Rowe, R.C. 2013: MJA Dr Eric Dark Creative Writing Prize - Enough?. Medical Journal of Australia 199(2): 131-132

Farey, J.E. 2013: MJA Dr Eric Dark Creative Writing Prize - Esther. Medical Journal of Australia 199(2): 132-133

Carr-Brown, L.; Carr-Brown, L. 2013: MJA Dr Eric Dark Creative Writing Prize - Joy to Mary. Medical Journal of Australia 199(4): 294

Lin, Y. 2012: MJA Dr Eric Dark Creative Writing Prize - My teacher. Medical Journal of Australia 196(11): 709-710

Mullins, G.C. 2013: MJA Dr Eric Dark Creative Writing Prize--A good hairdresser. Medical Journal of Australia 199(3): 213-214

Jureidini, J.N. 2008: MJA policy on sponsored supplements. Medical Journal of Australia 188(4): 260; Author Reply 260 Discussion 261

Habibullah, N.K. 2013: MJA, MDA National, Nossal Global Health Prize - Utilising humanism to (re)fortify global health leadership. Medical Journal of Australia 199(6): 426-427

Embong, M. 2008: MJMS : the past and future. Malaysian Journal of Medical Sciences: Mjms 15(4): 5-7

Mohamed, M. 2008: MJMS and the challenges of a research university. Malaysian Journal of Medical Sciences: Mjms 15(4): 8

Dewiputri, W.I.; Mohamad, I. 2011: MJMS at the Dawn of its Electronic Era. Malaysian Journal of Medical Sciences: Mjms 18(1): 1-5

Cam, E.; Yulug, B.; Ozan, E. 2008: MK 801: a possible neuroprotective agent by poststroke depression?. Journal of Neuropsychiatry and Clinical Neurosciences 20(3): 367-368

Métifiot, M.; Johnson, B.; Smith, S.; Zhao, X.Z.; Marchand, C.; Burke, T.; Hughes, S.; Pommier, Y. 2011: MK-0536 inhibits HIV-1 integrases resistant to raltegravir. Antimicrobial Agents and ChemoTherapy 55(11): 5127-5133

Shih, C.-M.; Chen, Y.-H.; Lin, Y.-W.; Tsao, N.-W.; Wu, S.-C.; Kao, Y.-T.; Chiang, K.-H.; Li, C.-Y.; Chang, N.-C.; Lin, C.-Y.; Huang, C.-Y.; Lin, F.-Y. 2014: MK-0626, a dipeptidyl peptidase-4 inhibitor, improves neovascularization by increasing both the number of circulating endothelial progenitor cells and endothelial nitric oxide synthetase expression. Current Medicinal Chemistry 21(17): 2012-2022

Bernstein, J.A.; Liu, N.; Knorr, B.A.; Smugar, S.S.; Hanley, W.D.; Reiss, T.F.; Greenberg, S. 2011: MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary disease. Respiratory Medicine 105(3): 392-401

Adunsky, A.; Chandler, J.; Heyden, N.; Lutkiewicz, J.; Scott, B.B.; Berd, Y.; Liu, N.; Papanicolaou, D.A. 2011: MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study. Archives of Gerontology and Geriatrics 53(2): 183-189

Boot, J.D.; De Haas, S.L.; Van Gerven, J.M.A.; De Smet, M.; Leathem, T.; Wagner, J.; Denker, A.; Miller, D.; Van Doorn, M.B.A.; Schoemaker, R.C.; Cohen, A.F.; Diamant, Z. 2008: MK-0873, a PDE4 inhibitor, does not influence the pharmacokinetics of theophylline in healthy male volunteers. Pulmonary Pharmacology and Therapeutics 21(3): 573-577

Miyake, T.; Nimura, S.; Hamada, Y.; Nabeshima, K.; Shinohara, T.; Tanaka, S.; Yamashita, Y.; Takeshita, M.; Iwasaki, H. 2013: MK-1 expression in gastric carcinoma with liver metastasis. Japanese Journal of Clinical Oncology 43(4): 377-382

Bridges, K.A.; Hirai, H.; Buser, C.A.; Brooks, C.; Liu, H.; Buchholz, T.A.; Molkentine, J.M.; Mason, K.A.; Meyn, R.E. 2011: MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(17): 5638-5648

Rajeshkumar, N.V.; De Oliveira, E.; Ottenhof, N.; Watters, J.; Brooks, D.; Demuth, T.; Shumway, S.D.; Mizuarai, S.; Hirai, H.; Maitra, A.; Hidalgo, M. 2011: MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(9): 2799-2806

Hirai, H.; Arai, T.; Okada, M.; Nishibata, T.; Kobayashi, M.; Sakai, N.; Imagaki, K.; Ohtani, J.; Sakai, T.; Yoshizumi, T.; Mizuarai, S.; Iwasawa, Y.; Kotani, H. 2010: MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil. Cancer Biology and Therapy 9(7): 514-522

Burke, J.F.; Schlosser, L.; Harrison, A.D.; Kunnimalaiyaan, M.; Chen, H. 2013: MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition. Annals of Surgical Oncology 20(12): 3862-3868

Jiao, P.; Zhou, Y.-S.; Yang, J.-X.; Zhao, Y.-L.; Liu, Q.-Q.; Yuan, C.; Wang, F.-Z. 2013: MK-2206 induces cell cycle arrest and apoptosis in HepG2 cells and sensitizes TRAIL-mediated cell death. Molecular and Cellular Biochemistry 382(1-2): 217-224

Cheng, Y.; Zhang, Y.; Zhang, L.; Ren, X.; Huber-Keener, K.J.; Liu, X.; Zhou, L.; Liao, J.; Keihack, H.; Yan, L.; Rubin, E.; Yang, J-Ming. 2012: MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis. Molecular Cancer Therapeutics 11(1): 154-164

Sefton, E.C.; Qiang, W.; Serna, V.; Kurita, T.; Wei, J.-J.; Chakravarti, D.; Kim, J.J. 2013: MK-2206, an AKT inhibitor, promotes caspase-independent cell death and inhibits leiomyoma growth. Endocrinology 154(11): 4046-4057

Almhanna, K.; Cubitt, C.L.; Zhang, S.; Kazim, S.; Husain, K.; Sullivan, D.; Sebti, S.; Malafa, M. 2013: MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines. Cancer Biology and Therapy 14(10): 932-936

Hirai, H.; Sootome, H.; Nakatsuru, Y.; Miyama, K.; Taguchi, S.; Tsujioka, K.; Ueno, Y.; Hatch, H.; Majumder, P.K.; Pan, B.-S.; Kotani, H. 2010: MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Molecular Cancer Therapeutics 9(7): 1956-1967

Pan, B.-S.; Chan, G.K.Y.; Chenard, M.; Chi, A.; Davis, L.J.; Deshmukh, S.V.; Gibbs, J.B.; Gil, S.; Hang, G.; Hatch, H.; Jewell, J.P.; Kariv, I.; Katz, J.D.; Kunii, K.; Lu, W.; Lutterbach, B.A.; Paweletz, C.P.; Qu, X.; Reilly, J.F.; Szewczak, A.A.; Zeng, Q.; Kohl, N.E.; Dinsmore, C.J. 2010: MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptor. Cancer Research 70(4): 1524-1533

Anonymous 2014: MK-3475 effective against melanoma. Cancer discovery 4(8): 863-864

Wang, L.; Mason, K.A.; Ang, K.K.; Buchholz, T.; Valdecanas, D.; Mathur, A.; Buser-Doepner, C.; Toniatti, C.; Milas, L. 2012: MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Investigational new Drugs 30(6): 2113-2120

Shimomura, T.; Hasako, S.; Nakatsuru, Y.; Mita, T.; Ichikawa, K.; Kodera, T.; Sakai, T.; Nambu, T.; Miyamoto, M.; Takahashi, I.; Miki, S.; Kawanishi, N.; Ohkubo, M.; Kotani, H.; Iwasawa, Y. 2010: MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel. Molecular Cancer Therapeutics 9(1): 157-166

Gentile, I.; Buonomo, A.R.; Borgia, F.; Zappulo, E.; Castaldo, G.; Borgia, G. 2014: MK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection. Expert Opinion on Investigational Drugs 23(5): 719-728

Wu, N.-C.; Tong, S.-P.; Yang, Y.-C.; Wang, J.-C.; Wang, J.-J. 2014: MK-571 attenuates kidney ischemia and reperfusion-induced airway hypersensitivity in rats. Transplantation Proceedings 46(4): 1127-1130

Bhattacharjee, A.; Allister, E.M.; Wheeler, M.B. 2012: MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice. Canadian Journal of Physiology and Pharmacology 90(5): 663-668

Liverton, N.J.; Carroll, S.S.; Dimuzio, J.; Fandozzi, C.; Graham, D.J.; Hazuda, D.; Holloway, M.K.; Ludmerer, S.W.; McCauley, J.A.; McIntyre, C.J.; Olsen, D.B.; Rudd, M.T.; Stahlhut, M.; Vacca, J.P. 2010: MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease. Antimicrobial Agents and ChemoTherapy 54(1): 305-311

Dillon, G.M.; Lubbers, L.S.; Ferguson, M.T.; Lao, J.Z.; Huang, R.-R.C.; Xiao, J.C.; Fong, T.M.; Hale, J.J.; Rupprecht, K.; Miao, S.; Rowe, B.A.; Kornecook, T.J.; Dodart, J.-C. 2011: MK-7128, a novel CB1 receptor inverse agonist, improves scopolamine-induced learning and memory deficits in mice. Behavioural Pharmacology 22(2): 91-100

Kubík, S.ěp.án.; Buchtová, H.; Valeš, K.; Stuchlík, A.š 2014: MK-801 Impairs Cognitive Coordination on a Rotating Arena (Carousel) and Contextual Specificity of Hippocampal Immediate-Early Gene Expression in a Rat Model of Psychosis. Frontiers in Behavioral Neuroscience 8: 75

Young, B.W.; Sengelaub, D.R.; Steinmetz, J.E. 2010: MK-801 administration during neonatal ethanol withdrawal attenuates interpositus cell loss and juvenile eyeblink conditioning deficits. Alcohol 44(4): 359-369

Seibt, K.J.; da Luz Oliveira, R.; Rosemberg, D.B.; Savio, L.E.B.; Scherer, E.B.S.; Schmitz, F.; Wyse, A.T.S.; Bonan, C.D. 2012: MK-801 alters Na+, K+-ATPase activity and oxidative status in zebrafish brain: reversal by antipsychotic drugs. Journal of Neural Transmission 119(6): 661-667

Shi, T.-f.; Yang, C.-x.; Yang, D.-x.; Jiao, R.-s.; Zhang, G.-w.; Gao, H.-r.; Zhang, D.; Xu, M.-y. 2010: MK-801 changes the role of glutamic acid on modulation of algesia in nucleus accumbens. Biochemical and Biophysical Research Communications 395(3): 407-411

Sivarao, D.V.; Frenkel, M.; Chen, P.; Healy, F.L.; Lodge, N.J.; Zaczek, R. 2013: MK-801 disrupts and nicotine augments 40 Hz auditory steady state responses in the auditory cortex of the urethane-anesthetized rat. Neuropharmacology 73: 1-9

Selakovic, V.; Janac, B.; Radenovic, L. 2010: MK-801 effect on regional cerebral oxidative stress rate induced by different duration of global ischemia in gerbils. Molecular and Cellular Biochemistry 342(1-2): 35-50

Irifune, M.; Katayama, S.; Takarada, T.; Shimizu, Y.; Endo, C.; Takata, T.; Morita, K.; Dohi, T.; Sato, T.; Kawahara, M. 2007: MK-801 enhances gabaculine-induced loss of the righting reflex in mice, but not immobility. Canadian Journal of Anaesthesia 54(12): 998-1005

Ennaceur, A.; Michalikova, S.; van Rensburg, R.; Chazot, P.L. 2011: MK-801 increases the baseline level of anxiety in mice introduced to a spatial memory task without prior habituation. Neuropharmacology 61(5-6): 981-991

Traverso, L.M.; Ruiz, G.; De la Casa, L.G. 2012: MK-801 induces a low intensity conditioned taste aversion. Pharmacology Biochemistry and Behavior 100(3): 645-651

Yu, J.; Qi, D.; Xing, M.; Li, R.; Jiang, K.; Peng, Y.; Cui, D. 2011: MK-801 induces schizophrenic behaviors through downregulating Wnt signaling pathways in male mice. Brain Research 1385: 281-292

Paquette, M.A.; Anderson, A.M.; Lewis, J.R.; Meshul, C.K.; Johnson, S.W.; Paul Berger, S. 2010: MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism. Neuropharmacology 58(7): 1002-1008

Liu, C.; Min, S.; Wei, K.; Liu, D.; Dong, J.; Luo, J.; Liu, X.-B. 2012: MK-801 or DNQX reduces electroconvulsive shock-induced impairment of learning-memory and hyperphosphorylation of Tau in rats. Sheng Li Xue Bao: 64(4): 387-402

Hao, Y.; Wu, X.; Xu, L.; Guan, Y.; Hong, Z. 2012: MK-801 prevents overexpression of multidrug resistance protein 2 after status epilepticus. Neurological Research 34(5): 430-438

Vardigan, J.D.; Huszar, S.L.; McNaughton, C.H.; Hutson, P.H.; Uslaner, J.M. 2010: MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?. Pharmacology Biochemistry and Behavior 95(2): 223-229

Xu, B.; Xu, Z.; Deng, Y.; Liu, W.; Yang, H.; Wei, Y.-G. 2013: MK-801 protects against intracellular Ca(2+) overloading and improves N-methyl-D-aspartate receptor expression in cerebral cortex of methylmercury-poisoned rats. Journal of Molecular Neuroscience: Mn 49(1): 162-171

Alilain, W.J.; Goshgarian, H.G. 2007: MK-801 upregulates NR2A protein levels and induces functional recovery of the ipsilateral hemidiaphragm following acute C2 hemisection in adult rats. Journal of Spinal Cord Medicine 30(4): 346-354

Maćkowiak, M.; Guzik, R.ł; Dudys, D.; Bator, E.; Wędzony, K. 2013: MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex. Pharmacological Reports: Pr 65(5): 1112-1123

Burket, J.A.; Cannon, W.R.; Jacome, L.F.; Deutsch, S.I. 2010: MK-801, a noncompetitive NMDA receptor antagonist, elicits circling behavior in the genetically inbred Balb/c mouse strain. Brain Research Bulletin 83(6): 337-339

Furuie, H.; Yamada, K.; Ichitani, Y. 2013: MK-801-induced and scopolamine-induced hyperactivity in rats neonatally treated chronically with MK-801. Behavioural Pharmacology 24(8): 678-683

Cui, X.; Lefevre, E.; Turner, K.M.; Coelho, C.M.; Alexander, S.; Burne, T.H.J.; Eyles, D.W. 2015: MK-801-induced behavioural sensitisation alters dopamine release and turnover in rat prefrontal cortex. Psychopharmacology 232(3): 509-517

Bell, I.M.; Stump, C.A.; Gallicchio, S.N.; Staas, D.D.; Zartman, C.B.; Moore, E.L.; Sain, N.; Urban, M.; Bruno, J.G.; Calamari, A.; Kemmerer, A.L.; Mosser, S.D.; Fandozzi, C.; White, R.B.; Zrada, M.M.; Selnick, H.G.; Graham, S.L.; Vacca, J.P.; Kane, S.A.; Salvatore, C.A. 2012: MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in rats. Bioorganic and Medicinal Chemistry Letters 22(12): 3941-3945

Koeberle, A.; Siemoneit, U.; Northoff, H.; Hofmann, B.; Schneider, G.; Werz, O. 2009: MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregation. European Journal of Pharmacology 608(1-3): 84-90

Niemi, N.M.; Lanning, N.J.; Klomp, J.A.; Tait, S.W.; Xu, Y.; Dykema, K.J.; Murphy, L.O.; Gaither, L.A.; Xu, H.E.; Furge, K.A.; Green, D.R.; MacKeigan, J.P. 2011: MK-STYX, a catalytically inactive phosphatase regulating mitochondrially dependent apoptosis. Molecular and Cellular Biology 31(7): 1357-1368

Chang, E.; Heo, K.-S.; Woo, C.-H.; Lee, H.; Le, N.-T.; Thomas, T.N.; Fujiwara, K.; Abe, J.-i. 2011: MK2 SUMOylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting MK2 kinase and HSP27 phosphorylation. Blood 117(8): 2527-2537

Tietz, S.M.; Hofmann, R.; Thomas, T.; Tackenberg, Börn.; Gaestel, M.; Berghoff, M. 2014: MK2 and Fas receptor contribute to the severity of CNS demyelination. Plos one 9(6): E100363

Gorska, M.M.; Liang, Q.; Stafford, S.J.; Goplen, N.; Dharajiya, N.; Guo, L.; Sur, S.; Gaestel, M.; Alam, R. 2007: MK2 controls the level of negative feedback in the NF-kappaB pathway and is essential for vascular permeability and airway inflammation. Journal of Experimental Medicine 204(7): 1637-1652

Shi, J.-X.; Su, X.; Xu, J.; Zhang, W.-Y.; Shi, Y. 2012: MK2 posttranscriptionally regulates TNF-α-induced expression of ICAM-1 and IL-8 via tristetraprolin in human pulmonary microvascular endothelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 302(8): L793-L799

Johansen, C.; Vestergaard, C.; Kragballe, K.; Kollias, G.; Gaestel, M.; Iversen, L. 2009: MK2 regulates the early stages of skin tumor promotion. Carcinogenesis 30(12): 2100-2108

Seisenbacher, G.; Hafen, E.; Stocker, H. 2011: MK2-dependent p38b signalling protects Drosophila hindgut enterocytes against JNK-induced apoptosis under chronic stress. Plos Genetics 7(8): E1002168

Wilson, J.M.; Kunnimalaiyaan, S.; Gamblin, T.C.; Kunnimalaiyaan, M. 2014: MK2206 inhibits hepatocellular carcinoma cellular proliferation via induction of apoptosis and cell cycle arrest. Journal of Surgical Research 191(2): 280-285

Duraisamy, S.; Bajpai, M.; Bughani, U.; Dastidar, S.G.; Ray, A.; Chopra, P. 2008: MK2: a novel molecular target for anti-inflammatory therapy. Expert Opinion on Therapeutic Targets 12(8): 921-936

Guo, L.; Zhang, W.; Chang, S.; Zhang, L.; Ott, J.; Wang, J. 2012: MK4MDD: a multi-level knowledge base and analysis platform for major depressive disorder. Plos one 7(10): E46335

Zhou, J.; Wan, B.; Liu, X.-M.; Li, R.; Wang, Y.; Yu, L. 2012: MK5 is degraded in response to doxorubicin and negatively regulates doxorubicin-induced apoptosis in hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications 427(3): 581-586

Sarveswaran, S.; Myers, C.E.; Ghosh, J. 2010: MK591, a leukotriene biosynthesis inhibitor, induces apoptosis in prostate cancer cells: synergistic action with LY294002, an inhibitor of phosphatidylinositol 3'-kinase. Cancer Letters 291(2): 167-176

Morimoto, Y.; Kikuchi, K.; Ito, T.; Tokuda, M.; Matsuyama, T.; Noma, S.; Hashiguchi, T.; Torii, M.; Maruyama, I.; Kawahara, K.-I. 2009: MK615 attenuates Porphyromonas gingivalis lipopolysaccharide-induced pro-inflammatory cytokine release via MAPK inactivation in murine macrophage-like RAW264.7 cells. Biochemical and Biophysical Research Communications 389(1): 90-94

Sakuraoka, Y.; Sawada, T.; Okada, T.; Shiraki, T.; Miura, Y.; Hiraishi, K.; Ohsawa, T.; Adachi, M.; Takino, J.-i.; Takeuchi, M.; Kubota, K. 2010: MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells. World Journal of Gastroenterology 16(42): 5334-5341

Okada, T.; Sawada, T.; Osawa, T.; Adachi, M.; Kubota, K. 2008: MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora a and B kinases. World Journal of Gastroenterology 14(9): 1378-1382

Al-Jahdari, W.S.; Sakurai, H.; Yoshida, Y.; Mobaraki, A.; Suzuki, Y.; Nakano, T. 2011: MK615, a prospective anti-proliferative agent, enhances CD4/CD8 ratio after exposure to irradiation. International Journal of Radiation Biology 87(1): 81-90

Esposito, E.; Paterniti, I.; Mazzon, E.; Genovese, T.; Galuppo, M.; Meli, R.; Bramanti, P.; Cuzzocrea, S. 2011: MK801 attenuates secondary injury in a mouse experimental compression model of spinal cord trauma. Bmc Neuroscience 12: 31

Kuhlmann, C.R.W.; Zehendner, C.M.; Gerigk, M.; Closhen, D.; Bender, B.; Friedl, P.; Luhmann, H.J. 2009: MK801 blocks hypoxic blood-brain-barrier disruption and leukocyte adhesion. Neuroscience Letters 449(3): 168-172

Wen, D.; Liu, S.; Mao, J.; Tan, X.; Xia, C.; Yin, C. 2012: MK801 controls form-deprivation myopia by nitric oxide-cyclic GMP signaling pathway in guinea pig. Zhong Nan da Xue Xue Bao. Yi Xue Ban 37(7): 737-742

Da Silva, A.L.ço.; Silva Martins, B.ár.d.; Linck, V.d.M.; Herrmann, A.P.; Mai, N.; Nunes, D.S.; Elisabetsky, E. 2009: MK801- and scopolamine-induced amnesias are reversed by an Amazonian herbal locally used as a "brain tonic". Psychopharmacology 202(1-3): 165-172

Turner, C.P.; Debenedetto, D.; Ware, E.; Walburg, C.; Lee, A.; Stowe, R.; Swanson, J.; Lambert, A.; Lyle, M.; Desai, P.; Johnson, R.; Liu, C. 2009: MK801-induced activated caspase-3 exhibits selective co-localization with GAD67. Neuroscience Letters 462(2): 152-156

Li, Y.; Yin, S.; Nie, D.; Xie, S.; Ma, L.; Wang, X.; Wu, Y.; Xiao, J. 2011: MK886 inhibits the proliferation of HL-60 leukemia cells by suppressing the expression of mPGES-1 and reducing prostaglandin E2 synthesis. International Journal of Hematology 94(5): 472-478

Hawkes, C.A.; Shaw, J.E.; Brown, M.; Sampson, A.P.; McLaurin, J.; Carare, R.O. 2014: MK886 reduces cerebral amyloid angiopathy severity in TgCRND8 mice. Neuro-Degenerative Diseases 13(1): 17-23

Lim, J.Y.; Oh, J.H.; Jung, J.R.; Kim, S.M.; Ryu, C.H.; Kim, H.-T.; Jeun, S.-S. 2010: MK886-induced apoptosis depends on the 5-LO expression level in human malignant glioma cells. Journal of Neuro-Oncology 97(3): 339-346

Takashina, K.; Bessho, T.; Mori, R.; Eguchi, J.; Saito, K.-I. 2008: MKC-231, a choline uptake enhancer: (2) Effect on synthesis and release of acetylcholine in AF64A-treated rats. Journal of Neural Transmission 115(7): 1027-1035

Takashina, K.; Bessho, T.; Mori, R.; Kawai, K.; Eguchi, J.; Saito, K.-I. 2008: MKC-231, a choline uptake enhancer: (3) Mode of action of MKC-231 in the enhancement of high-affinity choline uptake. Journal of Neural Transmission 115(7): 1037-1046

Bessho, T.; Takashina, K.; Eguchi, J.; Komatsu, T.; Saito, K.-I. 2008: MKC-231, a choline-uptake enhancer: (1) long-lasting cognitive improvement after repeated administration in AF64A-treated rats. Journal of Neural Transmission 115(7): 1019-1025

Ijaz, A.Z.; Song, M.; Lee, D. 2010: MKEM: a Multi-level Knowledge Emergence Model for mining undiscovered public knowledge. Bmc Bioinformatics 11 Suppl. 2: S3

Mannam, P.; Shinn, A.S.; Srivastava, A.; Neamu, R.F.; Walker, W.E.; Bohanon, M.; Merkel, J.; Kang, M.-J.; Dela Cruz, C.S.; Ahasic, A.M.; Pisani, M.A.; Trentalange, M.; West, A.P.; Shadel, G.S.; Elias, J.A.; Lee, P.J. 2014: MKK3 regulates mitochondrial biogenesis and mitophagy in sepsis-induced lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 306(7): L604-L619

Zhang, G.; He, L.-S.; Wong, Y.H.; Qian, P.-Y. 2013: MKK3 was involved in larval settlement of the barnacle Amphibalanus amphitrite through activating the kinase activity of p38MAPK. Plos one 8(7): E69510

Sorkin, L.S.; Boyle, D.L.; Hammaker, D.; Herman, D.S.; Vail, E.; Firestein, G.S. 2009: MKK3, an upstream activator of p38, contributes to formalin phase 2 and late allodynia in mice. Neuroscience 162(2): 462-471

Cunningham, S.C.; Gallmeier, E.; Kern, S.E. 2010: MKK4 as oncogene or tumor suppressor: in cancer and senescence, the story's getting old. Aging 2(11): 752-753

Kim, J.-E.; Kwon, J.Y.; Lee, D.E.; Kang, N.J.; Heo, Y.-S.; Lee, K.W.; Lee, H.J. 2009: MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin. Biochemical Pharmacology 77(3): 412-421

Szmulewitz, R.Z.; Clark, R.; Lotan, T.; Otto, K.; Taylor Veneris, J.; Macleod, K.; Rinker-Schaeffer, C. 2012: MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression. International Journal of Cancer 130(3): 509-520

Ahn, Y-Ho.; Kurie, J.M. 2009: MKK4/SEK1 is negatively regulated through a feedback loop involving the E3 ubiquitin ligase itch. Journal of Biological Chemistry 284(43): 29399-29404

Xing, Y.; Cao, Q.; Zhang, Q.; Qin, L.; Jia, W.; Zhang, J. 2013: MKK5 regulates high light-induced gene expression of Cu/Zn superoxide dismutase 1 and 2 in Arabidopsis. Plant and Cell Physiology 54(7): 1217-1227

Kim, M.Y.; Choi, T.-Y.; Kim, J.-H.; Lee, J.H.; Kim, J.G.; Sohn, K.-C.; Yoon, K.-S.; Kim, C.D.; Lee, J.-H.; Yoon, T.-J. 2010: MKK6 increases the melanocyte dendricity through the regulation of Rho family GTPases. Journal of Dermatological Science 60(2): 114-119

Parray, A.A.; Baba, R.A.; Bhat, H.F.; Wani, L.; Mokhdomi, T.A.; Mushtaq, U.; Bhat, S.S.; Kirmani, D.; Kuchay, S.; Wani, M.M.; Khanday, F.A. 2014: MKK6 is upregulated in human esophageal, stomach, and colon cancers. Cancer Investigation 32(8): 416-422

Kotsinas, A.; Papanagnou, P.; Galanos, P.; Schramek, D.; Townsend, P.; Penninger, J.M.; Bartek, J.; Gorgoulis, V.G. 2014: MKK7 and ARF: new players in the DNA damage response scenery. Cell Cycle 13(8): 1227-1236

Sakai, H.; Sato, A.; Aihara, Y.; Ikarashi, Y.; Midorikawa, Y.; Kracht, M.; Nakagama, H.; Okamoto, K. 2014: MKK7 mediates miR-493-dependent suppression of liver metastasis of colon cancer cells. Cancer Science 105(4): 425-430

Haeusgen, W.; Herdegen, T.; Waetzig, V. 2011: MKK7γ1 reverses nerve growth factor signals: proliferation and cell death instead of neuritogenesis and protection. Cellular Signalling 23(8): 1281-1290

Hirayama, S.; Yamazaki, Y.; Kitamura, A.; Oda, Y.; Morito, D.; Okawa, K.; Kimura, H.; Cyr, D.M.; Kubota, H.; Nagata, K. 2008: MKKS is a centrosome-shuttling protein degraded by disease-causing mutations via CHIP-mediated ubiquitination. Molecular Biology of the Cell 19(3): 899-911

Jacob, V.; Sadler, K.C. 2014: MKKing the most of liver regeneration: an in vivo screen identifies the MKK4 pathway as a suppressor of regeneration. Hepatology 59(3): 1201-1203

Hinrichs, C.; Singh, V.; Xu, G.; Johnson, S. 2009: MKL for robust multi-modality AD classification. Medical Image Computing and Computer-Assisted Intervention: Miccai . International Conference on Medical Image Computing and Computer-Assisted Intervention 12(Part 2): 786-794

Elberg, G.; Chen, L.; Elberg, D.; Chan, M.D.; Logan, C.J.; Turman, M.A. 2008: MKL1 mediates TGF-beta1-induced alpha-smooth muscle actin expression in human renal epithelial cells. American Journal of Physiology. Renal Physiology 294(5): F1116-F1128

Xu, Y.; Li, B.; Bao, Y.-Z.; Zhang, X.-Y.; Zhu, Z.-Y.; Zhao, X.-F.; Shi, Y.-N.; Li, D.; Chen, S.-H.; Guo, Y.; Cui, C.-H. 2014: MKL1-184C>T gene polymorphism is associated with coronary artery disease in the Chinese Han population. Genetics and Molecular Research: Gmr 13(1): 590-597

Xie, L. 2014: MKL1/2 and ELK4 co-regulate distinct serum response factor (SRF) transcription programs in macrophages. Bmc Genomics 15: 301

Kalita, K.; Kuzniewska, B.; Kaczmarek, L. 2012: MKLs: co-factors of serum response factor (SRF) in neuronal responses. International Journal of Biochemistry and Cell Biology 44(9): 1444-1447

Perdiguero, E.; Kharraz, Y.; Serrano, A.L.; Muñoz-Cánoves, P. 2012: MKP-1 coordinates ordered macrophage-phenotype transitions essential for stem cell-dependent tissue repair. Cell Cycle 11(5): 877-886

Zhou, X.; Ferraris, J.D.; Dmitrieva, N.I.; Liu, Y.; Burg, M.B. 2008: MKP-1 inhibits high NaCl-induced activation of p38 but does not inhibit the activation of TonEBP/OREBP: opposite roles of p38alpha and p38delta. Proceedings of the National Academy of Sciences of the United States of America 105(14): 5620-5625

Jin, Y.; Pang, T.; Nelin, L.D.; Wang, W.; Wang, Y.; Yan, J.; Zhao, C. 2015: MKP-1 is a target of miR-210 and mediate the negative regulation of miR-210 inhibitor on hypoxic hPASMC proliferation. Cell Biology International 39(1): 113-120

Zhang, Y.; Reynolds, J.M.; Chang, S.H.; Martin-Orozco, N.; Chung, Y.; Nurieva, R.I.; Dong, C. 2009: MKP-1 is necessary for T cell activation and function. Journal of Biological Chemistry 284(45): 30815-30824

Kuwano, Y.; Kim, H.Ho.; Abdelmohsen, K.; Pullmann, R.; Martindale, J.L.; Yang, X.; Gorospe, M. 2008: MKP-1 mRNA stabilization and translational control by RNA-binding proteins HuR and NF90. Molecular and Cellular Biology 28(14): 4562-4575

Nicoletti-Carvalho, J.é E.; Lellis-Santos, C.; Yamanaka, T.S.; Nogueira, T.C.; Caperuto, L.C.; Leite, A.R.; Anhê, G.F.; Bordin, S. 2010: MKP-1 mediates glucocorticoid-induced ERK1/2 dephosphorylation and reduction in pancreatic ß-cell proliferation in islets from early lactating mothers. American Journal of Physiology. Endocrinology and Metabolism 299(6): E1006-E1015

Yu, H.; Sun, Y.; Haycraft, C.; Palanisamy, V.; Kirkwood, K.L. 2011: MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1. Cytokine 56(2): 245-255

Valerio, M.S.; Herbert, B.A.; Griffin, A.C.; Wan, Z.; Hill, E.G.; Kirkwood, K.L. 2014: MKP-1 signaling events are required for early osteoclastogenesis in lineage defined progenitor populations by disrupting RANKL-induced NFATc1 nuclear translocation. Bone 60: 16-25

Berk, E.; Muthuswamy, R. 2011: MKP-1 signaling translates innate signals into adaptive responses. ImmunoTherapy 3(12): 1427-1428

Manetsch, M.; Che, W.; Seidel, P.; Chen, Y.; Ammit, A.J. 2012: MKP-1: a negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells. Cellular Signalling 24(4): 907-913

Lawan, A.; Torrance, E.; Al-Harthi, S.; Shweash, M.; Alnasser, S.; Neamatallah, T.; Schroeder, J.; Plevin, R. 2012: MKP-2: out of the DUSP-bin and back into the limelight. Biochemical Society Transactions 40(1): 235-239

Masuda, K.; Katagiri, C.; Nomura, M.; Sato, M.; Kakumoto, K.; Akagi, T.; Kikuchi, K.; Tanuma, N.; Shima, H. 2010: MKP-7, a JNK phosphatase, blocks ERK-dependent gene activation by anchoring phosphorylated ERK in the cytoplasm. Biochemical and Biophysical Research Communications 393(2): 201-206

Nizamutdinova, I.T.; Kim, Y.M.; Lee, J.H.; Chang, K.C.; Kim, H.J. 2012: MKP-7, a negative regulator of JNK, regulates VCAM-1 expression through IRF-1. Cellular Signalling 24(4): 866-872

Shin, H-Sung.; Yoo, I-Hwa.; Kim, Y-Jae.; Lee, J-Yun.; Kim, H-Bai.; Jin, S.; Ha, U-Hwan. 2010: MKP1 regulates the induction of MCP1 by Streptococcus pneumoniae pneumolysin in human epithelial cells. Molecules and Cells 30(3): 263-270

Ha, U-Hwan.; Lim, J.Hyang.; Kim, H-Joong.; Wu, W.; Jin, S.; Xu, H.; Li, J-Dong. 2008: MKP1 regulates the induction of MUC5AC mucin by Streptococcus pneumoniae pneumolysin by inhibiting the PAK4-JNK signaling pathway. Journal of Biological Chemistry 283(45): 30624-30631

Shin, H.-S.; Yoo, I.-H.; Kim, Y.-J.; Kim, H.-B.; Jin, S.; Ha, U.-H. 2010: MKP1 regulates the induction of inflammatory response by pneumococcal pneumolysin in human epithelial cells. Fems Immunology and Medical Microbiology 60(2): 171-178

Cortes-Sempere, M.ía.; Chattopadhyay, S.; Rovira, A.; Rodriguez-Fanjul, V.; Belda-Iniesta, C.; Tapia, M.; Cejas, P.; Machado-Pinilla, R.; Manguan-García, C.; Sánchez-Pérez, I.; Nistal, M.; Moratilla, C.; de Castro-Carpeño, J.; Gonzalez-Barón, M.; Albanell, J.; Perona, R. 2009: MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer. Cancer Letters 286(2): 206-216

Vaitheesvaran, B.; LeRoith, D.; Kurland, I.J. 2010: MKR mice have increased dynamic glucose disposal despite metabolic inflexibility, and hepatic and peripheral insulin insensitivity. Diabetologia 53(10): 2224-2232

Ko, A.; Lee, E.-W.; Yeh, J.-Y.; Yang, M.-R.; Oh, W.; Moon, J.-S.; Song, J. 2010: MKRN1 induces degradation of West Nile virus capsid protein by functioning as an E3 ligase. Journal of Virology 84(1): 426-436

Yaqub, F. 2013: MKRN3 and central precocious puberty. LANCET. Diabetes and Endocrinology 1(Suppl 1): S15

Schreiner, F.; Gohlke, B.; Hamm, M.; Korsch, E.; Woelfle, J. 2014: MKRN3 mutations in familial central precocious puberty. Hormone Research in Paediatrics 82(2): 122-126

Williams, C.L.; Li, C.; Kida, K.; Inglis, P.N.; Mohan, S.; Semenec, L.; Bialas, N.J.; Stupay, R.M.; Chen, N.; Blacque, O.E.; Yoder, B.K.; Leroux, M.R. 2011: MKS and NPHP modules cooperate to establish basal body/transition zone membrane associations and ciliary gate function during ciliogenesis. Journal of Cell Biology 192(6): 1023-1041

Gunay-Aygun, M.; Parisi, M.A.; Doherty, D.; Tuchman, M.; Tsilou, E.; Kleiner, D.E.; Huizing, M.; Turkbey, B.; Choyke, P.; Guay-Woodford, L.; Heller, T.; Szymanska, K.; Johnson, C.A.; Glass, I.; Gahl, W.A. 2009: MKS3-related ciliopathy with features of autosomal recessive polycystic kidney disease, nephronophthisis, and Joubert Syndrome. Journal of Pediatrics 155(3): 386-92.E1

Liu, J.; Wang, Q.-C.; Cui, X.-S.; Wang, Z.-B.; Kim, N.-H.; Sun, S.-C. 2013: MKlp2 inhibitor paprotrain affects polar body extrusion during mouse oocyte maturation. Reproductive Biology and Endocrinology: Rb&e 11: 117

Som, A. 2009: ML or NJ-MCL? a comparison between two robust phylogenetic methods. Computational Biology and Chemistry 33(5): 373-378

Saquib, S.S.; Bouman, C.A.; Sauer, K. 1998: ML parameter estimation for Markov random fields with applications to Bayesian tomography. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 7(7): 1029-1044

De Bernardi, E.; Fiorani Gallotta, F.; Gianoli, C.; Zito, F.; Gerundini, P.; Baselli, G. 2010: ML segmentation strategies for object interference compensation in FDG-PET lesion quantification. Methods of Information in Medicine 49(5): 537-541

Yuan, K.-H.; Yang-Wallentin, F.; Bentler, P.M. 2012: ML versus Mi for Missing Data with Violation of Distribution Conditions. Sociological Methods and Research 41(4): 598-629

Corral, I.és.; Yáñez, M. 2011: ML(n)]2+ doubly charged systems: modeling, bonding, life times and unimolecular reactivity. Physical Chemistry Chemical Physics: Pccp 13(33): 14848-14864

Rezaei, A.; Defrise, M.; Nuyts, J. 2014: ML-reconstruction for TOF-PET with simultaneous estimation of the attenuation factors. IEEE Transactions on Medical Imaging 33(7): 1563-1572

Geluk, A.; van den Eeden, S.J.F.; Dijkman, K.; Wilson, L.; Kim, H.J.; Franken, K.L.M.C.; Spencer, J.S.; Pessolani, M.C.V.; Pereira, G.M.B.; Ottenhoff, T.H.M. 2011: ML1419c peptide immunization induces Mycobacterium leprae-specific HLA-A*0201-restricted CTL in vivo with potential to kill live mycobacteria. Journal of Immunology 187(3): 1393-1402

Ryu, M.-H.; Kang, Y.-K. 2009: ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer. Expert Review of Anticancer Therapy 9(12): 1745-1751

Youngsaye, W.; Hartland, C.L.; Morgan, B.J.; Ting, A.; Nag, P.P.; Vincent, B.; Mosher, C.A.; Bittker, J.A.; Dandapani, S.; Palmer, M.; Whitesell, L.; Lindquist, S.; Schreiber, S.L.; Munoz, B. 2013: ML212: a small-molecule probe for investigating fluconazole resistance mechanisms in Candida albicans. Beilstein Journal of Organic Chemistry 9: 1501-1507

Hakenjos, J.P.; Bejai, S.; Ranftl, Q.; Behringer, C.; Vlot, A.C.; Absmanner, B.; Hammes, U.; Heinzlmeir, S.; Kuster, B.; Schwechheimer, C. 2013: ML3 is a NEDD8- and ubiquitin-modified protein. Plant Physiology 163(1): 135-149

Qu, Y.; Fu, L.; Han, W.; Zhu, Y.; Wang, J. 2014: MLAOS: a multi-point linear array of optical sensors for coniferous foliage clumping index measurement. Sensors 14(5): 9271-9289

Medici, M.C.; Tummolo, F.; Calderaro, A.; Elia, G.; Banyai, K.àn.; De Conto, F.; Arcangeletti, M.C.; Chezzi, C.; Buonavoglia, C.; Martella, V. 2014: MLB1 astrovirus in children with gastroenteritis, Italy. Emerging Infectious Diseases 20(1): 169-170

Schiefer, H.; Seelentag, W.W.; Roth, J.; Krusche, B. 2008: MLC positioning checks and calibration with a portal imaging system. Zeitschrift für Medizinische Physik 18(1): 51-58

Mamalui-Hunter, M.; Li, H.; Low, D.A. 2008: MLC quality assurance using EPID: a fitting technique with subpixel precision. Medical Physics 35(6): 2347-2355

Davies, G.A.; Poludniowski, G.; Webb, S. 2011: MLC tracking for Elekta VMAT: a modelling study. Physics in Medicine and Biology 56(23): 7541-7554

Lanciotti, A.; Brignone, M.S.; Camerini, S.; Serafini, B.; Macchia, G.; Raggi, C.; Molinari, P.; Crescenzi, M.; Musumeci, M.; Sargiacomo, M.; Aloisi, F.; Petrucci, T.C.; Ambrosini, E. 2010: MLC1 trafficking and membrane expression in astrocytes: role of caveolin-1 and phosphorylation. Neurobiology of Disease 37(3): 581-595

Quintard, H.; Lorivel, T.; Gandin, C.; Lazdunski, M.; Heurteaux, C. 2014: MLC901, a Traditional Chinese Medicine induces neuroprotective and neuroregenerative benefits after traumatic brain injury in rats. Neuroscience 277: 72-86

Quintard, H.; Borsotto, M.; Veyssiere, J.; Gandin, C.; Labbal, F.; Widmann, C.; Lazdunski, M.; Heurteaux, C. 2011: MLC901, a traditional Chinese medicine protects the brain against global ischemia. Neuropharmacology 61(4): 622-631

Park, S.Y.; Shim, J.H.; Kim, M.; Sun, Y.H.; Kwak, H.S.; Yan, X.; Choi, B.-C.; Im, C.; Sim, S.S.; Jeong, J.H.; Kim, I.K.; Min, Y.S.; Sohn, U.D. 2010: MLCK and PKC Involvements via Gi and Rho a Protein in Contraction by the Electrical Field Stimulation in Feline Esophageal Smooth Muscle. Korean Journal of Physiology and Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology 14(1): 29-35

Leitman, E.M.; Tewari, A.; Horn, M.; Urbanski, M.; Damanakis, E.; Einheber, S.; Salzer, J.L.; de Lanerolle, P.; Melendez-Vasquez, C.V. 2011: MLCK regulates Schwann cell cytoskeletal organization, differentiation and myelination. Journal of Cell Science 124(Part 22): 3784-3796

Yu, D.; Marchiando, A.M.; Weber, C.R.; Raleigh, D.R.; Wang, Y.; Shen, L.; Turner, J.R. 2010: MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proceedings of the National Academy of Sciences of the United States of America 107(18): 8237-8241

Deng, M.; Ding, W.; Min, X.; Xia, Y. 2011: MLCK-independent phosphorylation of MLC20 and its regulation by MAP kinase pathway in human bladder smooth muscle cells. Cytoskeleton 68(3): 139-149

Wandt, H.; Schäkel, U.; Kroschinsky, F.; Prange-Krex, G.; Mohr, B.; Thiede, C.; Pascheberg, U.; Soucek, S.; Schaich, M.; Ehninger, G. 2008: MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients. Blood 111(4): 1855-1861

Sugaya, Y. 2012: MLEP: an R package for exploring the maximum likelihood estimates of penetrance parameters. Bmc Research Notes 5: 465

Wyatt, A.W.; Ragge, N. 2009: MLGA: a cost-effective approach to the diagnosis of gene deletions in eye development anomalies. Molecular Vision 15: 1445-1448

Hu, F.; Lin, Y.; Tang, J. 2014: MLGO: phylogeny reconstruction and ancestral inference from gene-order data. Bmc Bioinformatics 15: 354

Allan, J.M.; Shorto, J.; Adlard, J.; Bury, J.; Coggins, R.; George, R.; Katory, M.; Quirke, P.; Richman, S.; Scott, D.; Scott, K.; Seymour, M.; Travis, L.B.; Worrillow, L.J.; Bishop, D.T.; Cox, A. 2008: MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer. International Journal of Cancer 123(10): 2456-2459

Raptis, S.; Mrkonjic, M.; Green, R.C.; Pethe, V.V.; Monga, N.; Chan, Y.Man.; Daftary, D.; Dicks, E.; Younghusband, B.H.; Parfrey, P.S.; Gallinger, S.S.; McLaughlin, J.R.; Knight, J.A.; Bapat, B. 2007: MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. Journal of the National Cancer Institute 99(6): 463-474

Santibanez Koref, M.; Wilson, V.; Cartwright, N.; Cunnington, M.S.; Mathers, J.C.; Bishop, D.T.; Curtis, A.; Dunlop, M.G.; Burn, J. 2010: MLH1 Differential allelic expression in mutation carriers and controls. Annals of Human Genetics 74(6): 479-488

Schneider, B.G.; Sahni, D.; Torres, J.C.; Dushku, N.; Reid, T.W. 2007: MLH1 and MSH2 expression in pterygia. Cornea 26(4): 468-472

Tanyi, M.; Olasz, J.; Tanyi, J.L.; Tóth, L.; Antal-Szalmás, P.; Ress, Z.; Bubán, T.; Palatka, K.; András, C.; Urbancsek, H.; Garami, Z.; Csuka, O.; Damjanovich, L. 2014: MLH1 and MSH2 mutation screening in HNPCC families of Hungary - two new MMR gene mutations. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 40(11): 1445-1452

Muñiz-Mendoza, R.; Ayala-Madrigal, M.L.; Partida-Pérez, M.; Peregrina-Sandoval, J.; Leal-Ugarte, E.; Macías-Gómez, N.; Peralta-Leal, V.; Meza-Espinoza, J.P.; Moreno-Ortiz, J.M.; Ramírez-Ramírez, R.; Suárez-Villanueva, S.; Gutiérrez-Angulo, M. 2012: MLH1 and XRCC1 polymorphisms in Mexican patients with colorectal cancer. Genetics and Molecular Research: Gmr 11(3): 2315-2320

Flanagan, S.A.; Krokosky, C.M.; Mannava, S.; Nikiforov, M.A.; Shewach, D.S. 2008: MLH1 deficiency enhances radiosensitization with 5-fluorodeoxyuridine by increasing DNA mismatches. Molecular Pharmacology 74(3): 863-871

Borràs, E.; Pineda, M.; Blanco, I.; Jewett, E.M.; Wang, F.; Teulé, A.; Caldés, T.; Urioste, M.; Martínez-Bouzas, C.; Brunet, J.; Balmaña, J.; Torres, A.ón.; Ramón y Cajal, T.; Sanz, J.; Pérez-Cabornero, L.ía.; Castellví-Bel, S.; Alonso, A.; Lanas, A.; González, S.; Moreno, V.íc.; Gruber, S.B.; Rosenberg, N.A.; Mukherjee, B.; Lázaro, C.; Capellá, G. 2010: MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families. Cancer Research 70(19): 7379-7391

Jackson, T.; Ahmed, M.A.H.; Seth, R.; Jackson, D.; Ilyas, M. 2011: MLH1 function is context dependent in colorectal cancers. Journal of Clinical Pathology 64(2): 141-145

Hitchins, M.P.; Ward, R.L. 2008: MLH1 germ-line epimutations: is there strong evidence of its inheritance?. Gastroenterology 134(1): 359-360

Xu, J.-L.; Yin, Z.-Q.; Huang, M.-D.; Wang, X.-F.; Gao, W.; Liu, L.-X.; Wang, R.-S.; Huang, P.-W.; Yin, Y.-M.; Liu, P.; Shu, Y.-Q. 2012: MLH1 polymorphisms and cancer risk: a meta-analysis based on 33 case-control studies. Asian Pacific Journal of Cancer Prevention: Apjcp 13(3): 901-907

Zhou, H.-H.; Yan, S.-Y.; Zhou, X.-Y.; Du, X.; Zhang, T.-M.; Cai, X.; Lu, Y.-M.; Cai, S.-J.; Shi, D.-R. 2008: MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families. World Journal of Gastroenterology 14(48): 7329-7334

Li, X.; Yao, X.; Wang, Y.; Hu, F.; Wang, F.; Jiang, L.; Liu, Y.; Wang, D.; Sun, G.; Zhao, Y. 2013: MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features. Plos one 8(3): E59064

Gay, L.J.; Arends, M.J.; Mitrou, P.N.; Bowman, R.; Ibrahim, A.E.; Happerfield, L.; Luben, R.; McTaggart, A.; Ball, R.Y.; Rodwell, S.A. 2011: MLH1 promoter methylation, diet, and lifestyle factors in mismatch repair deficient colorectal cancer patients from EPIC-Norfolk. Nutrition and Cancer 63(7): 1000-1010

Raymond, V.M.; Morris, A.M.; Hafez, K.S.; Greenson, J.K. 2015: MLH1 promotor hypermethylation does not rule out a diagnosis of Lynch syndrome: a case report. Familial Cancer 14(1): 77-80

Imesch, P.; Dedes, K.J.; Furlato, M.; Fink, D.; Fedier, A. 2009: MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin a in colon tumor cells. International Journal of Oncology 35(3): 631-640

Savio, A.J.; Lemire, M.; Mrkonjic, M.; Gallinger, S.; Zanke, B.W.; Hudson, T.J.; Bapat, B. 2012: MLH1 region polymorphisms show a significant association with CpG island shore methylation in a large cohort of healthy individuals. Plos one 7(12): E51531

Kim, W-Ju.; Rajasekaran, B.; Brown, K.D. 2007: MLH1- and ATM-dependent MAPK signaling is activated through c-Abl in response to the alkylator N-methyl-N'-nitro-N'-nitrosoguanidine. Journal of Biological Chemistry 282(44): 32021-32031

Whiffin, N.; Broderick, P.; Lubbe, S.J.; Pittman, A.M.; Penegar, S.; Chandler, I.; Houlston, R.S. 2011: MLH1-93G > a is a risk factor for MSi colorectal cancer. Carcinogenesis 32(8): 1157-1161

Imesch, P.; Goerens, A.; Fink, D.; Fedier, A.é 2012: MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine) in vitro. Oncology Letters 3(2): 441-444

Donehower, L.A.; Creighton, C.J.; Schultz, N.; Shinbrot, E.; Chang, K.; Gunaratne, P.H.; Muzny, D.; Sander, C.; Hamilton, S.R.; Gibbs, R.A.; Wheeler, D. 2013: MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes. Journal of Pathology 229(1): 99-110

Govil, M.; Segre, A.M.; Vieland, V.J. 2008: MLIP: using multiple processors to compute the posterior probability of linkage. Bmc Bioinformatics 9 Suppl. 6: S2

Jiang, J.X.; Török, N.J. 2014: MLK3 as a regulator of disease progression in Non-alcoholic steatohepatitis. Liver International: Official Journal of the International Association for the Study of the Liver 34(8): 1131-1132

Jung, S.K.; Ha, S.J.; Kim, Y.A.; Lee, J.; Lim, T.-G.; Kim, Y.T.; Lee, N.H.; Park, J.S.; Yeom, M.-H.; Lee, H.J.; Lee, K.W. 2015: MLK3 is a novel target of dehydroglyasperin D for the reduction in UVB-induced COX-2 expression in vitro and in vivo. Journal of Cellular and Molecular Medicine 19(1): 135-142

Lee, H-Sung.; Hwang, C.Young.; Shin, S-Young.; Kwon, K-Sun.; Cho, K-Hyun. 2014: MLK3 is part of a feedback mechanism that regulates different cellular responses to reactive oxygen species. Science Signaling 7(328): Ra52

Swenson-Fields, K.I.; Sandquist, J.C.; Rossol-Allison, J.; Blat, I.C.; Wennerberg, K.; Burridge, K.; Means, A.R. 2008: MLK3 limits activated Galphaq signaling to Rho by binding to p63RhoGEF. Molecular Cell 32(1): 43-56

Zhang, J.; Lu, L.; Xiong, Y.; Qin, W.; Zhang, Y.; Qian, Y.; Jiang, H.; Liu, W. 2014: MLK3 promotes melanoma proliferation and invasion and is a target of microRNA-125b. Clinical and Experimental Dermatology 39(3): 376-384

Zou, W.; Greenblatt, M.B.; Shim, J.-H.; Kant, S.; Zhai, B.; Lotinun, S.; Brady, N.; Hu, D.Z.; Gygi, S.P.; Baron, R.; Davis, R.J.; Jones, D.; Glimcher, L.H. 2011: MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice. Journal of Clinical Investigation 121(11): 4383-4392

Polesskaya, O.; Wong, C.; Lebron, L.; Chamberlain, J.M.; Gelbard, H.A.; Goodfellow, V.; Kim, M.; Daiss, J.L.; Dewhurst, S. 2014: MLK3 regulates fMLP-stimulated neutrophil motility. Molecular Immunology 58(2): 214-222

Chen, J.; Gallo, K.A. 2012: MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis. Cancer Research 72(16): 4130-4140

Zhou, F.; Xu, Y.; Hou, X-Yu. 2014: MLK3-MKK3/6-P38MAPK cascades following N-methyl-D-aspartate receptor activation contributes to amyloid-β peptide-induced apoptosis in SH-SY5Y cells. Journal of Neuroscience Research 92(6): 808-817

Dondelinger, Y.; Declercq, W.; Montessuit, S.; Roelandt, R.; Goncalves, A.; Bruggeman, I.; Hulpiau, P.; Weber, K.; Sehon, C.A.; Marquis, R.W.; Bertin, J.; Gough, P.J.; Savvides, S.; Martinou, J.-C.; Bertrand, M.J.M.; Vandenabeele, P. 2014: MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Reports 7(4): 971-981

Caslini, C.; Connelly, J.A.; Serna, A.; Broccoli, D.; Hess, J.L. 2009: MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription. Molecular and Cellular Biology 29(16): 4519-4526

Yokoyama, A.; Ficara, F.; Murphy, M.J.; Meisel, C.; Hatanaka, C.; Kitabayashi, I.; Cleary, M.L. 2013: MLL becomes functional through intra-molecular interaction not by proteolytic processing. Plos one 8(9): E73649

Mater, D.V.; Goodman, B.K.; Wang, E.; Gaca, A.M.; Wechsler, D.S. 2012: MLL duplication in a pediatric patient with B-cell lymphoblastic lymphoma. Journal of Pediatric Hematology/Oncology 34(3): E120-E123

Muntean, A.G.; Chen, W.; Jones, M.; Granowicz, E.M.; Maillard, I.; Hess, J.L. 2013: MLL fusion protein-driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interaction. Blood 122(11): 1914-1922

Okuda, H.; Kawaguchi, M.; Kanai, A.; Matsui, H.; Kawamura, T.; Inaba, T.; Kitabayashi, I.; Yokoyama, A. 2014: MLL fusion proteins link transcriptional coactivators to previously active CpG-rich promoters. Nucleic Acids Research 42(7): 4241-4256

Wang, Q.-F.; Wu, G.; Mi, S.; He, F.; Wu, J.; Dong, J.; Luo, R.T.; Mattison, R.; Kaberlein, J.J.; Prabhakar, S.; Ji, H.; Thirman, M.J. 2011: MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome. Blood 117(25): 6895-6905

Van der Linden, M.H.; Willekes, M.; van Roon, E.; Seslija, L.; Schneider, P.; Pieters, R.; Stam, R.W. 2014: MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL. Cell Cycle 13(5): 834-844

Liu, H.; Cheng, E.H.Y.; Hsieh, J.J.D. 2009: MLL fusions: pathways to leukemia. Cancer Biology and Therapy 8(13): 1204-1211

Tang, G.; DiNardo, C.; Zhang, L.; Ravandi, F.; Khoury, J.D.; Huh, Y.O.; Muzzafar, T.; Medeiros, L.J.; Wang, S.A.; Bueso-Ramos, C.E. 2015: MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation. Human Pathology 46(1): 65-73

Aljurf, M.; Saleh, A.J.M.; Ahmed, S.O. 2011: MLL gene in maternal and infantile acute lymphoblastic leukemia and the effect of estrogen. Leukemia Research 35(7): E127

Sam, T.N.; Kersey, J.H.; Linabery, A.M.; Johnson, K.J.; Heerema, N.A.; Hilden, J.M.; Davies, S.M.; Reaman, G.H.; Ross, J.A. 2012: MLL gene rearrangements in infant leukemia vary with age at diagnosis and selected demographic factors: a Children's Oncology Group (COG) study. Pediatric Blood and Cancer 58(6): 836-839

Ansari, K.I.; Mishra, B.P.; Mandal, S.S. 2009: MLL histone methylases in gene expression, hormone signaling and cell cycle. Frontiers in Bioscience 14(9): 3483-3495

Brassesco, M.ía.S.; Montaldi, A.P.; Gras, D.E.; de Paula Queiroz, R.G.; Martinez-Rossi, N.M.; Tone, L.G.; Sakamoto-Hojo, E.T. 2009: MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals. Genetics and Molecular Biology 32(2): 234-241

Douet-Guilbert, N.; Eveillard, J-Richard.; Meyer, C.; Ugo, Vérie.; Le Bris, M-Josée.; Basinko, A.; Morel, Fédéric.; Marschalek, R.; De Braekeleer, M. 2014: MLL partner genes in secondary acute lymphoblastic leukemia: report of a new partner PRRC1 and review of the literature. Leukemia Research 38(11): 1316-1319

Park, T.Sung.; Lee, S.Tae.; Song, J.; Lee, K-A.; Lee, S-Guk.; Kim, J.; Suh, B.; Kim, S.Jung.; Lee, J-Han.; Park, R.; Choi, J.Rak. 2008: MLL rearrangement with t(6;11)(q15;q23) as a sole abnormality in a patient with de novo acute myeloid leukemia: conventional cytogenetics, FISH, and multicolor FISH analyses for detection of rare MLL-related chromosome abnormalities. Cancer Genetics and Cytogenetics 187(1): 50-53

Zangrando, A.; Dell'orto, M.C.; Te Kronnie, G.; Basso, G. 2009: MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures. Bmc Medical Genomics 2: 36

Manara, E.; Baron, E.; Tregnago, C.; Aveic, S.; Bisio, V.; Bresolin, S.; Masetti, R.; Locatelli, F.; Basso, G.; Pigazzi, M. 2014: MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia. Blood 124(2): 263-272

Monroe, S.C.; Jo, S.Y.; Sanders, D.S.; Basrur, V.; Elenitoba-Johnson, K.S.; Slany, R.K.; Hess, J.L. 2011: MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia. Experimental hematology 39(1): 77-86.e1-5

Wu, B.; Li, F.; Zou, S. 2014: MLL-AF9 rearrangement in myeloid sarcomas involving the breast. Annals of Hematology 93(4): 709-710

Thiel, A.T.; Blessington, P.; Zou, T.; Feather, D.; Wu, X.; Yan, J.; Zhang, H.; Liu, Z.; Ernst, P.; Koretzky, G.A.; Hua, X. 2010: MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele. Cancer Cell 17(2): 148-159

De Braekeleer, E.; Douet-Guilbert, N.; Meyer, C.; Morel, F.éd.ér.; Marschalek, R.; De Braekeleer, M. 2012: MLL-ELL fusion gene in two infants with acute monoblastic leukemia and myeloid sarcoma. Leukemia and Lymphoma 53(6): 1222-1224

Jaracz-Ros, A.; Lewandowski, D.; Barroca, V.; Lavau, C.; Roméo, P.-H. 2011: MLL-ENL leukemia burden initiated in femoral diaphysis and preceded by mature B-cell depletion. Haematologica 96(12): 1770-1778

Launay, E.; Henry, C.; Meyer, C.; Chappé, C.él.; Taque, S.; Boulland, M.-L.; Ben Abdelali, R.; Dugay, F.éd.ér.; Marschalek, R.; Bastard, C.; Fest, T.; Gandemer, V.; Belaud-Rotureau, M.-A. 2014: MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t(11;22)(q23;q11). Leukemia and Lymphoma 55(3): 662-667

Cerveira, N.; Bizarro, S.; Teixeira, M.R. 2011: MLL-SEPTIN gene fusions in hematological malignancies. Biological Chemistry 392(8-9): 713-724

Burbury, K.L.; Bishton, M.J.; Johnstone, R.W.; Dickinson, M.J.; Szer, J.; Prince, H.M. 2011: MLL-aberrant leukemia: complete cytogenetic remission following treatment with a histone deacetylase inhibitor (HDACi). Annals of Hematology 90(7): 847-849

Juszczynski, P.; Rodig, S.J.; Ouyang, J.; O'Donnell, E.; Takeyama, K.; Mlynarski, W.; Mycko, K.; Szczepanski, T.; Gaworczyk, A.; Krivtsov, A.; Faber, J.; Sinha, A.U.; Rabinovich, G.A.; Armstrong, S.A.; Kutok, J.L.; Shipp, M.A. 2010: MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16(7): 2122-2130

Bernt, K.M.; Zhu, N.; Sinha, A.U.; Vempati, S.; Faber, J.; Krivtsov, A.V.; Feng, Z.; Punt, N.; Daigle, A.; Bullinger, L.; Pollock, R.M.; Richon, V.M.; Kung, A.L.; Armstrong, S.A. 2011: MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell 20(1): 66-78

Fu, J.-F.; Hsu, C.-L.; Shih, L.-Y. 2010: MLL/AF10(OM-LZ)-immortalized cells expressed cytokines and induced host cell proliferation in a mouse bone marrow transplantation model. International Journal of Cancer 126(7): 1621-1629

Gindin, T.; Murty, V.; Alobeid, B.; Bhagat, G. 2015: MLL/KMT2A translocations in diffuse large B-cell lymphomas. Hematological Oncology 33(4): 239-246

Djabali, M. 2013: MLL1 and menin: not partners in crime?. Blood 122(12): 1995

Wang, X.; Zhu, K.; Li, S.; Liao, Y.; Du, R.; Zhang, X.; Shu, H.-B.; Guo, A.-Y.; Li, L.; Wu, M. 2012: MLL1, a H3K4 methyltransferase, regulates the TNFα-stimulated activation of genes downstream of NF-κB. Journal of Cell Science 125(Part 17): 4058-4066

Wu, M.; Shu, H.-B. 2011: MLL1/WDR5 complex in leukemogenesis and epigenetic regulation. Chinese Journal of Cancer 30(4): 240-246

Miyake, N.; Koshimizu, E.; Okamoto, N.; Mizuno, S.; Ogata, T.; Nagai, T.; Kosho, T.; Ohashi, H.; Kato, M.; Sasaki, G.; Mabe, H.; Watanabe, Y.; Yoshino, M.; Matsuishi, T.; Takanashi, J.-i.; Shotelersuk, V.; Tekin, M.; Ochi, N.; Kubota, M.; Ito, N.; Ihara, K.; Hara, T.; Tonoki, H.; Ohta, T.; Saito, K.; Matsuo, M.; Urano, M.; Enokizono, T.; Sato, A.; Tanaka, H.; Ogawa, A.; Fujita, T.; Hiraki, Y.; Kitanaka, S.; Matsubara, Y.; Makita, T.; Taguri, M.; Nakashima, M.; Tsurusaki, Y.; Saitsu, H.; Yoshiura, K.-i.; Matsumoto, N.; Niikawa, N. 2013: MLL2 and KDM6A mutations in patients with Kabuki syndrome. American Journal of Medical Genetics. Part a 161a (9): 2234-2243

Andreu-Vieyra, C.V.; Chen, R.; Agno, J.E.; Glaser, S.; Anastassiadis, K.; Stewart, A.F.; Matzuk, M.M. 2010: MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing. Plos Biology 8(8)

Banka, S.; Howard, E.; Bunstone, S.; Chandler, K.E.; Kerr, B.; Lachlan, K.; McKee, S.; Mehta, S.G.; Tavares, A.L.T.; Tolmie, J.; Donnai, D. 2013: MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome. Clinical Genetics 83(5): 467-471

Paulussen, A.ée.D.C.; Stegmann, A.P.A.; Blok, M.J.; Tserpelis, D.; Posma-Velter, C.; Detisch, Y.; Smeets, E.E.J.G.L.; Wagemans, A.; Schrander, J.J.P.; van den Boogaard, M.-J.é H.; van der Smagt, J.; van Haeringen, A.; Stolte-Dijkstra, I.; Kerstjens-Frederikse, W.S.; Mancini, G.M.; Wessels, M.W.; Hennekam, R.C.M.; Vreeburg, M.; Geraedts, J.; de Ravel, T.; Fryns, J.-P.; Smeets, H.J.; Devriendt, K.; Schrander-Stumpel, C.T.R.M. 2011: MLL2 mutation spectrum in 45 patients with Kabuki syndrome. Human Mutation 32(2): E2018-E2025

Chen, C.; Liu, Y.; Rappaport, A.R.; Kitzing, T.; Schultz, N.; Zhao, Z.; Shroff, A.S.; Dickins, R.A.; Vakoc, C.R.; Bradner, J.E.; Stock, W.; LeBeau, M.M.; Shannon, K.M.; Kogan, S.; Zuber, J.; Lowe, S.W. 2014: MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell 25(5): 652-665

Zhang, Y.; Wong, J.; Klinger, M.; Tran, M.T.; Shannon, K.M.; Killeen, N. 2009: MLL5 contributes to hematopoietic stem cell fitness and homeostasis. Blood 113(7): 1455-1463

Milne, T.A. 2014: MLL5 expression as a biomarker for DNA hypermethylation and sensitivity to epigenetic therapy. Haematologica 99(9): 1405-1407

Liu, H.; Westergard, T.D.; Hsieh, J.J.-D. 2009: MLL5 governs hematopoiesis: a step closer. Blood 113(7): 1395-1396

Liu, J.; Cheng, F.; Deng, L.-W. 2012: MLL5 maintains genomic integrity by regulating the stability of the chromosomal passenger complex through a functional interaction with Borealin. Journal of Cell Science 125(Part 19): 4676-4685

Sebastian, S.; Sreenivas, P.; Sambasivan, R.; Cheedipudi, S.; Kandalla, P.; Pavlath, G.K.; Dhawan, J. 2009: MLL5, a trithorax homolog, indirectly regulates H3K4 methylation, represses cyclin A2 expression, and promotes myogenic differentiation. Proceedings of the National Academy of Sciences of the United States of America 106(12): 4719-4724

Burmeister, T. 2010: MLL: exploring the methylome. Blood 115(23): 4627-4628

Yamada, M.; Clark, J.; Iulianella, A. 2014: MLLT11/AF1q is differentially expressed in maturing neurons during development. Gene Expression Patterns: Gep 15(2): 80-87

Pina, C.; May, G.; Soneji, S.; Hong, D.; Enver, T. 2008: MLLT3 regulates early human erythroid and megakaryocytic cell fate. Cell Stem Cell 2(3): 264-273

Qu, J.; Zhou, M.; Song, Q.; Hong, E.E.; Smith, A.D. 2013: MLML: consistent simultaneous estimates of DNA methylation and hydroxymethylation. Bioinformatics 29(20): 2645-2646

Shi, J.Q.; Lasky, K.; Shinde, V.; Stringer, B.; Qian, M.G.; Liao, D.; Liu, R.; Driscoll, D.; Nestor, M.T.; Amidon, B.S.; Rao, Y.; Duffey, M.O.; Manfredi, M.G.; Vos, T.J.; D' Amore, N.; Hyer, M.L. 2012: MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphoma. Molecular Cancer Therapeutics 11(9): 2045-2053

Wei, X.; Zhou, P.; Lin, X.; Lin, Y.; Wu, S.; Diao, P.; Xie, H.; Xie, K.; Tang, P. 2014: MLN2238 synergizes BH3 mimetic ABT-263 in castration-resistant prostate cancer cells by induction of NOXA. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(10): 10213-10221

Gu, J.J.; Hernandez-Ilizaliturri, F.J.; Mavis, C.; Czuczman, N.M.; Deeb, G.; Gibbs, J.; Skitzki, J.J.; Patil, R.; Czuczman, M.S. 2013: MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical models. Anti-Cancer Drugs 24(10): 1030-1038

Vergunst, C.E.; Gerlag, D.M.; von Moltke, L.; Karol, M.; Wyant, T.; Chi, X.; Matzkin, E.; Leach, T.; Tak, P.P. 2009: MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study. Arthritis and Rheumatism 60(12): 3572-3581

Hakenjos, J.P.; Richter, R.é; Dohmann, E.M.N.; Katsiarimpa, A.; Isono, E.; Schwechheimer, C. 2011: MLN4924 is an efficient inhibitor of NEDD8 conjugation in plants. Plant Physiology 156(2): 527-536

El-Mesery, M.; Seher, A.; Stühmer, T.; Siegmund, D.; Wajant, H. 2015: MLN4924 sensitizes monocytes and maturing dendritic cells for TNF-dependent and -independent necroptosis. British Journal of Pharmacology 172(5): 1222-1236

Milhollen, M.A.; Traore, T.; Adams-Duffy, J.; Thomas, M.P.; Berger, A.J.; Dang, L.; Dick, L.R.; Garnsey, J.J.; Koenig, E.; Langston, S.P.; Manfredi, M.; Narayanan, U.; Rolfe, M.; Staudt, L.M.; Soucy, T.A.; Yu, J.; Zhang, J.; Bolen, J.B.; Smith, P.G. 2010: MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma. Blood 116(9): 1515-1523

Gu, Y.; Kaufman, J.L.; Bernal, L.; Torre, C.; Matulis, S.M.; Harvey, R.D.; Chen, J.; Sun, S.-Y.; Boise, L.H.; Lonial, S. 2014: MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells. Blood 123(21): 3269-3276

Nawrocki, S.T.; Griffin, P.; Kelly, K.R.; Carew, J.S. 2012: MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy. Expert Opinion on Investigational Drugs 21(10): 1563-1573

Noble, C.G.; Song, H. 2007: MLN51 stimulates the RNA-helicase activity of eIF4AIIi. Plos one 2(3): E303

Charman, M.; Kennedy, B.E.; Osborne, N.; Karten, B. 2010: MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein. Journal of Lipid Research 51(5): 1023-1034

Liapis, A.; Chen, F.W.; Davies, J.P.; Wang, R.; Ioannou, Y.A. 2012: MLN64 transport to the late endosome is regulated by binding to 14-3-3 via a non-canonical binding site. Plos one 7(4): E34424

Moretti, L.; Niermann, K.; Schleicher, S.; Giacalone, N.J.; Varki, V.; Kim, K.W.; Kopsombut, P.; Jung, D.K.; Lu, B. 2011: MLN8054, a small molecule inhibitor of aurora kinase a, sensitizes androgen-resistant prostate cancer to radiation. International Journal of Radiation Oncology Biology Physics 80(4): 1189-1197

Huck, J.J.; Zhang, M.; McDonald, A.; Bowman, D.; Hoar, K.M.; Stringer, B.; Ecsedy, J.; Manfredi, M.G.; Hyer, M.L. 2010: MLN8054, an inhibitor of Aurora a kinase, induces senescence in human tumor cells both in vitro and in vivo. Molecular Cancer Research: Mcr 8(3): 373-384

Alrifai, D.; Pettengell, R. 2014: MLN8237 ( alisertib ) and its role in peripheral T-cell lymphoma. Expert Opinion on Investigational Drugs 23(12): 1731-1736

Kilbourn, J.P. 2010: MLO "observing 40 years". Mlo: Medical Laboratory Observer 42(6): 6; Author Reply 6

Buyandelger, B.; Ng, K.-E.; Miocic, S.; Piotrowska, I.; Gunkel, S.; Ku, C.-H.; Knöll, R. 2011: MLP (muscle LIM protein) as a stress sensor in the heart. Pflugers Archiv: European Journal of Physiology 462(1): 135-142

Oberhauser, N.; Nurisso, A.; Carrupt, P.-A. 2014: MLP Tools: a PyMOL plugin for using the molecular lipophilicity potential in computer-aided drug design. Journal of Computer-Aided Molecular Design 28(5): 587-596

Grassi, M.; Soranzo, A. 2009: MLP: a MATLAB toolbox for rapid and reliable auditory threshold estimation. Behavior Research Methods 41(1): 20-28

Gunkel, S.; Heineke, J.ör.; Hilfiker-Kleiner, D.; Knöll, R. 2009: MLP: a stress sensor goes nuclear. Journal of Molecular and Cellular Cardiology 47(4): 423-425

Ji, X.; Zhang, J.; Xu, Y.; Long, F.; Sun, W.; Liu, X.; Chen, Y.; Jiang, W. 2015: MLPA Application in Clinical Diagnosis of DMD/BMD in Shanghai. Journal of clinical laboratory analysis 29(5): 405-411

Fagali, C.; Kok, F.; Nicola, P.; Kim, C.; Bertola, Débora.; Albano, Lílian.; Koiffmann, Célia.P. 2009: MLPA analysis in 30 Sotos syndrome patients revealed one total NSD1 deletion and two partial deletions not previously reported. European Journal of Medical Genetics 52(5): 333-336

Todorova, A.; Todorov, T.; Georgieva, B.; Lukova, M.; Guergueltcheva, V.; Kremensky, I.; Mitev, V. 2008: MLPA analysis/complete sequencing of the DMD gene in a group of Bulgarian Duchenne/Becker muscular dystrophy patients. Neuromuscular Disorders: Nmd 18(8): 667-670

Den Dunnen, J.T.; White, S.J. 2006: MLPA and MAPH: sensitive detection of deletions and duplications. Current Protocols in Human Genetics Chapter 7: Unit 7.14

Coutton, C.; Zouari, R.; Abada, F.; Ben Khelifa, M.; Merdassi, G.; Triki, C.; Escalier, D.; Hesters, L.; Mitchell, V.ér.; Levy, R.; Sermondade, N.; Boitrelle, F.; Vialard, F.ço.; Satre, V.ér.; Hennebicq, S.; Jouk, P.-S.; Arnoult, C.; Lunardi, J.ël.; Ray, P.F. 2012: MLPA and sequence analysis of DPY19L2 reveals point mutations causing globozoospermia. Human Reproduction 27(8): 2549-2558

Diego-Alvarez, D.; Rodriguez de Alba, M.; Cardero-Merlo, R.; Diaz-Recasens, J.; Ayuso, C.; Ramos, C.; Lorda-Sanchez, I. 2007: MLPA as a screening method of aneuploidy and unbalanced chromosomal rearrangements in spontaneous miscarriages. Prenatal Diagnosis 27(8): 765-771

Acquila, M.; Pasino, M.; Di Duca, M.; Bottini, F.; Molinari, A.C.; Bicocchi, M.P. 2008: MLPA assay in F8 gene mutation screening. Haemophilia: the Official Journal of the World Federation of Hemophilia 14(3): 625-627

Hills, A.; Ahn, J.W.; Donaghue, C.; Thomas, H.; Mann, K.; Ogilvie, C.M. 2010: MLPA for confirmation of array CGH results and determination of inheritance. Molecular Cytogenetics 3: 19

Schouten, J.; Galjaard, R.-J. 2008: MLPA for prenatal diagnosis of commonly occurring aneuploidies. Methods in Molecular Biology 444: 111-122

Alpár, D.át.; de Jong, D.; Savola, S.; Yigittop, H.; Kajtár, B.él.; Kereskai, L.ás.ó; Pajor, L.ás.ó; Szuhai, K.ár. 2012: MLPA is a powerful tool for detecting lymphoblastic transformation in chronic myeloid leukemia and revealing the clonal origin of relapse in pediatric acute lymphoblastic leukemia. Cancer Genetics 205(9): 465-469

Gomez, L.C.; Marzese, D.M.; Adi, J.é; Bertani, D.; Ibarra, J.; Mol, B.; Vos, I.J.; De Marchi, G.; Roqué, M.ía. 2009: MLPA mutation detection in Argentine HNPCC and FAP families. Familial Cancer 8(1): 67-73

Engert, S.; Wappenschmidt, B.; Betz, B.; Kast, K.; Kutsche, M.; Hellebrand, H.; Goecke, T.O.; Kiechle, M.; Niederacher, D.; Schmutzler, R.K.; Meindl, A. 2008: MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases. Human Mutation 29(7): 948-958

Hila, L.; Tébourbi, H.éd.; Abaied, L.; Rejeb, I.èn.; Ben Jemaa, L.; Chaabouni, H. 2009: MLPA subtelomere analysis in Tunisian mentally retarded patients. Biochemical Genetics 47(9-10): 727-733

Rusu, C.; Sireteanu, A.; Puiu, M.; Skrypnyk, C.; Tomescu, E.; Csep, K.; Creţ, V.; Barbarii, L. 2007: MLPA technique--principles and use in practice. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 111(4): 1001-1004

Varga, R.-E.; Mumtaz, R.; Jahic, A.; Rudenskaya, G.E.; Sánchez-Ferrero, E.; Auer-Grumbach, M.; Hübner, C.A.; Beetz, C. 2012: MLPA-based evidence for sequence gain: pitfalls in confirmation and necessity for exclusion of false positives. Analytical Biochemistry 421(2): 799-801

Mademont-Soler, I.; Morales, C.; Soler, A.; Clusellas, N.úr.; Margarit, E.; Martínez-Barrios, E.ía.; Martínez, J.é M.ía.; Sánchez, A. 2012: MLPA: a prenatal diagnostic tool for the study of congenital heart defects?. Gene 500(1): 151-154

Van Eijk, R.; Eilers, P.H.C.; Natté, R.; Cleton-Jansen, A.-M.; Morreau, H.; van Wezel, T.; Oosting, J. 2010: MLPAinter for MLPA interpretation: an integrated approach for the analysis, visualisation and data management of Multiplex Ligation-dependent Probe Amplification. Bmc Bioinformatics 11: 67

Coffa, J.; van de Wiel, M.A.; Diosdado, B.ña.; Carvalho, B.; Schouten, J.; Meijer, G.A. 2008: MLPAnalyzer: data analysis tool for reliable automated normalization of MLPA fragment data. Cellular Oncology: the Official Journal of the International Society for Cellular Oncology 30(4): 323-335

Cáceres, A.; Armengol, L.ís.; Villatoro, S.; González, J.R. 2011: MLPAstats: an R GUi package for the integrated analysis of copy number alterations using MLPA data. Bmc Bioinformatics 12: 147

Saporito, M.S.; Ochman, A.R.; Lipinski, C.A.; Handler, J.A.; Reaume, A.G. 2012: MLR-1023 is a potent and selective allosteric activator of Lyn kinase in vitro that improves glucose tolerance in vivo. Journal of Pharmacology and Experimental Therapeutics 342(1): 15-22

Tille, P.M.; Hall, H. 2011: MLS student active learning within a "cloud" technology program. Clinical Laboratory Science: Journal of the American Society for Medical Technology 24(4 Suppl): 4-4-10

Liu, L.; Gaboriaud, N.; Vougogianopoulou, K.; Tian, Y.; Wu, J.; Wen, W.; Skaltsounis, L.; Jove, R. 2014: MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells. Cancer Biology and Therapy 15(2): 178-184

Shivali, K.; Sasikala, C.; Ramana, C.V. 2012: MLSA barcoding of Marichromatium spp. and reclassification of Marichromatium fluminis (Sucharita et al., 2010) as Phaeochromatium fluminis gen. nov. comb. nov. Systematic and Applied Microbiology 35(4): 221-225

Cornick, K.E.; Brodsky, M.; Birk, M.; Feuer, M.D. 2007: MLSE receiver tolerance to all-order polarization mode dispersion. Optics Express 15(24): 15999-16004

Yasuhara, T.; Kugawa, S.; Tateishi, Y.; Ugajin, K.; Yoshida, K.; Fukuchi, K. 2013: MLST analysis of multiple antimicrobial resistant Acinetobacter baumannii. Rinsho Byori. Japanese Journal of Clinical Pathology 61(6): 488-492

Radhouani, H.; Pinto, L.; Coelho, C.; Sargo, R.; Araújo, C.; López, M.; Torres, C.; Igrejas, G.; Poeta, P. 2010: MLST and a genetic study of antibiotic resistance and virulence factors in vanA-containing Enterococcus from buzzards (Buteo buteo). Letters in Applied Microbiology 50(5): 537-541

Nielsen, L.N.; Sheppard, S.K.; McCarthy, N.D.; Maiden, M.C.J.; Ingmer, H.; Krogfelt, K.A. 2010: MLST clustering of Campylobacter jejuni isolates from patients with gastroenteritis, reactive arthritis and Guillain-Barré syndrome. Journal of Applied Microbiology 108(2): 591-599

Stone, D.; Davis, M.; Baker, K.; Besser, T.; Roopnarine, R.; Sharma, R. 2013: MLST genotypes and antibiotic resistance of Campylobacter spp. isolated from poultry in Grenada. Biomed Research International 2013: 794643

Bacila, I.; Jakab, E.; Ferencz, B.; Popescu, O. 2008: MLST method (Multilocus Sequence Typing). Bacteriologia Virusologia Parazitologia Epidemiologia 53(1): 13-17

Izdebski, R.; Baraniak, A.; Herda, M.; Fiett, J.; Bonten, M.J.M.; Carmeli, Y.; Goossens, H.; Hryniewicz, W.; Brun-Buisson, C.; Gniadkowski, M.; Grabowska, A.; Nikonorow, E.; Derde, L..P..G.; Dautzenberg, M..J.; Adler, A.; Kazma, M.; Navon-Venezia, S.; Malhotra-Kumar, S.; Lammens, C.; Dumpis, U.; Stradins, P.; Giamarellou, H.; Muzlovic, I.; Nardi, G.; Petrikkos, G..L.; Stammet, P.; Salomon, J.; Lawrence, C.; Legrand, P.; Rossini, A.; Salvia, A.; Samso, J..Vidal.; Fierro, J.; Paul, M.; Lerman, Y. 2015: MLST reveals potentially high-risk international clones of Enterobacter cloacae. Journal of Antimicrobial ChemoTherapy 70(1): 48-56

Adakal, H.; Meyer, D.F.; Carasco-Lacombe, C.; Pinarello, V.ér.; Allègre, F.; Huber, K.; Stachurski, F.; Morand, S.; Martinez, D.; Lefrançois, T.; Vachiery, N.; Frutos, R. 2009: MLST scheme of Ehrlichia ruminantium: genomic stasis and recombination in strains from Burkina-Faso. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 9(6): 1320-1328

Zhao, W.; Wang, R.; Zhang, W.; Liu, A.; Cao, J.; Shen, Y.; Yang, F.; Zhang, L. 2014: MLST subtypes and population genetic structure of Cryptosporidium andersoni from dairy cattle and beef cattle in northeastern China's Heilongjiang Province. Plos one 9(7): E102006

Arslan, U.ğu.; Demir, E.; Oryaşin, E.; Türk Dağı, H.; Tuncer, I.; Fındık, D.; Bozdoğan, B.ül. 2013: MLST types of vancomycin-resistant Enterococcus faecium strains isolated from blood cultures. Mikrobiyoloji Bulteni 47(3): 432-441

Guillouzouic, A.; Caroff, N.; Dauvergne, S.; Lepelletier, D.; Perrin Guyomard, A.; Kempf, I.; Reynaud, A.; Corvec, S. 2009: MLST typing of Escherichia coli isolates overproducing AmpC {beta}-lactamase. Journal of Antimicrobial ChemoTherapy 63(6): 1290-1292

Petersen, A.; Bisgaard, M.; Townsend, K.; Christensen, H. 2014: MLST typing of Pasteurella multocida associated with haemorrhagic septicaemia and development of a real-time PCR specific for haemorrhagic septicaemia associated isolates. Veterinary Microbiology 170(3-4): 335-341

Wang, H.-m.; Ke, C.-w.; Pan, W.-b.; Ke, B.-x.; Chen, J.-d.; Deng, X.-l.; Liu, M.-z.; Chen, G.-r.; Yang, X.-f.; Zhu, Z.-y. 2008: MLST typing of Streptococcus suis isolated from clinical patients in Guangdong Province in 2005. Nan Fang Yi Ke da Xue Xue Bao 28(8): 1438-1441

Klaassen, C.H.W. 2009: MLST versus microsatellites for typing Aspergillus fumigatus isolates. Medical Mycology 47 Suppl. 1: S27-S33

Tomasini, N.ás.; Lauthier, J.J.; Llewellyn, M.S.; Diosque, P. 2013: MLSTest: novel software for multi-locus sequence data analysis in eukaryotic organisms. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 20: 188-196

Meli, V.S.; Osuna, B.; Ruvkun, G.; Frand, A.R. 2010: MLT-10 defines a family of DUF644 and proline-rich repeat proteins involved in the molting cycle of Caenorhabditis elegans. Molecular Biology of the Cell 21(10): 1648-1661

Stark, M.; Berger, S.A.; Stamatakis, A.; von Mering, C. 2010: MLTreeMap--accurate Maximum Likelihood placement of environmental DNA sequences into taxonomic and functional reference phylogenies. Bmc Genomics 11: 461

Palidwor, G.A.; Andrade-Navarro, M.A. 2010: MLTrends: Graphing MEDLINE term usage over time. Journal of Biomedical Discovery and Collaboration 5: 1-6

Wu, D-Tze.; Roth, M.J. 2014: MLV based viral-like-particles for delivery of toxic proteins and nuclear transcription factors. Biomaterials 35(29): 8416-8426

Pizzato, M. 2010: MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1. Proceedings of the National Academy of Sciences of the United States of America 107(20): 9364-9369

LaFave, M.C.; Varshney, G.K.; Gildea, D.E.; Wolfsberg, T.G.; Baxevanis, A.D.; Burgess, S.M. 2014: MLV integration site selection is driven by strong enhancers and active promoters. Nucleic Acids Research 42(7): 4257-4269

Pessel-Vivares, L.; Ferrer, M.; Lainé, S.éb.; Mougel, M.èn. 2014: MLV requires Tap/NXF1-dependent pathway to export its unspliced RNA to the cytoplasm and to express both spliced and unspliced RNAs. Retrovirology 11: 21

Antwerpen, M.; Ilin, D.; Georgieva, E.; Meyer, H.; Savov, E.; Frangoulidis, D. 2011: MLVA and SNP analysis identified a unique genetic cluster in Bulgarian Bacillus anthracis strains. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 30(7): 923-930

Ross, I.L.; Davos, D.E.; Mwanri, L.; Raupach, J.; Heuzenroeder, M.W. 2011: MLVA and phage typing as complementary tools in the epidemiological investigation of Salmonella enterica serovar Typhimurium clusters. Current Microbiology 62(3): 1034-1038

Wuyts, V.ér.; Mattheus, W.; De Laminne de Bex, G.; Wildemauwe, C.; Roosens, N.H.C.; Marchal, K.; De Keersmaecker, S.C.J.; Bertrand, S. 2013: MLVA as a tool for public health surveillance of human Salmonella Typhimurium: prospective study in Belgium and evaluation of MLVA loci stability. Plos one 8(12): E84055

Hill, V.ér.; Zozio, T.; Sadikalay, S.; Viegas, S.; Streit, E.; Kallenius, G.; Rastogi, N. 2012: MLVA based classification of Mycobacterium tuberculosis complex lineages for a robust phylogeographic snapshot of its worldwide molecular diversity. Plos one 7(9): E41991

Zhang, X.; Hai, R.; Wei, J.; Cui, Z.; Zhang, E.; Song, Z.; Yu, D. 2009: MLVA distribution characteristics of Yersinia pestis in China and the correlation analysis. Bmc Microbiology 9: 205

Jiang, H.; Wang, H.; Xu, L.; Hu, G.; Ma, J.; Xiao, P.; Fan, W.; Di, D.; Tian, G.; Fan, M.; Mi, J.; Yu, R.; Song, L.; Zhao, H.; Piao, D.; Cui, B. 2013: MLVA genotyping of Brucella melitensis and Brucella abortus isolates from different animal species and humans and identification of Brucella suis vaccine strain S2 from cattle in China. Plos one 8(10): E76332

Jiang, H.; Fan, M.; Chen, J.; Mi, J.; Yu, R.; Zhao, H.; Piao, D.; Ke, C.; Deng, X.; Tian, G.; Cui, B. 2011: MLVA genotyping of Chinese human Brucella melitensis biovar 1, 2 and 3 isolates. Bmc Microbiology 11: 256

Christiansson, M.; Melin, S.; Matussek, A.; Löfgren, S.; Söderman, J. 2011: MLVA is a valuable tool in epidemiological investigations of Escherichia coli and for disclosing multiple carriage. Scandinavian Journal of Infectious Diseases 43(8): 579-586

Van Cuyck, H.él.èn.; Farbos-Granger, A.; Leroy, P.; Yith, V.; Guillard, B.; Sarthou, J.L.; Koeck, J.L.; Kruy, S.L. 2011: MLVA polymorphism of Salmonella enterica subspecies isolated from humans, animals, and food in Cambodia. Bmc Research Notes 4: 306

Peuchant, O.; Le Roy, C.é; Herrmann, B.ör.; Clerc, M.é; Bébéar, C.éc.; de Barbeyrac, B. 2012: MLVA subtyping of genovar e Chlamydia trachomatis individualizes the Swedish variant and anorectal isolates from men who have sex with men. Plos one 7(2): E31538

Jiang, H.; Mao, L.-l.; Zhao, H.-y.; Li, L.-y.; Piao, D.-r.; Yao, W.-q.; Cui, B.-y. 2010: MLVA typing and antibiotic susceptibility of Brucella human isolates from Liaoning, China. Transactions of the Royal Society of Tropical Medicine and Hygiene 104(12): 796-800

Campioni, Fábio.; Davis, M.; Medeiros, M.Inês.C.; Falcão, J.P.; Shah, D.H. 2013: MLVA typing reveals higher genetic homogeneity among S. Enteritidis strains isolated from food, humans and chickens in Brazil in comparison to the North American strains. International journal of food microbiology 162(2): 174-181

Garofolo, G.; Ancora, M.; Di Giannatale, E. 2013: MLVA-16 loci panel on Brucella spp. using multiplex PCR and multicolor capillary electrophoresis. Journal of Microbiological Methods 92(2): 103-107

Maquart, M.; Le Flèche, P.; Foster, G.; Tryland, M.; Ramisse, F.ço.; Djønne, B.; Al Dahouk, S.; Jacques, I.; Neubauer, H.; Walravens, K.; Godfroid, J.; Cloeckaert, A.; Vergnaud, G. 2009: MLVA-16 typing of 295 marine mammal Brucella isolates from different animal and geographic origins identifies 7 major groups within Brucella ceti and Brucella pinnipedialis. Bmc Microbiology 9: 145

Guigon, G.; Cheval, J.; Cahuzac, R.; Brisse, S. 2008: MLVA-NET--a standardised web database for bacterial genotyping and surveillance. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 13(19)

Ferreira, A.C.; Chambel, L.él.; Tenreiro, T.; Cardoso, R.; Flor, L.íd.; Dias, I.T.; Pacheco, T.; Garin-Bastuji, B.; Le Flèche, P.; Vergnaud, G.; Tenreiro, R.ér.; de Sá, M.I.ác.C.êa. 2012: MLVA16 typing of Portuguese human and animal Brucella melitensis and Brucella abortus isolates. Plos one 7(8): E42514

Vrablik, M.; Ceska, R.; Adamkova, V.; Peasey, A.; Pikhart, H.; Kubinova, R.; Marmot, M.; Bobak, M.; Hubacek, J.A. 2008: MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe. Human Genetics 124(5): 553-555

Dambournet, D.; Belharouak, I.; Amine, K. 2010: MLi2Ti6O14 (M = Sr, Ba, 2Na) lithium insertion titanate materials: a comparative study. Inorganic Chemistry 49(6): 2822-2826

Lange, K.; Zhou, H. 2014: MM Algorithms for Geometric and Signomial Programming. Mathematical Programming 143(1-2): 339-356

Zhou, H.; Lange, K. 2010: MM Algorithms for Some Discrete Multivariate Distributions. Journal of Computational and Graphical Statistics: a Joint Publication of American Statistical Association Institute of Mathematical Statistics Interface Foundation of North America 19(3): 645-665

Belaidi, O.; Adjim, M.; Bouchaour, T.; Maschke, U. 2015: MM and QM: conformational and vibrational spectra analysis of 2-hydroxyethyl acrylate. Spectrochimica Acta. Part a Molecular and Biomolecular Spectroscopy 137: 50-57

Dudich, E. 2007: MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases. Current Opinion in Molecular Therapeutics 9(6): 603-610

Fitzgerald, J.B.; Johnson, B.W.; Baum, J.; Adams, S.; Iadevaia, S.; Tang, J.; Rimkunas, V.; Xu, L.; Kohli, N.; Rennard, R.; Razlog, M.; Jiao, Y.; Harms, B.D.; Olivier, K.J.; Schoeberl, B.; Nielsen, U.B.; Lugovskoy, A.A. 2014: MM-141, an IGF-IR- and ErbB3-directed bispecific antibody, overcomes network adaptations that limit activity of IGF-IR inhibitors. Molecular Cancer Therapeutics 13(2): 410-425

Saif, M.W. 2014: MM-398 achieves primary endpoint of overall survival in phase IIi study in patients with gemcitabine refractory metastatic pancreatic cancer. Jop: Journal of the Pancreas 15(3): 278-279

Chen, Y.; Meyer, C.A.; Liu, T.; Li, W.; Liu, J.S.; Liu, X.S. 2011: MM-ChIP enables integrative analysis of cross-platform and between-laboratory ChIP-chip or ChIP-seq data. Genome Biology 12(2): R11

Guimarães, C.R.W. 2012: MM-GB/SA rescoring of docking poses. Methods in Molecular Biology 819: 255-268

Guimarães, C.R.W.; Cardozo, M. 2008: MM-GB/SA rescoring of docking poses in structure-based lead optimization. Journal of Chemical Information and Modeling 48(5): 958-970

Zoete, V.; Irving, M.B.; Michielin, O. 2010: MM-GBSA binding free energy decomposition and T cell receptor engineering. Journal of Molecular Recognition: Jmr 23(2): 142-152

Hout, M.C.; Goldinger, S.D.; Brady, K.J. 2014: MM-MDS: a multidimensional scaling database with similarity ratings for 240 object categories from the Massive Memory picture database. Plos one 9(11): E112644

Khalil, I.T.; Sarkis, T.; Naaman, A. 2013: MM-MTA for direct pulp capping: a histologic comparison with ProRoot MTA in rat molars. Journal of Contemporary Dental Practice 14(6): 1019-1023

Wong, S.; Amaro, R.E.; McCammon, J.A. 2009: MM-PBSA Captures Key Role of Intercalating Water Molecules at a Protein-Protein Interface. Journal of Chemical Theory and Computation 5(2): 422-429

Mukherjee, S.; Zhang, Y. 2009: MM-align: a quick algorithm for aligning multiple-chain protein complex structures using iterative dynamic programming. Nucleic Acids Research 37(11): E83

Podar, K. 2012: MM-associated anemia: more than "crowding out" HSPCs. Blood 120(13): 2539-2540

Gregory, C. 2008: MM-induced osteolysis: partners in crime. Blood 112(1): 3-4

Genheden, S. 2011: MM/GBSA and LIE estimates of host-guest affinities: dependence on charges and solvation model. Journal of Computer-Aided Molecular Design 25(11): 1085-1093

Greenidge, P.A.; Kramer, C.; Mozziconacci, J.-C.; Wolf, R.M. 2013: MM/GBSA binding energy prediction on the PDBbind data set: successes, failures, and directions for further improvement. Journal of Chemical Information and Modeling 53(1): 201-209

Allegri, R.F.; Bartoloni, L.; Iturry, M.ón.; Romero, C.; Begué, C.án.; Sevlever, G.; Taratuto, A.L.ía. 2014: MM1+2C sporadic Creutzfeldt-Jakob disease presenting as rapidly progressive nonfluent aphasia. Journal of Alzheimer's Disease: Jad 39(1): 13-17

Hoshino, A.; Iwasaki, Y.; Izumi, M.; Kimura, S.; Ibi, T.; Kitamoto, T.; Yoshida, M.; Hashizume, Y.; Sahashi, K. 2008: MM1-type sporadic Creutzfeldt-Jakob disease with unusually prolonged disease duration presenting with panencephalopathic-type pathology. Neuropathology: Official Journal of the Japanese Society of Neuropathology 28(3): 326-332

Petrovic, I.N.; Martin-Bastida, A.; Massey, L.; Ling, H.; O'Sullivan, S.S.; Williams, D.R.; Holton, J.L.; Revesz, T.; Ironside, J.W.; Lees, A.J.; Silveira-Moriyama, L. 2013: MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy. Journal of Neurology 260(4): 1031-1036

Niimi, Y.; Iwasaki, Y.; Umemura, T.; Tanaka, F.; Yoshida, M.; Hashizume, Y.; Kitamoto, T.; Hirayama, M.; Sobue, G. 2008: MM2-cortical-type sporadic Creutzfeldt-Jakob disease with early stage cerebral cortical pathology presenting with a rapidly progressive clinical course. Neuropathology: Official Journal of the Japanese Society of Neuropathology 28(6): 645-651

Ubeira, F.M.; Muiño, L.; Valero, M.A.; Periago, M.V.; Pérez-Crespo, I.; Mezo, M.; González-Warleta, M.; Romarís, F.; Paniagua, E.; Cortizo, S.; Llovo, J.é; Más-Coma, S. 2009: MM3-ELISA detection of Fasciola hepatica coproantigens in preserved human stool samples. American Journal of Tropical Medicine and Hygiene 81(1): 156-162

Valero, M.A.; Ubeira, F.M.; Khoubbane, M.; Artigas, P.; Muiño, L.; Mezo, M.; Pérez-Crespo, I.; Periago, M.V.; Mas-Coma, S. 2009: MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica. Veterinary Parasitology 159(1): 77-81

Honda, H.; Hamasaki, R.; Ejima, C.; Shimizu, N.; Kiyohara, S.; Sawa, S. 2011: MM31/EIR1 promotes lateral root formation in Arabidopsis. Plant Signaling and Behavior 6(7): 968-973

Gonzalez-Campoy, J.M. 2005: Obesity and Hispanic health. Minnesota Medicine 88(2): 15

Joyce, J.J. 2012: MMA board overreached on marriage. Minnesota Medicine 95(7): 5

Dehen, J.J. 2007: MMA calls for focus on reform. Minnesota Medicine 90(12): 16

Anonymous 2011: MMA finds significant errors in Medica's physician ratings. Minnesota Medicine 94(2): 17

Anonymous 2013: MMA kicks off policy forums. Minnesota Medicine 96(4): 28

Smith, S.D. 2009: E-prescribing 101. Minnesota Medicine 92(1): 17-19

Pellegrini, W.; Bresciani, G.; De Zorzi, A.; Marocolo, D.; Ungari, M.; Facchetti, F. 2007: MMA monoclonal antibody is a superior anti-CD15 reagent for the diagnosis of classical Hodgkin's lymphoma?. Haematologica 92(5): 708-709

Bostwick, J.Michael. 2014: MMA not support of medical marijuana legislation. Minnesota Medicine 97(4): 28

Mettner, J. 2010: Never too old to play. Minnesota Medicine 93(12): 26-30

Thorson, D. 2013: MMA scores with MERC at Legislature. Minnesota Medicine 96(6): 48

Ainslie, M.B. 2008: MMA vision shapes health care reform. Minnesota Medicine 91(6): 20

Anonymous 2012: MMA warns against "pox parties". Minnesota Medicine 95(2): 28

Liebner, D.A.; Huang, K.; Parvin, J.D. 2014: MMAD: microarray microdissection with analysis of differences is a computational tool for deconvoluting cell type-specific contributions from tissue samples. Bioinformatics 30(5): 682-689

Yu, J.; Niu, C.; Wang, D.; Li, M.; Teo, W.; Sun, G.; Wang, J.; Liu, J.; Gao, Q. 2011: MMAR_2770, a new enzyme involved in biotin biosynthesis, is essential for the growth of Mycobacterium marinum in macrophages and zebrafish. Microbes and Infection 13(1): 33-41

Dixon, H.; Clark, A.P-Z.; Cabell, L.A.; McDonough, J.A. 2013: MMB4 DMS nanoparticle suspension formulation with enhanced stability for the treatment of nerve agent intoxication. International Journal of Toxicology 32(4 Suppl): 18s-29s

Roche, B.M.; Vinci, T.M.; Hawk, M.A.; Hassler, C.R.; Pressburger, D.T.; Osheroff, M.R.; Ritchie, G.D.; Burback, B.L. 2013: MMB4 DMS: cardiovascular and pulmonary effects on dogs and neurobehavioral effects on rats. International Journal of Toxicology 32(4 Suppl): 49s-58s

Turro, E.; Lewin, A.; Rose, A.; Dallman, M.J.; Richardson, S. 2010: MMBGX: a method for estimating expression at the isoform level and detecting differential splicing using whole-transcript Affymetrix arrays. Nucleic Acids Research 38(1): E4

Ghequire, M.G.K.; Loris, R.; De Mot, R.é 2012: MMBL proteins: from lectin to bacteriocin. Biochemical Society Transactions 40(6): 1553-1559

Downs, D.M.; Darwin, C. 2009: MMBR to highlight microbial evolution, diversity, and ecology in 2009. Microbiology and molecular biology reviews: MMBR 73(1): 13

Howells, L.; Cook, W. 2013: MMC Reforms: have they put paid to the pluripotent medical student?. Journal of the Royal Society of Medicine 106(7): 252-253

Brown, C.; Khan, A. 2007: MMC, Britain's aid deficit, and overseas health-care shortages. Lancet 370(9588): 655-656

Waksman, R. 2007: ACUITY-PCI: one drug does not fit all. Lancet 369(9565): 881-882

Madej, T.; Lanczycki, C.J.; Zhang, D.; Thiessen, P.A.; Geer, R.C.; Marchler-Bauer, A.; Bryant, S.H. 2014: MMDB and VAST+: tracking structural similarities between macromolecular complexes. Nucleic Acids Research 42(Database Issue): D297-D303

Schweikert, G.; Cseke, B.; Clouaire, T.; Bird, A.; Sanguinetti, G. 2013: MMDiff: quantitative testing for shape changes in ChIP-Seq data sets. Bmc Genomics 14: 826

McVey, M.; Lee, S.Eun. 2008: MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. Trends in Genetics: Tig 24(11): 529-538

Schmidt, H.; Brockmann, J. 2007: MMF to EC-MPS conversion: what makes the difference?. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 13(5): 773

Wang, T.; Kettenbach, A.N.; Gerber, S.A.; Bailey-Kellogg, C. 2012: MMFPh: a maximal motif finder for phosphoproteomics datasets. Bioinformatics 28(12): 1562-1570

Ylilauri, M.; Pentikäinen, O.T. 2013: MMGBSA as a tool to understand the binding affinities of filamin-peptide interactions. Journal of Chemical Information and Modeling 53(10): 2626-2633

Jeon, N.-R.; Koppula, S.; Kim, B.-W.; Park, S.-H.; Lee, H.-W.; Choi, D.-K. 2010: MMHD [(S,E)-2-methyl-1-(2-methylthiazol-4-yl) hexa-1,5-dien-ol], a novel synthetic compound derived from epothilone, suppresses nuclear factor-kappaB-mediated cytokine expression in lipopolysaccharide-stimulated BV-2 microglia. Journal of Pharmacological Sciences 112(2): 158-166

West, B.; Honkanen, S. 2004: MMi devices with weak guiding designed in three dimensions using a genetic algorithm. Optics Express 12(12): 2716-2722

Bakhtazad, A.; McMullin, J.; Haugen, C.; Decorby, R. 2001: MMi multiplexer for dual-channel erbium-doped waveguide amplifiers. Optics Express 9(4): 178-183

Xu, L.; Yates, C.C.; Lockyer, P.; Xie, L.; Bevilacqua, A.; He, J.; Lander, C.; Patterson, C.; Willis, M. 2014: MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition. Journal of Molecular and Cellular Cardiology 77: 86-101

Wyllie, M.G. 2009: MMIX: annus festine lente?. Bju International 103(1): 113-114

Chang, D.C.; Dokos, S.; Lovell, N.H. 2010: MML toolkit and work flow overview: Creating temporo-spatial heart models from CellML. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2010: 1481-1484

Roudebush, B.T.; Milano, A.F.; Hart, A.R. 2008: MMLC - ISCS aviation and hazardous sports study. Journal of Insurance Medicine 40(1): 44-54

Agüero-Chapín, G.ín.; Gonzalez-Díaz, H.; de la Riva, G.; Rodríguez, E.; Sanchez-Rodríguez, A.; Podda, G.; Vazquez-Padrón, R.I. 2008: MMM-QSAR recognition of ribonucleases without alignment: comparison with an HMM model and isolation from Schizosaccharomyces pombe, prediction, and experimental assay of a new sequence. Journal of Chemical Information and Modeling 48(2): 434-448

Sugimoto, M.; Ikeda, S.; Niigata, K.; Tomita, M.; Sato, H.; Soga, T. 2012: MMMDB: Mouse Multiple Tissue Metabolome Database. Nucleic Acids Research 40(Database Issue): D809-D814

Mattos, A.M.d.; Marques, A.D.; Parrela, C.P.íc.O.; Fish, J.M.d.C.; Artigalas, O.A.P.; Ranzan, J.; Winkcler, M.I.B.; Ohlweiler, L.; Riesgo, R.D.S. 2010: MMMM syndrome (macrocephaly, megalocornea, motor and mental retardation) and refractory epilepsy. Arquivos de Neuro-Psiquiatria 68(4): 642-644

Morlet, D.; Fischer, C. 2014: MMN and novelty P3 in coma and other altered states of consciousness: a review. Brain Topography 27(4): 467-479

Sculthorpe, L.D.; Ouellet, D.R.; Campbell, K.B. 2009: MMN elicitation during natural sleep to violations of an auditory pattern. Brain Research 1290: 52-62

Lai, Y.; Tian, Y.; Yao, D. 2011: MMN evidence for asymmetry in detection of IOi shortening and lengthening at behavioral indifference tempo. Brain Research 1367: 170-180

Horton, J.; Millar, A.; Labelle, A.; Knott, V.J. 2011: MMN responsivity to manipulations of frequency and duration deviants in chronic, clozapine-treated schizophrenia patients. Schizophrenia Research 126(1-3): 202-211

Harschnitz, O.; Jongbloed, B.A.; Franssen, H.; Straver, D.C.G.; van der Pol, W.L.; van den Berg, L.H. 2014: MMN: from immunological cross-talk to conduction block. Journal of Clinical Immunology 34(Suppl 1): S112-S119

Kaczmarek, L.D.; Drążkowski, D. 2014: MMORPG escapism predicts decreased well-being: examination of gaming time, game realism beliefs, and online social support for offline problems. Cyberpsychology Behavior and Social Networking 17(5): 298-302

Montagner, A.F.; Sarkis-Onofre, R.; Pereira-Cenci, T.; Cenci, M.S. 2014: MMP Inhibitors on Dentin Stability: A Systematic Review and Meta-analysis. Journal of Dental Research 93(8): 733-743

Sorsa, T.; Mäntylä, P.äi.; Tervahartiala, T.; Pussinen, P.J.; Gamonal, J.; Hernandez, M. 2011: MMP activation in diagnostics of periodontitis and systemic inflammation. Journal of Clinical Periodontology 38(9): 817-819

Kasper, G.; Glaeser, J.; Geissler, S.; Ode, A.; Tuischer, J.; Matziolis, G.; Perka, C.; Duda, G. 2007: MMP activity is an essential link between mechanical stimulus and mesenchymal stem cell behaviour. Journal of Stem Cells and Regenerative Medicine 2(1): 56-57

Sapienza, P.; Borrelli, V.; di Marzo, L.; Cavallaro, A. 2009: MMP and TIMP alterations in asymptomatic and symptomatic severe recurrent carotid artery stenosis. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 37(5): 525-530

Grey, S. 2011: MMP delivers for women. Nursing New Zealand 17(5): 37

McKeown, S.; Richter, A.G.; O'Kane, C.; McAuley, D.F.; Thickett, D.R. 2009: MMP expression and abnormal lung permeability are important determinants of outcome in IPF. European Respiratory Journal 33(1): 77-84

Mathalone, N.; Marmor, S.; Rahat, M.A.; Lahat, N.; Oron, Y.; Geyer, O. 2011: MMP expression in leaking filtering blebs and tears after glaucoma filtering surgery. Graefe's Archive for Clinical and Experimental Ophthalmology 249(7): 1047-1055

Jung, Y.W.; Zindl, C.L.; Lai, J.-F.; Weaver, C.T.; Chaplin, D.D. 2009: MMP induced by Gr-1+ cells are crucial for recruitment of Th cells into the airways. European Journal of Immunology 39(8): 2281-2292

Woenne, E.C.; Lederle, W.; Zwick, S.; Palmowski, M.; Krell, H.; Semmler, W.; Mueller, M.M.; Kiessling, F. 2010: MMP inhibition blocks fibroblast-dependent skin cancer invasion, reduces vascularization and alters VEGF-A and PDGF-BB expression. Anticancer Research 30(3): 703-711

Wang, J.; Radomski, M.W.; Medina, C.; Gilmer, J.F. 2013: MMP inhibition by barbiturate homodimers. Bioorganic and Medicinal Chemistry Letters 23(2): 444-447

Dormán, Görgy.; Kocsis-Szommer, K.; Spadoni, C.; Ferdinandy, Péter. 2007: MMP inhibitors in cardiac diseases: an update. Recent Patents on Cardiovascular Drug Discovery 2(3): 186-194

Khan, O.F.; Jean-Francois, J.; Sefton, M.V. 2010: MMP levels in the response to degradable implants in the presence of a hydroxamate-based matrix metalloproteinase sequestering biomaterial in vivo. Journal of Biomedical Materials Research. Part a 93(4): 1368-1379

Sand, J.M.; Larsen, L.; Hogaboam, C.; Martinez, F.; Han, M.; Røssel Larsen, M.; Nawrocki, A.; Zheng, Q.; Karsdal, M.A.; Leeming, D.J. 2013: MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis--validation of two novel biomarker assays. Plos one 8(12): E84934

Veidal, S.S.år.; Karsdal, M.A.; Vassiliadis, E.; Nawrocki, A.; Larsen, M.R.øs.; Nguyen, Q.H.T.; Hägglund, P.; Luo, Y.; Zheng, Q.; Vainer, B.; Leeming, D.J. 2011: MMP mediated degradation of type Vi collagen is highly associated with liver fibrosis--identification and validation of a novel biochemical marker assay. Plos one 6(9): E24753

Veidal, S.S.; Larsen, D.V.; Chen, X.; Sun, S.; Zheng, Q.; Bay-Jensen, A.-C.; Leeming, D.J.; Nawrocki, A.; Larsen, M.R.; Schett, G.; Karsdal, M.A. 2012: MMP mediated type V collagen degradation (C5M) is elevated in ankylosing spondylitis. Clinical Biochemistry 45(7-8): 541-546

Gorovetz, M.; Schwob, O.; Krimsky, M.; Yedgar, S.; Reich, R. 2008: MMP production in human fibrosarcoma cells and their invasiveness are regulated by group IB secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2. Frontiers in Bioscience: a Journal and Virtual Library 13: 1917-1925

Struglics, A.é; Hansson, M. 2012: MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover. Biochemical Journal 446(2): 213-223

Zhou, C.; Petroll, W.M. 2014: MMP regulation of corneal keratocyte motility and mechanics in 3-D collagen matrices. Experimental Eye Research 121: 147-160

Jakobs, M.; Häupl, T.; Krenn, V.; Guenther, R. 2009: MMP- and FAP-mediated non-inflammation-related destruction of cartilage and bone in rheumatoid arthritis. Zeitschrift für Rheumatologie 68(8): 683-694

Tandara, A.A.; Mustoe, T.A. 2011: MMP- and TIMP-secretion by human cutaneous keratinocytes and fibroblasts--impact of coculture and hydration. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 64(1): 108-116

Djuric, T.; Zivkovic, M.; Milosevic, B.; Andjelevski, M.; Cvetkovic, M.; Kostic, M.; Stankovic, A. 2014: MMP-1 and -3 haplotype is associated with congenital anomalies of the kidney and urinary tract. Pediatric Nephrology 29(5): 879-884

Skorupski, P.ł; Miotła, P.ł; Jankiewicz, K.; Rechberger, T. 2010: MMP-1 and MMP-3 gene encoding polymorphism and the risk of the development of pelvic organ prolapse and stress urinary incontinence. Ginekologia Polska 81(8): 594-599

Lombardi, F.; Belletti, S.; Battezzati, P.M.; Pacciolla, R.; Biondi, M.L. 2011: MMP-1 and MMP-3 polymorphism and arrhythmia recurrence after electrical cardioversion in patients with persistent atrial fibrillation. Journal of Cardiovascular Medicine 12(1): 37-42

Rao, V.H.; Kansal, V.; Stoupa, S.; Agrawal, D.K. 2014: MMP-1 and MMP-9 regulate epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells. Physiological Reports 2(2): E00224

Du, X.; Lin, B.C.; Wang, Q.-R.; Li, H.; Ingalla, E.; Tien, J.; Rooney, I.; Ashkenazi, A.; Penuel, E.; Qing, J. 2014: MMP-1 and Pro-MMP-10 as potential urinary pharmacodynamic biomarkers of FGFR3-targeted therapy in patients with bladder cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(24): 6324-6335

Elkington, P.; Shiomi, T.; Breen, R.; Nuttall, R.K.; Ugarte-Gil, C.A.; Walker, N.F.; Saraiva, L.ís.; Pedersen, B.; Mauri, F.; Lipman, M.; Edwards, D.R.; Robertson, B.D.; D'Armiento, J.; Friedland, J.S. 2011: MMP-1 drives immunopathology in human tuberculosis and transgenic mice. Journal of Clinical Investigation 121(5): 1827-1833

Grimm, M.; Lazariotou, M.; Kircher, S.; Stuermer, L.; Reiber, C.; Höfelmayr, A.; Gattenlöhner, S.; Otto, C.; Germer, C.T.; von Rahden, B.H.A. 2010: MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status. Journal of Translational Medicine 8: 99

Xu, D.; Sun, Y.; Bao, G.; Liu, W.; Zhu, X.; Cui, S.; Fan, J.; Cui, Z. 2013: MMP-1 overexpression induced by IL-1β: possible mechanism for inflammation in degenerative lumbar facet joint. Journal of Orthopaedic Science: Official Journal of the Japanese Orthopaedic Association 18(6): 1012-1019

Arakaki, P.A.; Marques, M.R.; Santos, M.C.L.G. 2009: MMP-1 polymorphism and its relationship to pathological processes. Journal of Biosciences 34(2): 313-320

Checa, M.; Ruiz, V.íc.; Montaño, M.; Velázquez-Cruz, R.; Selman, M.és.; Pardo, A. 2008: MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Human Genetics 124(5): 465-472

Baroneza, Jé.Eduardo.; Godoy-Santos, A.; Ferreira Massa, B.; Boçon de Araujo Munhoz, F.; Diniz Fernandes, Túlio.; Leme Godoy dos Santos, M.Cristina. 2014: MMP-1 promoter genotype and haplotype association with posterior tibial tendinopathy. Gene 547(2): 334-337

Godoy-Santos, A.; Cunha, M.V.; Ortiz, R.Trevisan.; Fernandes, Túlio.Diniz.; Mattar, R.; dos Santos, M.Cristina.L.G. 2013: MMP-1 promoter polymorphism is associated with primary tendinopathy of the posterior tibial tendon. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 31(7): 1103-1107

Lehrke, M.; Greif, M.; Broedl, U.C.; Lebherz, C.; Laubender, R.üd.P.; Becker, A.; von Ziegler, F.; Tittus, J.; Reiser, M.; Becker, C.; Göke, B.; Steinbeck, G.; Leber, A.W.; Parhofer, K.G. 2009: MMP-1 serum levels predict coronary atherosclerosis in humans. Cardiovascular Diabetology 8: 50

Wang, C.-H.; Lin, H.-C.; Lin, S.-M.; Huang, C.-D.; Liu, C.-Y.; Huang, K.-H.; Hsieh, L.-L.; Chung, K.F.; Kuo, H.-P. 2010: MMP-1(-1607G) polymorphism as a risk factor for fibrosis after pulmonary tuberculosis in Taiwan. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 14(5): 627-634

Asundi, K.R.; Rempel, D.M. 2008: MMP-1, IL-1beta, and COX-2 mRNA expression is modulated by static load in rabbit flexor tendons. Annals of Biomedical Engineering 36(2): 237-243

Wang, F.-q.; Fisher, J.; Fishman, D.A. 2011: MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion. Gynecologic Oncology 120(2): 247-255

Peng, H.-H.; Zhang, X.; Cao, P.-G. 2012: MMP-1/PAR-1 signal transduction axis and its prognostic impact in esophageal squamous cell carcinoma. Brazilian Journal of Medical and Biological Research 45(1): 86-92

Boyd, S.; Virolainen, S.; Pärssinen, J.; Skoog, T.; van Hogerlinden, M.; Latonen, L.; Kyllönen, L.; Toftgard, R.; Saarialho-Kere, U. 2009: MMP-10 (Stromelysin-2) and MMP-21 in human and murine squamous cell cancer. Experimental Dermatology 18(12): 1044-1052

Bobadilla, M.ír.; Sáinz, N.; Rodriguez, J.é A.; Abizanda, G.; Orbe, J.; de Martino, A.; García Verdugo, J.é M.; Páramo, J.é A.; Prósper, F.; Pérez-Ruiz, A. 2014: MMP-10 is required for efficient muscle regeneration in mouse models of injury and muscular dystrophy. Stem Cells 32(2): 447-461

Deraz, E.M.; Kudo, Y.; Yoshida, M.; Obayashi, M.; Tsunematsu, T.; Tani, H.; Siriwardena, S.B.S.M.; Keikhaee, M.R.; Kiekhaee, M.R.; Qi, G.; Iizuka, S.; Ogawa, I.; Campisi, G.; Lo Muzio, L.; Abiko, Y.; Kikuchi, A.; Takata, T. 2011: MMP-10/stromelysin-2 promotes invasion of head and neck cancer. Plos one 6(10): E25438

Xu, C.-J.; Xu, F. 2014: MMP-11 and VEGF-C expression correlate with clinical features of colorectal adenocarcinoma. International Journal of Clinical and Experimental Medicine 7(9): 2883-2888

Del Porto, F.; Cifani, N.; Proietta, M.; Taurino, M. 2014: MMP-12 and macrophage activation in acute aortic dissection. Cardiology 128(4): 314-5; Discussion 316

Proietta, M.; Tritapepe, L.; Cifani, N.; Ferri, L.; Taurino, M.; Del Porto, F. 2014: MMP-12 as a new marker of Stanford-A acute aortic dissection. Annals of Medicine 46(1): 44-48

Taddese, S.; Jung, M.C.; Ihling, C.; Heinz, A.; Neubert, R.H.H.; Schmelzer, C.E.H. 2010: MMP-12 catalytic domain recognizes and cleaves at multiple sites in human skin collagen type i and type IIi. Biochimica et Biophysica Acta 1804(4): 731-739

Stawski, L.; Haines, P.; Fine, A.; Rudnicka, L.; Trojanowska, M. 2014: MMP-12 deficiency attenuates angiotensin II-induced vascular injury, M2 macrophage accumulation, and skin and heart fibrosis. Plos one 9(10): E109763

Rodríguez-Pla, A.; Martínez-Murillo, F.; Savino, P.J.; Eagle, R.C.; Seo, P.; Soloski, M.J. 2009: MMP-12, a novel matrix metalloproteinase associated with giant cell arteritis. Rheumatology 48(11): 1460-1461

Leonardi, R.; Loreto, C.; Barbato, E.; Caltabiano, R.; Lombardo, C.; Musumeci, G.; Lo Muzio, L. 2008: MMP-13 (collagenase 3) localization in human temporomandibular joint discs with internal derangement. Acta Histochemica 110(4): 314-318

Hernández, M.; Martínez, B.ín.; Tejerina, J.é M.ía.; Valenzuela, M.ía.A.; Gamonal, J. 2007: MMP-13 and TIMP-1 determinations in progressive chronic periodontitis. Journal of Clinical Periodontology 34(9): 729-735

Leonardi, R.; Matthews, J.B.; Caltabiano, R.; Greco, M.; Lombardo, C.; Loreto, C.; Santarelli, A.; Lo Muzio, L. 2010: MMP-13 expression in keratocyst odontogenic tumour associated with NBCCS and sporadic keratocysts. Oral Diseases 16(8): 795-800

Kominsky, S.L.; Doucet, M.; Thorpe, M.; Weber, K.L. 2008: MMP-13 is over-expressed in renal cell carcinoma bone metastasis and is induced by TGF-beta1. Clinical and Experimental Metastasis 25(8): 865-870

Hattori, N.; Mochizuki, S.; Kishi, K.; Nakajima, T.; Takaishi, H.; D'Armiento, J.; Okada, Y. 2009: MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing. American Journal of Pathology 175(2): 533-546

Pirhan, D.; Atilla, G.ül.; Emingil, G.ül.; Tervahartiala, T.; Sorsa, T.; Berdeli, A. 2009: MMP-13 promoter polymorphisms in patients with chronic periodontitis: effects on GCF MMP-13 levels and outcome of periodontal therapy. Journal of Clinical Periodontology 36(6): 474-481

Toriseva, M.; Laato, M.; Carpén, O.; Ruohonen, S.T.; Savontaus, E.; Inada, M.; Krane, S.M.; Kähäri, V.-M. 2012: MMP-13 regulates growth of wound granulation tissue and modulates gene expression signatures involved in inflammation, proteolysis, and cell viability. Plos one 7(8): E42596

Fobian, Y.M.; Freskos, J.N.; Barta, T.E.; Bedell, L.J.; Heintz, R.; Kassab, D.J.; Kiefer, J.R.; Mischke, B.V.; Molyneaux, J.M.; Mullins, P.; Munie, G.E.; Becker, D.P. 2011: MMP-13 selective alpha-sulfone hydroxamates: identification of selective P1' amides. Bioorganic and Medicinal Chemistry Letters 21(10): 2823-2825

Kolodziej, S.A.; Hockerman, S.L.; DeCrescenzo, G.A.; McDonald, J.J.; Mischke, D.A.; Munie, G.E.; Fletcher, T.R.; Stehle, N.; Swearingen, C.; Becker, D.P. 2010: MMP-13 selective isonipecotamide alpha-sulfone hydroxamates. Bioorganic and Medicinal Chemistry Letters 20(12): 3561-3564

Barta, T.E.; Becker, D.P.; Bedell, L.J.; Easton, A.M.; Hockerman, S.L.; Kiefer, J.; Munie, G.E.; Mathis, K.J.; Li, M.H.; Rico, J.G.; Villamil, C.I.; Williams, J.M. 2011: MMP-13 selective α-sulfone hydroxamates: a survey of P1' heterocyclic amide isosteres. Bioorganic and Medicinal Chemistry Letters 21(10): 2820-2822

Pivetta, E.; Scapolan, M.; Pecolo, M.; Wassermann, B.; Abu-Rumeileh, I.; Balestreri, L.; Borsatti, E.; Tripodo, C.; Colombatti, A.; Spessotto, P. 2011: MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases. Breast Cancer Research: Bcr 13(5): R105

Zhang, H.; Liu, M.; Sun, Y.; Lu, J. 2009: MMP-14 can serve as a prognostic marker in patients with supraglottic cancer. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 266(9): 1427-1434

Kaitu'u-Lino, T.'u.J.; Palmer, K.R.; Whitehead, C.L.; Williams, E.; Lappas, M.; Tong, S. 2012: MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin. American Journal of Pathology 180(3): 888-894

Lund, D.K.; Mouly, V.; Cornelison, D.D.W. 2014: MMP-14 is necessary but not sufficient for invasion of three-dimensional collagen by human muscle satellite cells. American Journal of Physiology. Cell Physiology 307(2): C140-C149

Seomun, Y.; Kim, J.-T.; Joo, C.-K. 2008: MMP-14 mediated MMP-9 expression is involved in TGF-beta1-induced keratinocyte migration. Journal of Cellular Biochemistry 104(3): 934-941

Wang, Y.-Z.; Wu, K.-P.; Wu, A.-B.; Yang, Z.-C.; Li, J.-M.; Mo, Y.-L.; Xu, M.; Wu, B.; Yang, Z.-X. 2014: MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(10): 9815-9821

Kaitu'u-Lino, T.'u.J.; Palmer, K.; Tuohey, L.; Ye, L.; Tong, S. 2012: MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin. Plos one 7(6): E39864

Zagouri, F.; Sergentanis, T.N.; Gazouli, M.; Dimitrakakis, C.; Tsigginou, A.; Papaspyrou, I.; Chrysikos, D.; Lymperi, M.; Zografos, G.C.; Antsaklis, A.; Dimopoulos, M.-A.; Papadimitriou, C.A. 2013: MMP-2 -1306C>T polymorphism in breast cancer: a case-control study in a South European population. Molecular Biology Reports 40(8): 5035-5040

Chetty, C.; Lakka, S.S.; Bhoopathi, P.; Rao, J.S. 2010: MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells. International Journal of Cancer 127(5): 1081-1095

Ao, R.; Du, Y.-Q.; Wang, Y.; Chen, Y.-S.; Wang, B.-Y. 2013: MMP-2 and DcR3 expression in esophageal cancer tissue and correlation with patient survival. International Journal of Clinical and Experimental Medicine 6(8): 700-705

Reel, B.; Oktay, G.; Ozkal, S.; Islekel, H.; Ozer, E.; Ozsarlak-Sozer, G.; Cavdar, Z.; Akhisaroglu, S.T.; Kerry, Z. 2009: MMP-2 and MMP-9 alteration in response to collaring in rabbits: the effects of endothelin receptor antagonism. Journal of Cardiovascular Pharmacology and Therapeutics 14(4): 292-301

Lubetzky, R.; Mandel, D.; Mimouni, F.B.; Herman, L.; Reich, R.; Reif, S. 2010: MMP-2 and MMP-9 and their tissue inhibitor in preterm human milk. Journal of Pediatric Gastroenterology and Nutrition 51(2): 210-212

Fang, L.; Teuchert, M.; Huber-Abel, F.; Schattauer, D.; Hendrich, C.; Dorst, J.; Zettlmeissel, H.; Wlaschek, M.; Scharffetter-Kochanek, K.; Kapfer, T.; Tumani, H.; Ludolph, A.C.; Brettschneider, J. 2010: MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS. Journal of the Neurological Sciences 294(1-2): 51-56

Wågsäter, D.; Zhu, C.; Björkegren, J.; Skogsberg, J.; Eriksson, P. 2011: MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-)Apob(100/100) mouse. International Journal of Molecular Medicine 28(2): 247-253

Seiler, R.; Thalmann, G.N.; Fleischmann, A. 2011: MMP-2 and MMP-9 in lymph-node-positive bladder cancer. Journal of Clinical Pathology 64(12): 1078-1082

Nolan, A.; Kwon, S.; Cho, S.J.; Naveed, B.; Comfort, A.L.; Prezant, D.J.; Rom, W.N.; Weiden, M.D. 2014: MMP-2 and TIMP-1 predict healing of WTC-lung injury in new York City firefighters. Respiratory Research 15: 5

Gai, X.; Zhang, Z.; Liang, Y.; Chen, Z.; Yang, X.; Hou, J.; Lan, X.; Zheng, W.; Hou, J.; Huang, M. 2010: MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease. Clinica Chimica Acta; International Journal of Clinical Chemistry 411(9-10): 719-724

Rey, M.Carolina.W.; Bonamigo, R.R.; Cartell, Aé.; Furian, R.; Bonfá, R.; Bonfá, R. 2011: MMP-2 and TIMP-2 in cutaneous melanoma: association with prognostic factors and description in cutaneous metastases. American Journal of Dermatopathology 33(4): 413-414

Rochel-Maia, S.S.; Santos, F.C.A.; Vilamaior, P.S.L.; Justulin, L.A.; Felisbino, S.L.; Góes, R.M.; Taboga, S.R. 2011: MMP-2 and TIMP-2 in the prostates of male and female mongolian gerbils: effects of hormonal manipulation. Histology and Histopathology 26(11): 1423-1434

Noh, S.; Jung, J.-J.; Jung, M.; Kim, T.S.; Park, C.H.; Lim, S.J.; Jeung, H.-C.; Cheol, H.; Chung, H.C.; Rha, S.Y. 2011: MMP-2 as a putative biomarker for carcinomatosis in gastric cancer. Hepato-Gastroenterology 58(112): 2015-2019

Boland, L.; Danger, R.; Cabon, Q.; Rabillard, M.; Brouard, S.; Bouvy, B.; Gauthier, O. 2014: MMP-2 as an early synovial biomarker for cranial cruciate ligament disease in dogs. Veterinary and Comparative Orthopaedics and Traumatology: V.C.O.T 27(3): 210-215

Bruni-Cardoso, A.; Lynch, C.C.; Rosa-Ribeiro, R.; Matrisian, L.M.; Carvalho, H.F. 2010: MMP-2 contributes to the development of the mouse ventral prostate by impacting epithelial growth and morphogenesis. Developmental Dynamics: An Official Publication of the American Association of Anatomists 239(9): 2386-2392

Choi, J.-H.; Kim, H.; Kim, H.-S.; Um, S.H.; Choi, J.-W.; Oh, B.-K. 2013: MMP-2 detective silicon nanowire biosensor using enzymatic cleavage reaction. Journal of Biomedical Nanotechnology 9(4): 732-735

Gondi, C.S.; Dinh, D.H.; Klopfenstein, J.D.; Gujrati, M.; Rao, J.S. 2009: MMP-2 downregulation mediates differential regulation of cell death via ErbB-2 in glioma xenografts. International Journal of Oncology 35(2): 257-263

Howard, E.W.; Crider, B.J.; Updike, D.L.; Bullen, E.C.; Parks, E.E.; Haaksma, C.J.; Sherry, D.M.; Tomasek, J.J. 2012: MMP-2 expression by fibroblasts is suppressed by the myofibroblast phenotype. Experimental Cell Research 318(13): 1542-1553

Mallis, A.; Teymoortash, A.; Mastronikolis, N.S.; Werner, J.A.; Papadas, T.A. 2012: MMP-2 expression in 102 patients with glottic laryngeal cancer. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 269(2): 639-642

Jin, E-Jung.; Choi, Y-Ae.; Kyun Park, E.; Bang, O-Sun.; Kang, S-Sung. 2007: MMP-2 functions as a negative regulator of chondrogenic cell condensation via down-regulation of the FAK-integrin beta1 interaction. Developmental Biology 308(2): 474-484

Kenny, H.A.; Lengyel, E. 2009: MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle 8(5): 683-688

Yang, J.; Fan, X.-H.; Guan, Y.-Q.; Li, Y.; Sun, W.; Yang, X.-Z.; Liu, R. 2010: MMP-2 gene polymorphisms in type 2 diabetes mellitus diabetic retinopathy. International Journal of Ophthalmology 3(2): 137-140

Fiotti, N.; Xiong, W.; Giansante, C. 2010: MMP-2 genetic variant and plaque features of instability. Atherosclerosis 210(1): 43-44

Raffetto, J.D.; Barros, Y.V.R.; Wells, A.K.; Khalil, R.A. 2010: MMP-2 induced vein relaxation via inhibition of [Ca2+]e-dependent mechanisms of venous smooth muscle contraction. Role of RGD peptides. Journal of Surgical Research 159(2): 755-764

Korkmaz, K.S.; de Rooij, B.-J.F.; van Hoek, B.; Janse, M.; Coenraad, M.J.; van der Reijden, J.J.; Weersma, R.K.; Porte, R.J.; Voorneveld, P.W.; Baranski, A.G.; Verspaget, H.W. 2014: MMP-2 is a disease-modifying gene in primary sclerosing cholangitis. Liver International: Official Journal of the International Association for the Study of the Liver 34(2): 274-280

Fredrich, M.; Illing, R.-B. 2010: MMP-2 is involved in synaptic remodeling after cochlear lesion. Neuroreport 21(5): 324-327

Hughes, B.G.; Fan, X.; Cho, W.J.; Schulz, R. 2014: MMP-2 is localized to the mitochondria-associated membrane of the heart. American Journal of Physiology. Heart and Circulatory Physiology 306(5): H764-H770

Verslegers, M.; Van Hove, I.; Dekeyster, E.; Gantois, I.; Hu, T.-T.; D'Hooge, R.; Arckens, L.; Moons, L. 2015: MMP-2 mediates Purkinje cell morphogenesis and spine development in the mouse cerebellum. Brain Structure and Function 220(3): 1601-1617

Odenbach, J.; Wang, X.; Cooper, S.; Chow, F.L.; Oka, T.; Lopaschuk, G.; Kassiri, Z.; Fernandez-Patron, C. 2011: MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE. Hypertension 57(1): 123-130

Xiong, W.; Meisinger, T.; Knispel, R.; Worth, J.M.; Baxter, B.T. 2012: MMP-2 regulates Erk1/2 phosphorylation and aortic dilatation in Marfan syndrome. Circulation Research 110(12): E92

Choi, W.-S.; Jeon, O.-H.; Kim, H.-H.; Kim, D.-S. 2008: MMP-2 regulates human platelet activation by interacting with integrin alphaIIbbeta3. Journal of Thrombosis and Haemostasis: Jth 6(3): 517-523

Bruni-Cardoso, A.; Rosa-Ribeiro, R.; Pascoal, V.D.B.; De Thomaz, A.A.; Cesar, C.L.; Carvalho, H.F. 2010: MMP-2 regulates rat ventral prostate development in vitro. Developmental Dynamics: An Official Publication of the American Association of Anatomists 239(3): 737-746

Chen, W.-H.; Luo, G.-F.; Lei, Q.; Jia, H.-Z.; Hong, S.; Wang, Q.-R.; Zhuo, R.-X.; Zhang, X.-Z. 2015: MMP-2 responsive polymeric micelles for cancer-targeted intracellular drug delivery. Chemical Communications 51(3): 465-468

Serra, P.; Bruczko, M.; Zapico, J.M.; Puckowska, A.; Garcia, M.A.; Martin-Santamaria, S.; Ramos, A.; de Pascual-Teresa, B. 2012: MMP-2 selectivity in hydroxamate-type inhibitors. Current Medicinal Chemistry 19(7): 1036-1064

Badiga, A.V.; Chetty, C.; Kesanakurti, D.; Are, D.; Gujrati, M.; Klopfenstein, J.D.; Dinh, D.H.; Rao, J.S. 2011: MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells. Plos one 6(6): E20614

Maddirela, D.R.; Kesanakurti, D.; Gujrati, M.; Rao, J.S. 2013: MMP-2 suppression abrogates irradiation-induced microtubule formation in endothelial cells by inhibiting αvβ3-mediated SDF-1/CXCR4 signaling. International Journal of Oncology 42(4): 1279-1288

Baig, S.; Kehoe, P.G.; Love, S. 2008: MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease. Neuropathology and Applied Neurobiology 34(2): 205-215

Kobayashi, T. 2014: MMP-2, -9 and TIMP-1, -2 assays in keratinocyte cultures. Methods in Molecular Biology 1195: 145-155

Jia, Y.; Hu, D.-N.; Zhu, D.; Zhang, L.; Gu, P.; Fan, X.; Zhou, J. 2014: MMP-2, MMP-3, TIMP-1, TIMP-2, and TIMP-3 protein levels in human aqueous humor: relationship with axial length. Investigative Ophthalmology and Visual Science 55(6): 3922-3928

Chen, D.; Wang, Q.; Ma, Z.-W.; Chen, F.-M.; Chen, Y.; Xie, G.-Y.; Wang, Q.-T.; Wu, Z.-F. 2007: MMP-2, MMP-9 and TIMP-2 gene polymorphisms in Chinese patients with generalized aggressive periodontitis. Journal of Clinical Periodontology 34(5): 384-389

Quaranta, M.; Daniele, A.; Coviello, M.; Venneri, M.T.; Abbate, I.; Caringella, M.E.; Di Tardo, S.; Divella, R.; Trerotoli, P.; Di Gennaro, M.; Schittulli, F.; Fransvea, E.; Giannelli, G. 2007: MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer. Anticancer Research 27(5b): 3593-3600

Leone, A.; Mauro, A.; Spatola, G.F.; Provenzano, S.; Caradonna, C.; Gerbino, A.; Buscemi, M. 2009: MMP-2, MMP-9, and iNOS expression in human dental pulp subjected to orthodontic traction. Angle Orthodontist 79(6): 1119-1125

Shaco-Levy, R.; Sharabi, S.; Piura, B.; Sion-Vardy, N. 2008: MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium. Acta Obstetricia et Gynecologica Scandinavica 87(8): 868-874

Sun, R.; Huang, Y.; Zhang, H.; Liu, R. 2013: MMP-2, TNF-α and NLRP1 polymorphisms in Chinese patients with ankylosing spondylitis and rheumatoid arthritis. Molecular Biology Reports 40(11): 6303-6308

Qin, Y.; Liu, X.-J.; Li, L.; Liu, X.-J.; Li, Y.; Gao, R.-J.; Shao, R.-G.; Zhen, Y.-S. 2014: MMP-2/9-oriented combinations enhance antitumor efficacy of EGFR/HER2-targeting fusion proteins and gemcitabine. Oncology Reports 32(1): 121-130

Givvimani, S.; Tyagi, N.; Sen, U.; Mishra, P.K.; Qipshidze, N.; Munjal, C.; Vacek, J.C.; Abe, O.A.; Tyagi, S.C. 2010: MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure. Archives of Physiology and Biochemistry 116(2): 63-72

Werner, S.R.; Dotzlaf, J.E.; Smith, R.C. 2008: MMP-28 as a regulator of myelination. Bmc Neuroscience 9: 83

Fujita, H.; Morisugi, T.; Tanaka, Y.; Kawakami, T.; Kirita, T.; Yoshimura, Y. 2009: MMP-3 activation is a hallmark indicating an early change in TMJ disorders, and is related to nitration. International Journal of Oral and Maxillofacial Surgery 38(1): 70-78

Romero, A.M.; Mastromatteo-Alberga, P.; Escalona, L.; Correnti, M.ía. 2013: MMP-3 and MMP-8 levels in patients with chronic periodontitis before and after nonsurgical periodontal therapy. Investigacion Clinica 54(2): 138-148

Chung, Y.Cheul.; Kim, Y-Seong.; Bok, E.; Yune, T.Young.; Maeng, S.; Jin, B.Kwan. 2013: MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson's disease. Mediators of Inflammation 2013: 370526

Munhoz, F.B.A.; Godoy-Santos, A.L.; Santos, M.C.L.G. 2010: MMP-3 polymorphism: Genetic marker in pathological processes (Review). Molecular Medicine Reports 3(5): 735-740

Muromachi, K.; Kamio, N.; Narita, T.; Annen-Kamio, M.; Sugiya, H.; Matsushima, K. 2012: MMP-3 provokes CTGF/CCN2 production independently of protease activity and dependently on dynamin-related endocytosis, which contributes to human dental pulp cell migration. Journal of Cellular Biochemistry 113(4): 1348-1358

Singh, H.; Jain, M.; Mittal, B. 2008: MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer. Gynecologic Oncology 110(1): 71-75

Ortega, P.; Moran, A.; Fernandez-Marcelo, T.; De Juan, C.; Frias, C.; Lopez-Asenjo, J.é-A.; Sanchez-Pernaute, A.és.; Torres, A.; Diaz-Rubio, E.; Iniesta, P.; Benito, M. 2010: MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway. International Journal of Oncology 36(5): 1209-1215

Letra, A.; Ghaneh, G.; Zhao, M.; Ray, H.; Francisconi, C.F.; Garlet, G.P.; Silva, R.M. 2013: MMP-7 and TIMP-1, new targets in predicting poor wound healing in apical periodontitis. Journal of Endodontics 39(9): 1141-1146

Ulivi, P.; Casoni, G.L.; Foschi, G.; Scarpi, E.; Tomassetti, S.; Romagnoli, M.; Ravaglia, C.; Mengozzi, M.; Zoli, W.; Poletti, V. 2013: MMP-7 and fcDNA serum levels in early NSCLC and idiopathic interstitial pneumonia: preliminary study. International Journal of Molecular Sciences 14(12): 24097-24112

Musiał, K.; Zwolińska, D. 2012: MMP-7 as a potential marker of cardiovascular complications in patients with chronic kidney disease (CKD). Basic and Clinical Pharmacology and Toxicology 111(2): 73-74

Koskensalo, S.; Louhimo, J.; Nordling, S.; Hagström, J.; Haglund, C. 2011: MMP-7 as a prognostic marker in colorectal cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 32(2): 259-264

Zhang, J.; Luo, J.; Ni, J.; Tang, L.; Zhang, H.P.; Zhang, L.; Xu, J.F.; Zheng, D. 2014: MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells. European Journal of Histochemistry: Ejh 58(1): 2262

Yeh, S.-I.; Han, K.-Y.; Sabri, A.; Rosenblatt, M.I.; Azar, D.T.; Jain, S.; Chang, J.-H. 2010: MMP-7 knock-in corneal fibroblast cell lines secrete MMP-7 with proteolytic activity towards collagen XVIIi. Current Eye Research 35(9): 799-805

Williams, H.; Johnson, J.L.; Jackson, C.L.; White, S.J.; George, S.J. 2010: MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis. Cardiovascular Research 87(1): 137-146

Koskensalo, S.; Mrena, J.; Wiksten, J.-P.; Nordling, S.; Kokkola, A.; Hagström, J.; Haglund, C. 2010: MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 31(3): 149-155

Atsuta, R. 2008: MMP-7 regulation of apoptosis via Fas-pathway in human airway epithelial cells. Nihon Kokyuki Gakkai Zasshi 46(1): 65

Chou, Y.-H.; Ho, Y.-P.; Lin, Y.-C.; Hu, K.-F.; Yang, Y.-H.; Ho, K.-Y.; Wu, Y.-M.; Hsi, E.; Tsai, C.-C. 2011: MMP-8 -799 C>T genetic polymorphism is associated with the susceptibility to chronic and aggressive periodontitis in Taiwanese. Journal of Clinical Periodontology 38(12): 1078-1084

González-López, A.án.; Aguirre, A.; López-Alonso, I.és.; Amado, L.; Astudillo, A.; Fernández-García, M.ía.S.; Suárez, M.ía.F.; Batalla-Solís, E.ía.; Colado, E.; Albaiceta, G.M. 2012: MMP-8 deficiency increases TLR/RAGE ligands S100A8 and S100A9 and exacerbates lung inflammation during endotoxemia. Plos one 7(6): E39940

Rella, J.M.; Jilma, B.; Fabry, A.; Kaynar, A.M.; Mayr, F.B. 2014: MMP-8 genotypes influence the inflammatory response in human endotoxemia. Inflammation 37(2): 451-456

Godoy-Santos, A.; Ortiz, R.T.; Mattar Junior, R.; Fernandes, T.D.; Santos, M.C.L.G. 2014: MMP-8 polymorphism is genetic marker to tendinopathy primary posterior tibial tendon. Scandinavian Journal of Medicine and Science in Sports 24(1): 220-223

Khatwa, U.A.; Kleibrink, B.E.; Shapiro, S.D.; Subramaniam, M. 2010: MMP-8 promotes polymorphonuclear cell migration through collagen barriers in obliterative bronchiolitis. Journal of Leukocyte Biology 87(1): 69-77

Rahimi, Z.; Rahimi, Z.; Shahsavandi, M.O.; Bidoki, K.; Rezaei, M. 2013: MMP-9 (-1562 C:T) polymorphism as a biomarker of susceptibility to severe pre-eclampsia. Biomarkers in Medicine 7(1): 93-98

Bendardaf, R.; Buhmeida, A.; Hilska, M.; Laato, M.; Syrjänen, S.; Syrjänen, K.; Collan, Y.ö; Pyrhönen, S. 2010: MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients. Cancer Investigation 28(1): 38-43

Lee, T.-Y.; Yu, C.-C.; Wu, C.-C.; Chang, C.-S.; Lin, J.-T.; Wu, M.-S.; Chen, H.-P.; Wu, C.-Y. 2013: MMP-9 -1562 Promoter Polymorphism Associated with Gastric Cancer Risk in Females. Hepato-Gastroenterology 60(126)

Pan, Y.; Li, D.; Cai, Q.; Zhang, W.; Ma, J.; Wang, M.; Wang, L. 2013: MMP-9 -1562C>T contributes to periodontitis susceptibility. Journal of Clinical Periodontology 40(2): 125-130

Wanninger, J.; Walter, R.; Bauer, S.; Eisinger, K.; Schäffler, A.; Dorn, C.; Weiss, T.S.; Hellerbrand, C.; Buechler, C. 2011: MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis. Experimental and Molecular Pathology 91(2): 603-607

Dwivedi, A.; Slater, S.C.; George, S.J. 2009: MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation. Cardiovascular Research 81(1): 178-186

Zambuzzi, W.F.; Paiva, K.úc.B.S.; Menezes, R.; Oliveira, R.C.; Taga, R.; Granjeiro, J.é M. 2009: MMP-9 and CD68(+) cells are required for tissue remodeling in response to natural hydroxyapatite. Journal of Molecular Histology 40(4): 301-309

Lettner, T.; Lang, R.; Klausegger, A.; Hainzl, S.; Bauer, J.W.; Wally, V. 2013: MMP-9 and CXCL8/IL-8 are potential therapeutic targets in epidermolysis bullosa simplex. Plos one 8(7): E70123

Sun, Y.; Ma, L.; Yan, F.; Liu, H.; Ding, Y.; Hou, J.; Jiang, L. 2012: MMP-9 and IL-6 are potential biomarkers for disease activity in Takayasu's arteritis. International Journal of Cardiology 156(2): 236-238

Fukunaga, S.; Ichiyama, T.; Maeba, S.; Okuda, M.; Nakata, M.; Sugino, N.; Furukawa, S. 2009: MMP-9 and TIMP-1 in the cord blood of premature infants developing BPD. Pediatric Pulmonology 44(3): 267-272

Sambursky, R.; O'Brien, T.P. 2011: MMP-9 and the perioperative management of LASIK surgery. Current Opinion in Ophthalmology 22(4): 294-303

Veeravalli, K.K.; Rao, J.S. 2012: MMP-9 and uPAR regulated glioma cell migration. Cell Adhesion and Migration 6(6): 509-512

Nanda, D.P.; Dutta, K.; Ganguly, K.K.; Hajra, S.; Mandal, S.S.; Biswas, J.; Sinha, D. 2014: MMP-9 as a potential biomarker for carcinoma of oral cavity: a study in eastern India. Neoplasma 61(6): 747-757

Bratcher, P.E.; Weathington, N.M.; Nick, H.J.; Jackson, P.L.; Snelgrove, R.J.; Gaggar, A. 2012: MMP-9 cleaves SP-D and abrogates its innate immune functions in vitro. Plos one 7(7): E41881

Kato, H.; Kuriyama, N.; Duarte, S.; Clavien, P.-A.; Busuttil, R.W.; Coito, A.J. 2014: MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury. Journal of Hepatology 60(5): 1032-1039

Nowak, E.; Galilejczyk, A.; Sypniewski, D.; Bednarek, I. 2013: MMP-9 directed sh RNAs as relevant inhibitors of matrix metalloproteinase 9 activity and signaling. Postepy Higieny i Medycyny Doswiadczalnej 67: 742-749

Barresi, V.; Vitarelli, E.; Tuccari, G.; Barresi, G. 2011: MMP-9 expression in meningiomas: a prognostic marker for recurrence risk?. Journal of Neuro-Oncology 102(2): 189-196

He, J-Rong.; Qin, H.; Ren, Z-Feng.; Cui, C.; Zhang, Y.; Ranatunga, D.; Zeng, Y-Xin.; Jia, W-Hua. 2011: MMP-9 expression in peripheral blood mononuclear cells and the association with clinicopathological features and prognosis of nasopharyngeal carcinoma. Clinical Chemistry and Laboratory Medicine 49(4): 705-710

Matheus, E.R.; Zonta, M.A.; Discacciati, M.G.; Paruci, P.; Velame, F.; Cardeal, L.B.S.; Barros, S.B.M.; Pignatari, A.C.; Maria-Engler, S.S. 2014: MMP-9 expression increases according to the grade of squamous intraepithelial lesion in cervical smears. Diagnostic Cytopathology 42(10): 827-833

Wu, Y.; Mukaida, N.; Liu, T.; Jia, Y.-q.; Zhu, H.-l.; Yang, Y.-m.; Xu, C.-g.; Hu, Z.-x. 2009: MMP-9 expression profile in inflammatory cells of Mip-1alpha knockout mice and Mip-1alpha receptor knockout mice. Sichuan da Xue Xue Bao. Yi Xue Ban 40(3): 374-377

Yousef, E.M.; Tahir, M.R.; St-Pierre, Y.; Gaboury, L.A. 2014: MMP-9 expression varies according to molecular subtypes of breast cancer. Bmc Cancer 14: 609

Mishra, P.K.; Metreveli, N.; Tyagi, S.C. 2010: MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA. Cell Biochemistry and Biophysics 57(2-3): 67-76

Bhargava, S.; Pushpakumar, S.; Metreveli, N.; Givvimani, S.; Tyagi, S.C. 2014: MMP-9 gene ablation mitigates hyperhomocystenemia-induced cognition and hearing dysfunction. Molecular Biology Reports 41(8): 4889-4898

Bonoiu, A.; Mahajan, S.D.; Ye, L.; Kumar, R.; Ding, H.; Yong, K.-T.; Roy, I.; Aalinkeel, R.; Nair, B.; Reynolds, J.L.; Sykes, D.E.; Imperiale, M.A.; Bergey, E.J.; Schwartz, S.A.; Prasad, P.N. 2009: MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier. Brain Research 1282: 142-155

Pinto, L.A.; Depner, M.; Klopp, N.; Illig, T.; Vogelberg, C.; von Mutius, E.; Kabesch, M. 2010: MMP-9 gene variants increase the risk for non-atopic asthma in children. Respiratory Research 11: 23

Kojima, C.; Ino, J.; Ishii, H.; Nitta, K.; Yoshida, M. 2010: MMP-9 inhibition by ACE inhibitor reduces oxidized LDL-mediated foam-cell formation. Journal of Atherosclerosis and Thrombosis 17(1): 97-105

Chen, D.; Zhang, X.; Guo, Y.; Shi, S.; Mao, X.; Pan, X.; Cheng, T. 2012: MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model. International Journal of Molecular Medicine 30(6): 1417-1423

Jia, F.; Yin, Y.H.; Gao, G.Y.; Wang, Y.; Cen, L.; Jiang, J.-Y. 2014: MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat. Journal of Neurotrauma 31(13): 1225-1234

Gaudet, J.G.; Yocum, G.T.; Lee, S.S.; Granat, A.; Mikami, M.; Connolly, E.S.; Heyer, E.J. 2010: MMP-9 levels in elderly patients with cognitive dysfunction after carotid surgery. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 17(4): 436-440

Reis, S.T.; Pontes-Junior, J.é; Antunes, A.A.; de Sousa-Canavez, J.M.; Dall'Oglio, M.F.; Passerotti, C.C.; Abe, D.K.; Crippa, A.; da Cruz, J.A.S.; Timoszczuk, L.M.S.; Srougi, M.; Leite, K.át.R.M. 2011: MMP-9 overexpression due to TIMP-1 and RECK underexpression is associated with prognosis in prostate cancer. International Journal of Biological Markers 26(4): 255-261

Morgan, J.; Rouche, A.ée.; Bausero, P.; Houssaïni, A.; Gross, J.; Fiszman, M.Y.; Alameddine, H.S. 2010: MMP-9 overexpression improves myogenic cell migration and engraftment. Muscle and Nerve 42(4): 584-595

Yang, Z.-H.; Li, S.-N.; Liu, J.-X.; Guo, Q.-X.; Sun, X.-W. 2012: MMP-9 polymorphisms are related to serum lipids levels but not associated with colorectal cancer susceptibility in Chinese population. Molecular Biology Reports 39(10): 9399-9404

Lowrey, G.E.; Henderson, N.; Blakey, J.D.; Corne, J.M.; Johnson, S.R. 2008: MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD. Respiratory Medicine 102(6): 845-851

Vaisar, T.ás.; Kassim, S.Y.; Gomez, I.G.; Green, P.S.; Hargarten, S.; Gough, P.J.; Parks, W.C.; Wilson, C.L.; Raines, E.W.; Heinecke, J.W. 2009: MMP-9 sheds the beta2 integrin subunit (CD18) from macrophages. Molecular and Cellular Proteomics: Mcp 8(5): 1044-1060

Wiernicki, I.; Millo, B.; Safranow, K.; Gorecka-Szyld, B.; Gutowski, P. 2011: MMP-9, homocysteine and CRP circulating levels are associated with intraluminal thrombus thickness of abdominal aortic aneurysms: new implication of the old biomarkers. Disease Markers 31(2): 67-74

Veeravalli, K.K.; Chetty, C.; Ponnala, S.; Gondi, C.S.; Lakka, S.S.; Fassett, D.; Klopfenstein, J.D.; Dinh, D.H.; Gujrati, M.; Rao, J.S. 2010: MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice. Plos one 5(7): E11583

Jotwani, R.; Eswaran, S.V.K.; Moonga, S.; Cutler, C.W. 2010: MMP-9/TIMP-1 imbalance induced in human dendritic cells by Porphyromonas gingivalis. Fems Immunology and Medical Microbiology 58(3): 314-321

Ibarra, J.M.; Jimenez, F.; Martinez, H.G.; Clark, K.; Ahuja, S.S. 2011: MMP-Activated Fluorescence Imaging Detects Early Joint Inflammation in Collagen-Antibody-Induced Arthritis in CC-Chemokine Receptor-2-Null Mice, In-Vivo. International Journal of Inflammation 2011: 691587

Hu, X.; Hu, Y.; Vogt, M.; Stumpfe, D.; Bajorath, J.ür. 2012: MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs. Journal of Chemical Information and Modeling 52(5): 1138-1145

Sato, M.; Hirayama, S.; Lara-Guerra, H.; Anraku, M.; Waddell, T.K.; Liu, M.; Keshavjee, S. 2009: MMP-dependent migration of extrapulmonary myofibroblast progenitors contributing to posttransplant airway fibrosis in the lung. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 9(5): 1027-1036

Savarin, C.; Bergmann, C.C.; Hinton, D.R.; Stohlman, S.A. 2013: MMP-independent role of TIMP-1 at the blood brain barrier during viral encephalomyelitis. Asn Neuro 5(5): E00127

Zhou, J.; Tan, J.; Yang, X.; Xu, X.; Li, D.; Chen, L. 2011: MMP-inhibitory effect of chlorhexidine applied in a self-etching adhesive. Journal of Adhesive Dentistry 13(2): 111-115

Zhao, X.L.; Li, G.Z.; Sun, B.; Zhang, Z.L.; Yin, Y.H.; Tian, Y.S.; Li, H.; Li, H.L.; Wang, D.S.; Zhong, D. 2010: MMP-mediated cleavage of beta-dystroglycan in myelin sheath is involved in autoimmune neuritis. Biochemical and Biophysical Research Communications 392(4): 551-556

Garvican, E.R.; Vaughan-Thomas, A.; Redmond, C.; Gabriel, N.; Clegg, P.D. 2010: MMP-mediated collagen breakdown induced by activated protein C in equine cartilage is reduced by corticosteroids. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 28(3): 370-378

Yang, Y.; Rosenberg, G.A. 2011: MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia. Methods in Molecular Biology 762: 333-345

Turturro, M.V.; Christenson, M.C.; Larson, J.C.; Young, D.A.; Brey, E.M.; Papavasiliou, G. 2013: MMP-sensitive PEG diacrylate hydrogels with spatial variations in matrix properties stimulate directional vascular sprout formation. Plos one 8(3): E58897

Pustovrh, M.C.; Capobianco, E.; Martínez, N.; Higa, R.; White, V.; Jawerbaum, A. 2009: MMP/ TIMP balance is modulated in vitro by 15dPGJ(2) in fetuses and placentas from diabetic rats. European Journal of Clinical Investigation 39(12): 1082-1090

Wong, S.; Belvisi, M.G.; Birrell, M.A. 2009: MMP/TIMP expression profiles in distinct lung disease models: implications for possible future therapies. Respiratory Research 10: 72

Küchler, E.C.; Menezes, R.; Callahan, N.; Costa, M.C.; Modesto, A.; Meira, R.; Patir, A.; Seymen, F.; Paiva, Kúcia.B.S.; Nunes, F.Daumas.; Granjeiro, Jé.Mauro.; Vieira, A.R. 2011: MMP1 and MMP20 contribute to tooth agenesis in humans. Archives of Oral Biology 56(5): 506-511

Affara, M.; Dunmore, B.J.; Sanders, D.A.; Johnson, N.; Print, C.G.; Charnock-Jones, D.S. 2011: MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms. Bmc Genomics 12: 43

Hu, J.; Pan, J.; Luo, Z.-G. 2012: MMP1 rs1799750 single nucleotide polymorphism and lung cancer risk: a meta-analysis. Asian Pacific Journal of Cancer Prevention: Apjcp 13(12): 5981-5984

Chimal-Ramírez, G.K.; Espinoza-Sánchez, N.A.; Utrera-Barillas, D.; Benítez-Bribiesca, L.; Velázquez, J.R.; Arriaga-Pizano, L.A.; Monroy-García, A.; Reyes-Maldonado, E.; Domínguez-López, M.L.; Piña-Sánchez, P.; Fuentes-Pananá, E.M. 2013: MMP1, MMP9, and COX2 expressions in promonocytes are induced by breast cancer cells and correlate with collagen degradation, transformation-like morphological changes in MCF-10A acini, and tumor aggressiveness. Biomed Research International 2013: 279505

Xiao, X.-Y.; Wang, X.-D.; Zang, D.-Y. 2012: MMP1-1607 1G/2G polymorphism and lung cancer risk: a meta-analysis. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 33(6): 2385-2392

Fakhoury, H.; Noureddine, S.; Chmaisse, H.N.; Tamim, H.; Makki, R.F. 2012: MMP1-1607(1G>2G) polymorphism and the risk of lung cancer in Lebanon. Annals of Thoracic Medicine 7(3): 130-132

Peruzzi, D.; Mori, F.; Conforti, A.; Lazzaro, D.; De Rinaldis, E.; Ciliberto, G.; La Monica, N.; Aurisicchio, L. 2009: MMP11: a novel target antigen for cancer immunotherapy. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(12): 4104-4113

Morita, H.; Nagai, R. 2010: MMP12, lung function, and COPD in high-risk populations. New England Journal of Medicine 362(13): 1241; Author Reply 1242

Lederle, W.; Hartenstein, B.; Meides, A.; Kunzelmann, H.; Werb, Z.; Angel, P.; Mueller, M.M. 2010: MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma. Carcinogenesis 31(7): 1175-1184

Hata, H.; Abe, R.; Suto, A.; Homma, E.; Fujita, Y.; Aoyagi, S.; Shimizu, H. 2015: MMP13 can be a useful differentiating marker between squamous cell carcinoma and benign hyperkeratotic lesions in recessive dystrophic epidermolysis bullosa. British Journal of Dermatology 172(3): 769-773

Huang, M.-Y.; Chang, H.-J.; Chung, F.-Y.; Yang, M.-J.; Yang, Y.-H.; Wang, J.-Y.; Lin, S.-R. 2010: MMP13 is a potential prognostic marker for colorectal cancer. Oncology Reports 24(5): 1241-1247

Chang, H.-J.; Yang, M.-J.; Yang, Y.-H.; Hou, M.-F.; Hsueh, E.-J.; Lin, S.-R. 2009: MMP13 is potentially a new tumor marker for breast cancer diagnosis. Oncology Reports 22(5): 1119-1127

Meierjohann, S.; Hufnagel, A.; Wende, E.; Kleinschmidt, M.A.; Wolf, K.; Friedl, P.; Gaubatz, S.; Schartl, M. 2010: MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation. Molecular Cancer 9: 201

Bonafé, L.; Liang, J.; Gorna, M.W.; Zhang, Q.; Ha-Vinh, R.; Campos-Xavier, A.B.; Unger, S.; Beckmann, J.S.; Le Béchec, A.; Stevenson, B.; Giedion, A.; Liu, X.; Superti-Furga, G.; Wang, W.; Spahr, A.é; Superti-Furga, A. 2014: MMP13 mutations are the cause of recessive metaphyseal dysplasia, Spahr type. American Journal of Medical Genetics. Part a 164a (5): 1175-1179

Tannure, P.N.; Küchler, E.C.; Falagan-Lotsch, P.; Amorim, L.M.F.; Raggio Luiz, R.; Costa, M.C.; Vieira, A.R.; Granjeiro, J.M. 2012: MMP13 polymorphism decreases risk for dental caries. Caries Research 46(4): 401-407

Ma, O.; Cai, W.-W.; Zender, L.; Dayaram, T.; Shen, J.; Herron, A.J.; Lowe, S.W.; Man, T.-K.; Lau, C.C.; Donehower, L.A. 2009: MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression. Cancer Research 69(6): 2559-2567

Beck, I.M.; Rückert, R.é; Brandt, K.; Mueller, M.S.; Sadowski, T.; Brauer, R.; Schirmacher, P.; Mentlein, R.; Sedlacek, R. 2008: MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses. Plos one 3(6): E2343

Eldred, J.A.; Hodgkinson, L.M.; Dawes, L.J.; Reddan, J.R.; Edwards, D.R.; Wormstone, I.M. 2012: MMP2 activity is critical for TGFβ2-induced matrix contraction--implications for fibrosis. Investigative Ophthalmology and Visual Science 53(7): 4085-4098

Frontczak-Baniewicz, M.łg.; Walski, M.ł; Madejska, G.; Sulejczak, D. 2009: MMP2 and MMP9 in immature endothelial cells following surgical injury of rat cerebral cortex--a preliminary study. Folia Neuropathologica 47(4): 338-346

Görmüş, U.; Kahraman, O.T.; Isbir, S.; Tekeli, A.; Isbir, T. 2011: MMP2 gene polymorphisms and MMP2 mRNA levels in patients with superficial varices of lower extremities. In Vivo 25(3): 387-391

Volcik, K.A.; Campbell, S.; Chambless, L.E.; Coresh, J.; Folsom, A.R.; Mosley, T.H.; Ni, H.; Wagenknecht, L.E.; Wasserman, B.A.; Boerwinkle, E. 2010: MMP2 genetic variation is associated with measures of fibrous cap thickness: the Atherosclerosis Risk in Communities Carotid MRi Study. Atherosclerosis 210(1): 188-193

Court, F.A.; Zambroni, D.ée.; Pavoni, E.; Colombelli, C.; Baragli, C.; Figlia, G.; Sorokin, L.; Ching, W.; Salzer, J.L.; Wrabetz, L.; Feltri, M.L. 2011: MMP2-9 cleavage of dystroglycan alters the size and molecular composition of Schwann cell domains. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 31(34): 12208-12217

Chaussain, C.; Eapen, A.S.; Huet, E.; Floris, C.; Ravindran, S.; Hao, J.; Menashi, S.; George, A. 2009: MMP2-cleavage of DMP1 generates a bioactive peptide promoting differentiation of dental pulp stem/progenitor cell. European Cells and Materials 18: 84-95

Yamakoshi, Y.; Simmer, J.P.; Bartlett, J.D.; Karakida, T.; Oida, S. 2013: MMP20 and KLK4 activation and inactivation interactions in vitro. Archives of Oral Biology 58(11): 1569-1577

Bartlett, J.D.; Yamakoshi, Y.; Simmer, J.P.; Nanci, A.; Smith, C.E. 2011: MMP20 cleaves E-cadherin and influences ameloblast development. Cells Tissues Organs 194(2-4): 222-226

Lee, S-K.; Seymen, F.; Kang, H-Y.; Lee, K-E.; Gencay, K.; Tuna, B.; Kim, J-W. 2010: MMP20 hemopexin domain mutation in amelogenesis imperfecta. Journal of Dental Research 89(1): 46-50

Guan, X.; Bartlett, J.D. 2013: MMP20 modulates cadherin expression in ameloblasts as enamel develops. Journal of Dental Research 92(12): 1123-1128

Gan, Y.; Herzog, E.L. 2014: MMP28 and macrophage polarization: orchestrating the attack of the mac. Journal of Leukocyte Biology 95(1): 1-3

Swingler, T.E.; Kevorkian, L.; Culley, K.L.; Illman, S.A.; Young, D.A.; Parker, A.E.; Lohi, J.; Clark, I.M. 2010: MMP28 gene expression is regulated by Sp1 transcription factor acetylation. Biochemical Journal 427(3): 391-400

Gharib, S.A.; Johnston, L.K.; Huizar, I.; Birkland, T.P.; Hanson, J.; Wang, Y.; Parks, W.C.; Manicone, A.M. 2014: MMP28 promotes macrophage polarization toward M2 cells and augments pulmonary fibrosis. Journal of Leukocyte Biology 95(1): 9-18

Sipos, F.; Germann, T.M.; Wichmann, B.ás.; Galamb, O.; Spisák, S.án.; Krenács, T.; Tulassay, Z.; Molnár, B.él.; Műzes, G.ör. 2014: MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 23(5): 336-343

Letra, A.; Silva, R.M.; Rylands, R.J.; Silveira, E.M.; de Souza, A.P.; Wendell, S.K.; Garlet, G.P.; Vieira, A.R. 2012: MMP3 and TIMP1 variants contribute to chronic periodontitis and may be implicated in disease progression. Journal of Clinical Periodontology 39(8): 707-716

Yuan-Yuan, M.; Li-Feng, Z.; Li-Jie, Z. 2012: MMP7 -181G allele is a low-penetrant risk factor for cancer development in East Asians. Dna and Cell Biology 31(5): 772-776

Bavi, P.P.; Bu, R.; Uddin, S.; Al-Kuraya, K.S. 2011: MMP7 Polymorphisms - a new tool in molecular pathology to understand esophageal cancer. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 17(5): 299-300

Wieczorek, E.; Reszka, E.; Wasowicz, W.; Grzegorczyk, A.; Konecki, T.; Sosnowski, M.; Jablonowski, Z. 2014: MMP7 and MMP8 genetic polymorphisms in bladder cancer patients. Central European Journal of Urology 66(4): 405-410

Ohashi, S.; Natsuizaka, M.; Nakagawa, H. 2011: MMP7 and activation of IGF-1R: a new insight into anti-EGFR therapeutic resistance in metastatic colorectal cancer. Cancer Biology and Therapy 11(2): 184-187

Polistena, A.; Cucina, A.; Dinicola, S.; Stene, C.; Cavallaro, G.; Ciardi, A.; Orlando, G.; Arena, R.; D'Ermo, G.; Cavallaro, A.; Johnson, L.B.; De Toma, G. 2014: MMP7 expression in colorectal tumours of different stages. In Vivo 28(1): 105-110

Fang, Y.-J.; Pan, Z.-Z.; Li, L.-R.; Lu, Z.-H.; Zhang, L.-Y.; Wan, D.-S. 2009: MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells. Journal of Experimental and Clinical Cancer Research: Cr 28: 132

Chen, P.; Abacherli, L.E.; Nadler, S.T.; Wang, Y.; Li, Q.; Parks, W.C. 2009: MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation. Plos one 4(8): E6565

Pei, J.; Lou, Y.; Zhong, R.; Han, B. 2014: MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(7): 6673-6678

Bengatta, S.; Arnould, C.; Letavernier, E.; Monge, M.; de Préneuf, H.él.èn.M.; Werb, Z.; Ronco, P.; Lelongt, B. 2009: MMP9 and SCF protect from apoptosis in acute kidney injury. Journal of the American Society of Nephrology: Jasn 20(4): 787-797

Fountzilas, G.; Kalogera-Fountzila, A.; Lambaki, S.; Wirtz, R.M.; Nikolaou, A.; Karayannopoulou, G.; Bobos, M.; Kotoula, V.; Murray, S.; Lambropoulos, A.; Aravantinos, G.; Markou, K.; Athanassiou, E.; Misailidou, D.; Kalogeras, K.T.; Skarlos, D. 2009: MMP9 but not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer. Journal of Oncology 2009: 305908

Pal-Ghosh, S.; Blanco, T.; Tadvalkar, G.; Pajoohesh-Ganji, A.; Parthasarathy, A.; Zieske, J.D.; Stepp, M.A. 2011: MMP9 cleavage of the β4 integrin ectodomain leads to recurrent epithelial erosions in mice. Journal of Cell Science 124(Part 15): 2666-2675

Savarin, C.; Stohlman, S.A.; Rietsch, A.M.; Butchi, N.; Ransohoff, R.M.; Bergmann, C.C. 2011: MMP9 deficiency does not decrease blood-brain barrier disruption, but increases astrocyte MMP3 expression during viral encephalomyelitis. Glia 59(11): 1770-1781

Wan, C.; Yuan, G.; Yang, J.; Sun, Q.; Zhang, L.; Zhang, J.; Zhang, L.; Chen, Z. 2014: MMP9 deficiency increased the size of experimentally induced apical periodontitis. Journal of Endodontics 40(5): 658-664

Zeng, R.; Zhang, X.; Wu, K.; Su, Y.; Wen, F. 2014: MMP9 gene polymorphism is not associated with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population. Ophthalmic Genetics 35(4): 235-240

Chen, Y.Dong.; Xu, X.; Xia, X.; Wu, H.; Liu, K.; Zheng, Z.; Zhu, D. 2008: MMP9 is involved in glycation end-products induced increase of retinal vascular permeability in rats and the therapeutic effect of minocycline. Current Eye Research 33(11): 977-983

Hald, A.; Rønø, B.; Melander, M.C.; Ding, M.; Holck, S.; Lund, L.R. 2011: MMP9 is protective against lethal inflammatory mass lesions in the mouse colon. Disease Models and Mechanisms 4(2): 212-227

Arnould, C.; Lelièvre-Pégorier, M.; Ronco, P.; Lelongt, B. 2009: MMP9 limits apoptosis and stimulates branching morphogenesis during kidney development. Journal of the American Society of Nephrology: Jasn 20(10): 2171-2180

Sun, D.; Wang, X.; Zhang, H.; Deng, L.; Zhang, Y. 2011: MMP9 mediates MICA shedding in human osteosarcomas. Cell Biology International 35(6): 569-574

Vermeer, P.D.; Denker, J.; Estin, M.; Moninger, T.O.; Keshavjee, S.; Karp, P.; Kline, J.N.; Zabner, J. 2009: MMP9 modulates tight junction integrity and cell viability in human airway epithelia. American Journal of Physiology. Lung Cellular and Molecular Physiology 296(5): L751-L762

Beeghly-Fadiel, A.; Lu, W.; Shu, X-Ou.; Long, J.; Cai, Q.; Xiang, Y.; Gao, Y-Tang.; Zheng, W. 2011: MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study. Breast cancer research and treatment 126(2): 507-513

Choi, S.-h.; Lee, H.-J.; Jin, Y.B.; Jang, J.; Kang, G.-y.; Lee, M.; Kim, C.-H.; Kim, J.; Yoon, S.S.; Lee, Y.-s.; Lee, Y.-J. 2014: MMP9 processing of HSPB1 regulates tumor progression. Plos one 9(1): E85509

Wang, X.; Yu, Y.Y.; Lieu, S.; Yang, F.; Lang, J.; Lu, C.; Werb, Z.; Hu, D.; Miclau, T.; Marcucio, R.; Colnot, C.él. 2013: MMP9 regulates the cellular response to inflammation after skeletal injury. Bone 52(1): 111-119

Inzitari, D.; Giusti, B.; Nencini, P.; Gori, A.M.; Nesi, M.; Palumbo, V.; Piccardi, B.; Armillis, A.; Pracucci, G.; Bono, G.; Bovi, P.; Consoli, D.; Guidotti, M.; Nucera, A.; Massaro, F.; Micieli, G.; Orlandi, G.; Perini, F.; Tassi, R.; Tola, M.R.; Sessa, M.; Toni, D.; Abbate, R. 2013: MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death. Stroke 44(10): 2901-2903

Campanera, J.M.; Pouplana, R. 2010: MMPBSA decomposition of the binding energy throughout a molecular dynamics simulation of amyloid-beta (Abeta(10-35)) aggregation. Molecules 15(4): 2730-2748

Doleys, D.M.; Brown, J. 2001: MMPi Profile as an Outcome "Predictor" in the Treatment of Noncancer Pain Patients Utilizing Intraspinal Opioid Therapy. Neuromodulation: Journal of the International Neuromodulation Society 4(3): 93-97

Kidner, C.L.; Gatchel, R.J.; Mayer, T.G. 2010: MMPi disability profile is associated with degree of opioid use in chronic work-related musculoskeletal disorders. Clinical Journal of Pain 26(1): 9-15

Gass, C.S.; Odland, A.P. 2014: MMPI-2 Symptom Validity (FBS) Scale: psychometric characteristics and limitations in a Veterans Affairs neuropsychological setting. Applied Neuropsychology. Adult 21(1): 1-8

Knabb, J.J.; Vogt, R.G.; Newgren, K.P. 2011: MMPI-2 characteristics of the Old Order Amish: a comparison of clinical, nonclinical, and United States normative samples. Psychological Assessment 23(4): 865-875

Gómez-Gil, E.; Vidal-Hagemeijer, A.; Salamero, M. 2008: MMPI-2 characteristics of transsexuals requesting sex reassignment: comparison of patients in prehormonal and presurgical phases. Journal of Personality Assessment 90(4): 368-374

Wicklund, A.H.; Ammar, A.; Weitlauf, J.C.; Heilbronner, R.L.; Fink, J.; Lee, R.C.; Kelley, K.; Pliskin, N.H. 2008: MMPI-2 patterns in electrical injury: a controlled investigation. Clinical Neuropsychologist 22(1): 98-111

Romeo, L.; Balducci, C.; Quintarelli, E.; Riolfi, A.; Pelizza, L.; Serpelloni, A.; Tisato, S.; Perbellini, L. 2013: MMPI-2 personality profiles and suicidal ideation and behavior in victims of bullying at work: a follow-up study. Violence and Victims 28(6): 1000-1014

Paolucci, T.; Vetrano, M.; Zangrando, F.; Vulpiani, M.C.; Grasso, M.R.; Trifoglio, D.; Di Franco, M.; Iannuccelli, C.; Sorgi, M.L.; Reis, V.; Saraceni, V.M.; Guidetti, L. 2015: MMPI-2 profiles and illness perception in fibromyalgia syndrome: the role of therapeutic exercise as adapted physical activity. Journal of Back and Musculoskeletal Rehabilitation 28(1): 101-109

Shercliffe, R.J.; Colotla, V. 2009: MMPI-2 profiles in civilian PTSD: an examination of differential responses between victims of crime and industrial accidents. Journal of Interpersonal Violence 24(2): 349-360

Kinder, B.N.; Walfish, S.; Scott Young, M.; Fairweather, A. 2008: MMPI-2 profiles of bariatric surgery patients: a replication and extension. Obesity Surgery 18(9): 1170-1179

Exterkate, C.C.; Bakker-Brehm, D.T.; de Jong, C.A.J. 2007: MMPI-2 profiles of women with eating disorders in a Dutch day treatment sample. Journal of Personality Assessment 88(2): 178-186

Johnson, A.L.; Storzbach, D.; Binder, L.M.; Barkhuizen, Aé.; Kent Anger, W.; Salinsky, M.C.; Tun, S-Myo.; Rohlman, D.S. 2010: MMPI-2 profiles: fibromyalgia patients compared to epileptic and non-epileptic seizure patients. Clinical Neuropsychologist 24(2): 220-234

Purdon, S.E.; Purser, S.M.; Goddard, K.M. 2011: MMPI-2 restructured form over-reporting scales in first-episode psychosis. Clinical Neuropsychologist 25(5): 829-842

Greiffenstein, M.F.; Baker, W.John.; Tsushima, W.T.; Boone, K.; Fox, D.D. 2010: MMPI-2 validity scores in defense- versus plaintiff-selected examinations: a repeated measures study of examiner effects. Clinical Neuropsychologist 24(2): 305-314

Fazio, R.L.; Wunderlich, T.; Wilson, N.; Akeson, S. 2014: MMPI-2-RF characteristics of individuals with interstitial cystitis. Journal of Psychosomatic Research 77(5): 359-362

Pennuto, T.O'Connor.; Archer, R.P. 2008: MMPI-A forensic case studies: uses in documented court decisions. Journal of Personality Assessment 90(3): 215-226

Bodde, N.M.G.; Bartelet, D.C.J.; Ploegmakers, M.; Lazeron, R.H.C.; Aldenkamp, A.P.; Boon, P.A.J.M. 2011: MMPI-Ii personality profiles of patients with psychogenic nonepileptic seizures. Epilepsy and Behavior: E&b 20(4): 674-680

Zhao, Y.-f.; Li, X.-l.; Sun, Y.-x.; Niu, W.; Hu, Z.-l.; Lin, L.; Kong, Q.-z. 2010: MMPT: a thiazolidin compound inhibits the growth of lung cancer H1792 cells via Fas-mediated and caspase-dependent apoptosis pathway. Investigational new Drugs 28(3): 318-325

Uzui, H.; Lee, J-Dae. 2007: MMPs. Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl. 4: 444-447

Osorio, R.; Yamauti, M.; Ruiz-Requena, M.ía.E.; Toledano, M. 2013: MMPs activity and bond strength in deciduous dentine-resin bonded interfaces. Journal of Dentistry 41(6): 549-555

Niedringhaus, M.; Chen, X.; Dzakpasu, R.; Conant, K. 2012: MMPs and soluble ICAM-5 increase neuronal excitability within in vitro networks of hippocampal neurons. Plos one 7(8): E42631

Durigova, M.; Nagase, H.; Mort, J.S.; Roughley, P.J. 2011: MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein. Matrix Biology: Journal of the International Society for Matrix Biology 30(2): 145-153

Müller-Quernheim, J. 2011: MMPs are regulatory enzymes in pathways of inflammatory disorders, tissue injury, malignancies and remodelling of the lung. European Respiratory Journal 38(1): 12-14

Fingleton, B. 2008: MMPs as therapeutic targets--still a viable option?. Seminars in Cell and Developmental Biology 19(1): 61-68

Karam, A.; Dorigo, O. 2012: MMPs in ovarian cancer as therapeutic targets. Anti-Cancer Agents in Medicinal Chemistry 12(7): 764-772

Agrawal, S.M.; Lau, L.; Yong, V.W. 2008: MMPs in the central nervous system: where the good guys go bad. Seminars in Cell and Developmental Biology 19(1): 42-51

De Groef, L.; Van Hove, I.; Dekeyster, E.; Stalmans, I.; Moons, L. 2014: MMPs in the neuroretina and optic nerve: modulators of glaucoma pathogenesis and repair?. Investigative Ophthalmology and Visual Science 55(3): 1953-1964

De Groef, L.; Van Hove, I.; Dekeyster, E.; Stalmans, I.; Moons, L. 2013: MMPs in the trabecular meshwork: promising targets for future glaucoma therapies?. Investigative Ophthalmology and Visual Science 54(12): 7756-7763

Salgame, P. 2011: MMPs in tuberculosis: granuloma creators and tissue destroyers. Journal of Clinical Investigation 121(5): 1686-1688

Chen, Y.; Zhang, W.; Geng, N.; Tian, K.; Jack Windsor, L. 2008: MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus. Head and Neck 30(9): 1237-1245

Kim, H.S.; Yoo, H.S. 2010: MMPs-responsive release of DNA from electrospun nanofibrous matrix for local gene therapy: in vitro and in vivo evaluation. Journal of Controlled Release: Official Journal of the Controlled Release Society 145(3): 264-271

Guillen-Marti, J.; Diaz, R.; Quiles, M.T.; Lopez-Cano, M.; Vilallonga, R.; Huguet, P.; Ramon-y-Cajal, S.; Sanchez-Niubo, A.; Reventós, J.; Armengol, M.; Arbos, M.A. 2009: MMPs/TIMPs and inflammatory signalling de-regulation in human incisional hernia tissues. Journal of Cellular and Molecular Medicine 13(11-12): 4432-4443

Chopra, K.; Baveja, A.; Kuhad, A. 2015: MMPs: a novel drug target for schizophrenia. Expert Opinion on Therapeutic Targets 19(1): 77-85

Zeidán-Chuliá, F.; Neves de Oliveira, B.-H.; Gursoy, M.; Könönen, E.; Fonseca Moreira, J.é C.áu.; Gursoy, U.K.; Uitto, V.-J. 2013: MMPREDOX/NO interplay in periodontitis and its inhibition with Satureja hortensis L. essential oil. Chemistry and Biodiversity 10(4): 507-523

Anonymous 2001: MMR (measles-mumps-rubella) vaccine. Paediatrics and Child Health 6(6): 390-397

Bandi, S.; Macdougall, C. 2010: MMR and egg allergy: to vaccinate or not to vaccinate?. British Journal of General Practice: the Journal of the Royal College of General Practitioners 60(578): 693-694

Abbasi, K. 2008: MMR and the value of word of mouth in social networks. Journal of the Royal Society of Medicine 101(5): 215

Godson, R. 2013: Additions to the UK routine immunisation schedule 2013-14. Community Practitioner: the Journal of the Community Practitioners' and Health Visitors' Association 86(6): 10

Ioana, M.; Angelescu, C.; Burada, F.; Mixich, F.; Riza, A.; Dumitrescu, T.; Alexandru, D.; Ciurea, T.; Cruce, M.; Saftoiu, A. 2010: MMR gene expression pattern in sporadic colorectal cancer. Journal of Gastrointestinal and Liver Diseases: Jgld 19(2): 155-159

Green, M. 2011: MMR is but the tip of the iceberg. Bmj 343: D7889; Author Reply 7890

Tanday, S. 2014: MMR lowers infection-related hospital admissions in children. LANCET. Respiratory Medicine 2(4): 263

Goodman, N.W. 2007: MMR scare stories: Some things are just too attractive to the media. Bmj 335(7613): 222

Hewitt, M. 2011: MMR scare. Are the GMC, news media, and BMJ the right tribunals?. Bmj 342: D812

Bates, T. 2011: MMR scare. in the wake of Wakefield. Bmj 342: D806

Kennedy, I. 2011: MMR scare. Response from the UK Research Integrity Office. Bmj 342: D807

Green, M. 2011: MMR scare. Robust procedures for research conduct are needed. Bmj 342: D805

Neri, I.; Ravaioli, G.M.; Faldella, G.; Capretti, M.G.; Arcuri, S.; Patrizi, A. 2017: Chlorhexidine-Induced Chemical Burns in very Low Birth Weight Infants. Journal of Pediatrics 191: 262-265.E2

Hayes, S.F. 2011: MMR scare: Piltdown--hoax or fraud?. Bmj 342: D469

Tooke, J.; Price, D. 2011: MMR scare: UCL's response. Bmj 342: D460

Patil, R.R. 2011: MMR vaccination and autism: learnings and implications. Human Vaccines 7(2): 281-282

Davidkin, I.; Kontio, M.; Paunio, M.; Peltola, H. 2010: MMR vaccination and disease elimination: the Finnish experience. Expert Review of Vaccines 9(9): 1045-1053

Mayor, S. 2014: MMR vaccination at right time is associated with lower admissions for all infections in young children. Bmj 348: G1779

Andersen, D.V.år.; Jørgensen, I.M. 2013: MMR vaccination of children with egg allergy is safe. Danish Medical Journal 60(2): A4573

Kemp, M.L.; Hart, M.B. 2010: MMR vaccine and autism: is there a link?. Jaapa: Official Journal of the American Academy of Physician Assistants 23(6): 48; 50

Poland, G.A. 2011: MMR vaccine and autism: vaccine nihilism and postmodern science. Mayo Clinic Proceedings 86(9): 869-871

Fina Avilés, F.; Campins Martí, M.; Martínez Gómez, X.; Rodrigo Pendás, J.A.; Lushchenkova, O.; Pimós Tella, L.; Vaqué Rafart, J. 2007: MMR vaccine and egg allergy. Experience in a hospital immunization unit. Anales de Pediatria 67(4): 362-367

Leask, J.; Booy, R.; McIntyre, P.B. 2010: MMR, Wakefield and the Lancet: what can we learn?. Medical Journal of Australia 193(1): 5-7

Abbasi, K. 2010: MMR, climate change, and orthopaedics: a bad month for peer review. Journal of the Royal Society of Medicine 103(3): 77-78

Sun, G.; Jin, S.; Baskaran, R. 2009: MMR/c-Abl-dependent activation of ING2/p73alpha signaling regulates the cell death response to N-methyl-N'-nitro-N-nitrosoguanidine. Experimental Cell Research 315(18): 3163-3175

Penn, R.; Kiddy, M. 2011: MMR: factors for uptake. Community Practitioner: the Journal of the Community Practitioners' and Health Visitors' Association 84(11): 42-43

Elliman, D.; Bedford, H. 2007: MMR: where are we now?. Archives of Disease in Childhood 92(12): 1055-1057

Siddiqui, O. 2011: MMRM versus MI in dealing with missing data--a comparison based on 25 NDA data sets. Journal of Biopharmaceutical Statistics 21(3): 423-436

Siddiqui, O.; Hung, H.M.James.; O'Neill, R. 2009: MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets. Journal of Biopharmaceutical Statistics 19(2): 227-246

Lee, H.-E.; Song, J.; Kim, S.Y.; Park, K.-C.; Min, K.H.; Kim, D.-S. 2013: MMS 1001 inhibits melanin synthesis via ERK activation. Die Pharmazie 68(3): 212-216

Stumpf, J.D.; Copeland, W.C. 2014: MMS exposure promotes increased MtDNA mutagenesis in the presence of replication-defective disease-associated DNA polymerase γ variants. Plos Genetics 10(10): E1004748

Ishida, T.; Yoshimura, M.; Miura, K.; Sugimoto, K. 2012: MMS21/HPY2 and SIZ1, two Arabidopsis SUMO E3 ligases, have distinct functions in development. Plos one 7(10): E46897

Tanaka, M.; Mazuyama, E.; Arakaki, A.; Matsunaga, T. 2011: MMS6 protein regulates crystal morphology during nano-sized magnetite biomineralization in vivo. Journal of Biological Chemistry 286(8): 6386-6392

Wong, J.W.H.; Abuhusain, H.J.; McDonald, K.L.; Don, A.S. 2012: MMSAT: automated quantification of metabolites in selected reaction monitoring experiments. Analytical Chemistry 84(1): 470-474

Albert, S.M. 2014: MMSE 2.0: a new approach to an old measure. Neuroepidemiology 43(1): 26-27

Crizzle, A.M.; Classen, S.; Bédard, M.; Lanford, D.; Winter, S. 2012: MMSE as a predictor of on-road driving performance in community dwelling older drivers. Accident; Analysis and Prevention 49: 287-292

Gabriel Franco, J.é; Santesteban, O.; Trzepacz, P.; Bernal, C.; Valencia, C.; Ocampo, M.ía.V.; Pablo, J.d.; Gaviria, A.M.; Vilella, E. 2014: MMSE items that predict incident delirium and hypoactive subtype in older medical inpatients. Psychiatry Research 220(3): 975-981

Huang, W.; Zheng, Y. 2008: MMSE reconstruction for 3D freehand ultrasound imaging. International Journal of Biomedical Imaging 2008: 274164

Kim, J.W. 2009: MMSEA section 111: do you know if it applies to your organization?. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 63(9): 44-46

Brito, J.L.R.; Walker, B.; Jenner, M.; Dickens, N.J.; Brown, N.J.M.; Ross, F.M.; Avramidou, A.; Irving, J.A.E.; Gonzalez, D.; Davies, F.E.; Morgan, G.J. 2009: MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells. Haematologica 94(1): 78-86

Xie, Z.; Chng, W.J. 2014: MMSET: role and therapeutic opportunities in multiple myeloma. Biomed Research International 2014: 636514

Fontelo, P.; Liu, F.; Muin, M.; Ducut, E.; Ackerman, M.; Paalan-Vasquez, F. 2007: MMSPix - a multimedia service (MMS) medical images weblog. AMIA . Annual Symposium Proceedings. AMIA Symposium 2007: 956

Perche, P.él.; Kotera, M.; Remy, J.-S. 2011: MMT, Npeoc-protected spermine, a valuable synthon for the solid phase synthesis of oligonucleotide oligospermine conjugates via guanidine linkers. Bioorganic and Medicinal Chemistry 19(6): 1972-1977

Lavorgna, M.; Attianese, I.; Buonocore, G.G.; Conte, A.; Del Nobile, M.A.; Tescione, F.; Amendola, E. 2014: MMT-supported Ag nanoparticles for chitosan nanocomposites: structural properties and antibacterial activity. Carbohydrate Polymers 102: 385-392

Wang, B.; Liu, M.-Z.; Liang, R.; Ding, S.-L.; Chen, Z.-B.; Chen, S.-L.; Jin, S.-P. 2008: MMTCA recognition by molecular imprinting in interpenetrating polymer network hydrogels based on poly(acrylic acid) and poly(vinyl alcohol). Macromolecular Bioscience 8(5): 417-425

Cruciani, R.A.; Esteban, S.; Seewald, R.M.; Altilio, T.; Bookbinder, M.; Sheu, R.; Portenoy, R.K. 2008: MMTP patients with chronic pain switching to pain management clinics. a problem or an acceptable practice?. Pain Medicine 9(3): 359-364

Ahn, S.J.; Kim, M.-S.; Jang, J.H.; Lim, S.U.; Lee, H.H. 2008: MMTS, a new subfamily of Tc1-like transposons. Molecules and Cells 26(4): 387-395

Ross, S.R. 2008: MMTV infectious cycle and the contribution of virus-encoded proteins to transformation of mammary tissue. Journal of Mammary Gland Biology and Neoplasia 13(3): 299-307

Taneja, P.; Frazier, D.P.; Kendig, R.D.; Maglic, D.; Sugiyama, T.; Kai, F.; Taneja, N.K.; Inoue, K. 2009: MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer. Expert Review of Molecular Diagnostics 9(5): 423-440

Yang, G.; Park, S.; Cao, G.; Goltsov, A.; Ren, C.; Truong, L.D.; Demayo, F.; Thompson, T.C. 2010: MMTV promoter-regulated caveolin-1 overexpression yields defective parenchymal epithelia in multiple exocrine organs of transgenic mice. Experimental and Molecular Pathology 89(1): 9-19

Fortin, J-Simon.; Genève, L.; Gauthier, C.; Shoukry, N.H.; Azar, G.A.; Younes, S.; Yassine-Diab, B.; Sékaly, R-Pierre.; Fremont, D.H.; Thibodeau, J. 2014: MMTV superantigens coerce an unconventional topology between the TCR and MHC class II. Journal of Immunology 192(4): 1896-1906

Robinson, G.W.; Hennighausen, L. 2011: MMTV-Cre transgenes can adversely affect lactation: considerations for conditional gene deletion in mammary tissue. Analytical Biochemistry 412(1): 92-95

Teissedre, B.; Pinderhughes, A.; Incassati, A.; Hatsell, S.J.; Hiremath, M.; Cowin, P. 2009: MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors. Plos one 4(2): E4537

Kordon, E.C. 2008: MMTV-induced pregnancy-dependent mammary tumors : early history and new perspectives. Journal of Mammary Gland Biology and Neoplasia 13(3): 289-297

Hannesdóttir, L.ár.; Daschil, N.; Philipp, S.; Tymoszuk, P.; Müller-Holzner, E.; Klima, G.ün.; Verdorfer, I.; Doppler, W. 2012: MMTV-neu mice deficient in STAT1 are susceptible to develop ovarian teratomas. International Journal of Developmental Biology 56(4): 279-283

Ubben, D.; Poll, E.M. 2013: MMV in partnership: the Eurartesim® experience. Malaria Journal 12: 211

Vaarkamp, H. 2010: MMVD? Internship? What is that?. Tijdschrift voor diergeneeskunde 135(11): 464

Wepner, U. 2008: MMW Drug Prize 2008 awarded. SQ allergens allow allergic patients to breathe deeply. MMWFortschrittederMedizin 150(26-27): 21

Füessl, H.S. 2006: MMW drug award for gemcitabine. Cytostatic drug with growing indications. MMW Fortschritte der Medizin 148(45): 6-7

Sandborn, W.J.; Kamm, M.A.; Lichtenstein, G.R.; Lyne, A.; Butler, T.; Joseph, R.E. 2007: MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials. Alimentary Pharmacology and Therapeutics 26(2): 205-215

Katz, S. 2009: MMX mesalamine is safe and efficacious in achieving clinical and endoscopic remission of active ulcerative colitis. Hospital Practice 37(1): 159-161

Hu, M.Y.; Peppercorn, M.A. 2008: MMX mesalamine: a novel high-dose, once-daily 5-aminosalicylate formulation for the treatment of ulcerative colitis. Expert Opinion on PharmacoTherapy 9(6): 1049-1058

Olea, D.; González-Prieto, R.; Priego, J.é L.; Barral, M.C.; de Pablo, P.J.; Torres, M.R.; Gómez-Herrero, J.; Jiménez-Aparicio, R.; Zamora, F.él. 2007: MMX polymer chains on surfaces. Chemical Communications 16: 1591-1593

Ito, S.; Tan, L.J.; Andoh, D.; Narita, T.; Seki, M.; Hirano, Y.; Narita, K.; Kuraoka, I.; Hiraoka, Y.; Tanaka, K. 2010: MMXD, a TFIIH-independent XPD-MMS19 protein complex involved in chromosome segregation. Molecular Cell 39(4): 632-640

Yang, L.P.H.; McCormack, P.L. 2011: MMX® Mesalazine: a review of its use in the management of mild to moderate ulcerative colitis. Drugs 71(2): 221-235

Stempor, P.A.; Cauchi, M.; Wilson, P. 2012: MMpred: functional miRNA--mRNA interaction analyses by miRNA expression prediction. Bmc Genomics 13: 620

Masciocchi, J.; Frau, G.; Fanton, M.; Sturlese, M.; Floris, M.; Pireddu, L.; Palla, P.; Cedrati, F.; Rodriguez-Tomé, P.; Moro, S. 2009: MMsINC: a large-scale chemoinformatics database. Nucleic Acids Research 37(Database Issue): D284-D290

Shelenkov, A.; Korotkov, A.; Korotkov, E. 2008: MMsat--a database of potential micro- and minisatellites. Gene 409(1-2): 53-60

Thorson, D. 2011: Improvement also applies to quality improvement. Minnesota Medicine 94(12): 21

Zhong, H.-Y.; Chen, L.; Lu, H.-L. 2009: MN hemolytic disease in a pair of newborn twins. Zhongguo Dang Dai Er Ke Za Zhi 11(9): 781-782

Polin, H.; Danzer, M.; Reiter, A.; Brisner, M.; Gaszner, W.; Weinberger, J.; Gabriel, C. 2014: MN typing discrepancies based on GYPA-B-A hybrid. Vox Sanguinis 107(4): 393-398

Li, G.; Feng, G.; Achour, Y.; Genin, C.; Tostain, J. 2007: MN/CA9 as a novel molecular marker for the detection of cancer. Expert Opinion on Medical Diagnostics 1(1): 91-97

Meester-Smoor, M.A.; Janssen, M.J.F.W.; Grosveld, G.C.; de Klein, A.; van IJcken, W.F.J.; Douben, H.; Zwarthoff, E.C. 2008: MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR/RXR-induced gene expression. Carcinogenesis 29(10): 2025-2034

Heuser, M.; Argiropoulos, B.; Kuchenbauer, F.; Yung, E.; Piper, J.; Fung, S.; Schlenk, R.F.; Dohner, K.; Hinrichsen, T.; Rudolph, C.; Schambach, A.; Baum, C.; Schlegelberger, B.; Dohner, H.; Ganser, A.; Humphries, R.K. 2007: MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. Blood 110(5): 1639-1647

Nofrini, V.; Berchicci, L.; La Starza, R.; Gorello, P.; Di Giacomo, D.; Arcioni, F.; Pierini, V.; Crescenzi, B.; Romoli, S.; Matteucci, C.; Mecucci, C. 2011: MN1-ETV6 fusion gene arising from MDS with 5q-. Leukemia Research 35(7): E123-E126

Amini, M. 2012: Pain, mental health and adolescence. SOINS. Pediatrie Puericulture 53(270): 38-41

Anonymous 2008: MN: Employee falsely records meds as given: difference in 'altering' & 'falsifying' records. Nursing Law's Regan Report 49(4): 3

Anonymous 2014: MNA RNs say: 'Robin Hood Tax' on Wall Street can heal Detroit. Michigan Nurse 87(2): 5 19

Karebian, J. 2013: MNA exercises its political strength. Michigan Nurse 86(1): 3

Harrell, G. 2012: MNA goes to Washington: ANA House of Delegates. Mississippi Rn 74(3): 1

Trossman, S. 2007: MNA nurses give all to help victims in Minnesota bridge collapse. American Nurse 39(5): 1; 4, 6

Sincox, A.K. 2008: MNA public health RNs advocate funding at the Capitol. Michigan Nurse 81(3): 14-15

Anonymous 2011: MNA tells Congressmen Camp and Upton to "listen up!" Supercommittee members have not responded to requests for public town halls. Michigan nurse 84(6): 3

Anonymous 2013: MNA wins back pay for 51 nurses at McLaren Lapeer Region. Michigan Nurse 86(1): 6

Kayahara, M.; Ohanian, J.; Ohanian, V.; Berry, A.; Vadlamudi, R.; Ray, D.W. 2008: MNAR functionally interacts with both NH2- and COOH-terminal GR domains to modulate transactivation. American Journal of Physiology. Endocrinology and Metabolism 295(5): E1047-E1055

Cheskis, B.J.; Greger, J.; Cooch, N.; McNally, C.; Mclarney, S.; Lam, H.-S.; Rutledge, S.; Mekonnen, B.; Hauze, D.; Nagpal, S.; Freedman, L.P. 2008: MNAR plays an important role in ERa activation of Src/MAPK and PI3K/Akt signaling pathways. Steroids 73(9-10): 901-905

Mokany, E.; Todd, A.V. 2013: MNAzyme qPCR: a superior tool for multiplex qPCR. Methods in Molecular Biology 1039: 31-49

Bone, S.M.; Todd, A.V. 2014: MNAzymes provide a universal mechanism for triggering DNAzyme synthesis cascades. Chemical Communications 50(87): 13243-13246

Mokany, E.; Bone, S.M.; Young, P.E.; Doan, T.B.; Todd, A.V. 2010: MNAzymes, a versatile new class of nucleic acid enzymes that can function as biosensors and molecular switches. Journal of the American Chemical Society 132(3): 1051-1059

Calvo, I.; Olivar, J.; Martínez, E.; Rico, A.; Díaz, J.; Gimena, M. 2012: MNA® Mini Nutritional Assessment as a nutritional screening tool for hospitalized older adults; rationales and feasibility. Nutricion Hospitalaria 27(5): 1619-1625

Tejedor, F.J.; Hämmerle, B. 2011: MNB/DYRK1A as a multiple regulator of neuronal development. Febs Journal 278(2): 223-235

Shiina, I.; Umezaki, Y.; Kuroda, N.; Iizumi, T.; Nagai, S.; Katoh, T. 2012: MNBA-mediated β-lactone formation: mechanistic studies and application for the asymmetric total synthesis of tetrahydrolipstatin. Journal of Organic Chemistry 77(11): 4885-4901

Rafi, J. 2010: MNCH research in Pakistan: trend and transition. Jpma. Journal of the Pakistan Medical Association 60(8): 698-699

Williams, D.E.; Peters, M.B.; Wang, B.; Merz, K.M. 2008: MNDO parameters for the prediction of 19F NMR chemical shifts in biologically relevant compounds. Journal of Physical Chemistry. a 112(37): 8829-8838

Dewar, M.J.; Kuhn, D.R. 1986: MNDO study of the reaction of tetramethylstannane with bromine. Journal of the American Chemical Society 108(3): 551-552

Gramfort, A.; Luessi, M.; Larson, E.; Engemann, D.A.; Strohmeier, D.; Brodbeck, C.; Parkkonen, L.; Hämäläinen, M.S. 2014: MNE software for processing MEG and EEG data. Neuroimage 86: 446-460

Eustache, F.; Desgranges, B.éa. 2008: MNESIS: towards the integration of current multisystem models of memory. Neuropsychology Review 18(1): 53-69

Blanié, S.; Gelfi, J.; Bertagnoli, S.ép.; Camus-Bouclainville, C. 2010: MNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection. Virology Journal 7: 56

Finkenstedt, A.; Schranz, M.; Bösch, S.; Karall, D.; Bürgi, S.S.; Ensinger, C.; Drach, M.; Mayr, J.A.; Janecke, A.R.; Vogel, W.; Nachbaur, D.; Zoller, H. 2013: MNGIE Syndrome: Liver Cirrhosis Should be Ruled out Prior to Bone Marrow Transplantation. Jimd Reports 10: 41-44

Silva, R.L.A.; Wendel, H.Guido. 2008: MNK, EIF4E and targeting translation for therapy. Cell Cycle 7(5): 553-555

Ziaei, S.; Shimada, N.; Kucharavy, H.; Hubbard, K. 2012: MNK1 expression increases during cellular senescence and modulates the subcellular localization of hnRNP A1. Experimental Cell Research 318(5): 500-508

Rannou, Y.; Salaun, P.; Benaud, C.; Khan, J.; Dutertre, S.ép.; Giet, R.ég.; Prigent, C. 2012: MNK1 kinase activity is required for abscission. Journal of Cell Science 125(Part 12): 2844-2852

Grzmil, M.; Huber, R.M.; Hess, D.; Frank, S.; Hynx, D.; Moncayo, G.; Klein, D.; Merlo, A.; Hemmings, B.A. 2014: MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomas. Journal of Clinical Investigation 124(2): 742-754

Shi, Y.; Frost, P.; Hoang, B.; Yang, Y.; Bardeleben, C.; Gera, J.; Lichtenstein, A. 2014: MNK1-induced eIF-4E phosphorylation in myeloma cells: a pathway mediating IL-6-induced expansion and expression of genes involved in metabolic and proteotoxic responses. Plos one 9(4): E94011

Emboras, A.; Najar, A.; Nambiar, S.; Grosse, P.; Augendre, E.; Leroux, C.; de Salvo, B.; de Lamaestre, R.E. 2012: MNOS stack for reliable, low optical loss, Cu based CMOS plasmonic devices. Optics Express 20(13): 13612-13621

Pisat, N.P.; Pandey, A.; Macdiarmid, C.W. 2009: MNR2 regulates intracellular magnesium storage in Saccharomyces cerevisiae. Genetics 183(3): 873-884

Aras, S.; Bai, M.; Lee, I.; Springett, R.; Hüttemann, M.; Grossman, L.I. 2015: MNRR1 (formerly CHCHD2) is a bi-organellar regulator of mitochondrial metabolism. Mitochondrion 20: 43-51

Reid, M.E. 2009: MNS blood group system: a review. Immunohematology 25(3): 95-101

Zhou, J.; Yang, F.; Leu, N.A.; Wang, P.J. 2012: MNS1 is essential for spermiogenesis and motile ciliary functions in mice. Plos Genetics 8(3): E1002516

Andersson, U.; Osterman, P.; Sjöström, S.; Johansen, C.; Henriksson, R.; Brännström, T.; Broholm, H.; Christensen, H.C.; Ahlbom, A.; Auvinen, A.; Feychting, M.; Lönn, S.; Kiuru, A.; Swerdlow, A.; Schoemaker, M.; Roos, G.ör.; Malmer, B. 2009: MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. International Journal of Cancer 125(4): 968-972

Hofer, P.; Zerelles, J.; Baierl, A.; Madersbacher, S.; Schatzl, G.; Maj-Hes, A.; Sutterlüty-Fall, H.; Gsur, A. 2013: MNS16A tandem repeat minisatellite of human telomerase gene and prostate cancer susceptibility. Mutagenesis 28(3): 301-306

Xia, X.; Rui, R.; Quan, S.; Zhong, R.; Zou, L.; Lou, J.; Lu, X.; Ke, J.; Zhang, T.; Zhang, Y.; Liu, L.; Yan, J.; Miao, X. 2013: MNS16A tandem repeats minisatellite of human telomerase gene and cancer risk: a meta-analysis. Plos one 8(8): E73367

Chen, T-Di.; Chen, D-Ping.; Wang, W-Ting.; Sun, C-Feng. 2014: MNSs blood group glycophorin variants in Taiwan: a genotype-serotype correlation study of 'Mi(a)' and St(a) with report of two new alleles for St(a). Plos one 9(5): E98166

Murakami, J. 2010: MNSs blood group system and antibodies(anti-M, -N, -S and -S antibodies). Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 6): 743-747

Gocke, E.; Ballantyne, M.; Whitwell, J.; Müller, L. 2009: MNT and MutaMouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU. Toxicology Letters 190(3): 286-297

Soares-Maia, R.; Faustino-Rocha, A.; Teixeira-Guedes, C.; Pinho-Oliveira, J.; Talhada, D.; Rema, A.; Faria, F.; Ginja, M.; Ferreira, R.; da Costa, R.; Oliveira, P.A.; Lopes, C. 2013: MNU-induced rat mammary carcinomas: immunohistology and estrogen receptor expression. Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 32(2): 157-163

Xiang, Z.; Tian, S.; Tong, W.; Chang, H.; Su, J.; Zhang, L.; Liu, X.; Li, Y.; Wei, Q.; Liu, Y. 2014: MNV primarily surveillance by a recombination VP1-derived ELISA in Beijing area in China. Journal of Immunological Methods 408: 70-77

Garcia-Barceló, M.-M.è; Lui, V.C.-H.; So, M.-t.; Miao, X.; Leon, T.Y.-y.; Yuan, Z.-w.; Ngan, E.S.-w.; Ehsan, T.; Chung, P.H.-y.; Khong, P.-l.; Wong, K.K.-y.; Tam, P.K.-h. 2009: MNX1 (HLXB9) mutations in Currarino patients. Journal of Pediatric Surgery 44(10): 1892-1898

Taketani, T.; Taki, T.; Sako, M.; Ishii, T.; Yamaguchi, S.; Hayashi, Y. 2008: MNX1-ETV6 fusion gene in an acute megakaryoblastic leukemia and expression of the MNX1 gene in leukemia and normal B cell lines. Cancer Genetics and Cytogenetics 186(2): 115-119

Claridge, T. 2009: MNova: NMR data processing, analysis, and prediction software. Journal of Chemical Information and Modeling 49(4): 1136-1137

Cantorias, M.V.; Howell, R.C.; Todaro, L.; Cyr, J.E.; Berndorff, D.; Rogers, R.D.; Francesconi, L.C. 2007: MO tripeptide diastereomers (M=99/99mTc, Re): models to identify the structure of 99mTc peptide targeted radiopharmaceuticals. Inorganic Chemistry 46(18): 7326-7340

Anonymous 2014: MO06.03 Bevacizumab and erlotinib or bevacizumab, cisplatin and pemetrexed in patients with metastatic non-small cell lung cancer: EGFR mutation based treatment allocation and repeat biopsy at progression in the SAKK19/09 (BIOPRO) trial. Clinical Advances in Hematology and Oncology: H&o 12(1 Suppl. 1): 13

Anonymous 2014: MO06.12 Efficacy and safety of paclitaxel and carboplatin with bevacizumab for the first-line treatment of patients with nonsquamous non-small cell lung cancer (NSCLC): analyses based on age in the phase 3 PointBreak and E4599 trials. Clinical Advances in Hematology and Oncology: H&o 12(1 Suppl. 1): 4-6

Dansin, E.; Cinieri, S.; Garrido, P.; Griesinger, F.; Isla, D.; Koehler, M.; Kohlhaeufl, M. 2012: MO19390 (SAiL): bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC. Lung Cancer 76(3): 373-379

Williams, N. 2011: Europe fisheries policy protest. Current Biology: Cb 21(1): R3-R4

Anonymous 2012: MO: City employee failed to follow protocols: act negated application of sovereign immunity. Richardson v. Burrow, ED97002 MOCAE (2/21/2012)-MO. Nursing Law's Regan Report 52(11): 3

Anonymous 2009: MO: Compensatory & punitive damage awards: did court err in awarding new trial to employer?. Nursing Law's Regan Report 49(8): 3

Sun, D.; Xi, Y.; Rodriguez, B.; Park, H.J.; Tong, P.; Meong, M.; Goodell, M.A.; Li, W. 2014: MOABS: model based analysis of bisulfite sequencing data. Genome Biology 15(2): R38

Cockfield, J.; Su, K.; Robbins, K.A. 2013: MOBBED: a computational data infrastructure for handling large collections of event-rich time series datasets in MATLAB. Frontiers in Neuroinformatics 7: 20

Martin, A.J.M.; Walsh, I.; Tosatto, S.C.E. 2010: MOBI: a web server to define and visualize structural mobility in NMR protein ensembles. Bioinformatics 26(22): 2916-2917

Dieppe, P.; Dixon, D.; Horwood, J.; Pollard, B.; Johnston, M. 2008: MOBILE and the provision of total joint replacement. Journal of Health Services Research and Policy 13 Suppl. 3: 47-56

Johnson, H.L. 1946: Permanent enrichment of flour and bread. Connecticut Health Bulletin 60(5): 110-112

Hodson, A.Z. 1949: The microbiological assay of folic acid as applied to milk. Journal of Nutrition 38(1): 25-40

Anonymous 1938: Mobilization on the Medical Front: District of Columbia Holc Experiment. California and Western Medicine 48(2): 150

Jilek, S.; Schluep, M.; Pantaleo, G.; Du Pasquier, R.A. 2013: MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 34(4): 539-543

Wasserman, S.I.; Vapniarek, L.J. 2011: MOC CME program. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 107(2): 183

Hertz, B.T. 2014: MOC changes aim to lessen burden on physicians, but debate continues. Medical Economics 91(6): 42; 44-49

Silva, E. 2011: MOC for dollars. Journal of the American College of Radiology: Jacr 8(11): 746-748

Kempen, P.M. 2014: MOC must go: one physician's viewpoint. A critic of Maintenance of Certification explains why the costly program burdens physicians. Medical Economics 91(2): 49-50 52 55

Pai, R.K.; West, R.B. 2009: MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray study. Applied Immunohistochemistry and Molecular Morphology: Aimm 17(3): 202-206

Swartz, W.M.; Lalonde, D.H. 2008: MOC-PS(SM) CME article: Dupuytren's disease. Plastic and Reconstructive Surgery 121(4 Suppl): 1-10

Friedland, J.A.; Maffi, T.R. 2008: MOC-PS(SM) CME article: abdominoplasty. Plastic and Reconstructive Surgery 121(4 Suppl): 1-11

Alpert, B.S.; Lalonde, D.H. 2008: MOC-PS(SM) CME article: breast augmentation. Plastic and Reconstructive Surgery 121(4 Suppl): 1-7

Guyuron, B. 2008: MOC-PS(SM) CME article: genioplasty. Plastic and Reconstructive Surgery 121(4 Suppl): 1-7

Guyuron, B. 2008: MOC-PS(SM) CME article: late cleft lip nasal deformity. Plastic and Reconstructive Surgery 121(4 Suppl): 1-11

Iverson, R.E.; Pao, V.S. 2008: MOC-PS(SM) CME article: liposuction. Plastic and Reconstructive Surgery 121(4 Suppl): 1-11

Reddy, V.; Stevenson, T.Ray. 2008: MOC-PS(SM) CME article: lower extremity reconstruction. Plastic and Reconstructive Surgery 121(4 Suppl): 1-7

Persing, J.A. 2008: MOC-PS(SM) CME article: management considerations in the treatment of craniosynostosis. Plastic and Reconstructive Surgery 121(4 Suppl): 1-11

Horton, J.Bauer.; Janis, J.E.; Rohrich, R.J. 2008: MOC-PS(SM) CME article: patient safety in the office-based setting. Plastic and Reconstructive Surgery 122(3 Suppl): 1-21

Hentz, V.R.; Lalonde, D.H. 2008: MOC-PS(SM) CME article: self-assessment and performance in practice: the carpal tunnel. Plastic and reconstructive surgery 121(4 Suppl): 1-10

Lehfeldt, M.; Ray, E.; Sherman, R. 2008: MOC-PS(SM) CME article: treatment of flexor tendon laceration. Plastic and Reconstructive Surgery 121(4 Suppl): 1-12

Seruya, M.; Baker, S.B. 2008: MOC-PS(SM) CME article: venous thromboembolism prophylaxis in plastic surgery patients. Plastic and Reconstructive Surgery 122(3 Suppl): 1-9

Trussler, A.P.; Rohrich, R.J. 2008: MOC-PSSM CME article: Blepharoplasty. Plastic and Reconstructive Surgery 121(1 Suppl): 1-10

Sigurdson, L.; Lalonde, D.H. 2008: MOC-PSSM CME article: Breast reconstruction. Plastic and Reconstructive Surgery 121(1 Suppl): 1-12

Nahai, F.R.; Nahai, F. 2008: MOC-PSSM CME article: Breast reduction. Plastic and Reconstructive Surgery 121(1 Suppl): 1-13

Stuzin, J.M. 2008: MOC-PSSM CME article: Face lifting. Plastic and Reconstructive Surgery 121(1 Suppl): 1-19

Cook, G.S.; Lalonde, D.H. 2008: MOC-PSSM CME article: Management of thumb carpometacarpal joint arthritis. Plastic and Reconstructive Surgery 121(1 Suppl): 1-9

Chin, S.H.; Vedder, N.B. 2008: MOC-PSSM CME article: Metacarpal fractures. Plastic and Reconstructive Surgery 121(1 Suppl): 1-13

Zbar, R.I.S.; Canady, J.W. 2008: MOC-PSSM CME article: Nonmelanoma facial skin malignancy. Plastic and Reconstructive Surgery 121(1 Suppl): 1-9

van Aalst, J.A.; Kolappa, K.Kumar.; Sadove, M. 2008: MOC-PSSM CME article: Nonsyndromic cleft palate. Plastic and Reconstructive Surgery 121(1 Suppl): 1-14

Bauer, J.; Phillips, L.G. 2008: MOC-PSSM CME article: Pressure sores. Plastic and Reconstructive Surgery 121(1 Suppl): 1-10

Evans, B.G.A.; Evans, G.R.D. 2008: MOC-PSSM CME article: Zygomatic fractures. Plastic and Reconstructive Surgery 121(1 Suppl): 1-11

Volpintesta, E. 2013: MOC: The grandchild of the Flexner Report?. Connecticut Medicine 77(9): 573

Block, S.H. 2011: MOC: we need more data and less hype. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 107(1): 91

Bendix, J.; Verdon, D.R. 2014: MOC: an examination of costs and impact to physicians. Medical Economics 91(14): 12-16

Peebles, R.S. 2011: MOC: data, no hype. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 107(4): 379-380

Hertz, B.T. 2013: MOC: debate intensifies as Medicare penalties loom. Medical Economics 90(12): 16-18; 20-22

Tachi, N.; Hashimoto, Y.; Matsuoka, M. 2012: MOCA is an integrator of the neuronal death signals that are activated by familial Alzheimer's disease-related mutants of amyloid β precursor protein and presenilins. Biochemical Journal 442(2): 413-422

Kultima, J.R.; Sunagawa, S.; Li, J.; Chen, W.; Chen, H.; Mende, D.R.; Arumugam, M.; Pan, Q.; Liu, B.; Qin, J.; Wang, J.; Bork, P. 2012: MOCAT: a metagenomics assembly and gene prediction toolkit. Plos one 7(10): E47656

Premuda, M.; Palazzi, E.; Ravegnani, F.; Bortoli, D.; Masieri, S.; Giovanelli, G. 2012: MOCRA: a Monte Carlo code for the simulation of radiative transfer in the atmosphere. Optics Express 20(7): 7973-7993

Golovnin, A.K.; Dvoretsky, E.V.; Kostyuchenko, M.V.; Shamsutdinov, M.F.; Georgiev, P.G.; Melnikova, L.S. 2013: MOD(MDG4)-64.2 protein, isoform of MOD(MDG4) loci, directly interacts with the Tweedle protein family of Drosophila melanogaster. DOKLADY. Biochemistry and Biophysics 452(1): 225-228

Omidi, S.; Schreiber, F.; Masoudi-Nejad, A. 2009: MODA: an efficient algorithm for network motif discovery in biological networks. Genes and Genetic Systems 84(5): 385-395

McLane, C.; Cecan, L. 2009: MODALL: a practical tool for designing and optimizing capture systems. Ground Water 47(2): 172-173; Discussion: 173-175

Pieper, U.; Eswar, N.; Webb, B.M.; Eramian, D.; Kelly, L.; Barkan, D.T.; Carter, H.; Mankoo, P.; Karchin, R.; Marti-Renom, M.A.; Davis, F.P.; Sali, A. 2009: MODBASE, a database of annotated comparative protein structure models and associated resources. Nucleic Acids Research 37(Database Issue): D347-D354

Miyazaki, M.; Kang, H.; Choi, C.M.; Han, N.S.; Song, J.K.; Kim, N.J.; Fujii, M. 2013: MODE-specific deactivation of adenine at the singlet excited states. Journal of Chemical Physics 139(12): 124311

Dwight, T. 1897: Model (4xn) of the Human Abdominal Viscera. Journal. Boston Society of Medical Sciences 2(1): 6-7

Greenwald, I. 1949: The history of goiter in Africa. Bulletin of the History of Medicine 23(2): 155-185

Anonymous 1948: MODEL tuberculosis control scheme in Poland. Chronicle of the World Health Organization 2(6): 120-124

Chowning, J.T.; Griswold, J.; Mathwig, J.; Massey, D. 2008: Modeling Early Embryology and Stem cell Concepts. American Biology Teacher 70(2): 77-78

Landerman, L.R.; Mustillo, S.A.; Land, K.C. 2011: Modeling Repeated Measures of Dichotomous Data: Testing Whether the Within-Person Trajectory of Change Varies across Levels of Between-Person Factors. Social Science Research 40(5): 1456-1464

Emadi Andani, M.; Bahrami, F.; Jabehdar Maralani, P.; Ijspeert, A.J. 2009: MODEM: a multi-agent hierarchical structure to model the human motor control system. Biological Cybernetics 101(5-6): 361-377

Taneda, A. 2011: MODENA: a multi-objective RNA inverse folding. Advances and Applications in Bioinformatics and Chemistry: Aabc 4: 1-12

Holmes, W.H. 1892: Modern Quarry Refuse and the Palaeolithic Theory. Science 20(512): 295-297

Marshall, W. 1947: Causes of the common cold. Medical Times 75(9): 267

McKNIGHT, W.K. 1948: Care of patient's family in a private mental hospital. Mental Health Bulletin 25(4): 6-8

Anonymous 1946: MODERN nurses home at Queen Charlotte's Maternity Hospital, London. Hospital 42: 7-11

Bryant, J.E. 1946: Tuberculosis case-finding project. Hospital Council Bulletin 9: 7-9

Gorgas, N. 1946: What is the future role of hospitals in nursing education?. Hospitals 20(2): 35-38

Anonymous 1946: MODERN treatment of osteomyelitis. Physician's bulletin 11(6): 163-167

Bonde, M.T.; Klausen, M.S.; Anderson, M.V.; Wallin, A.I.N.; Wang, H.H.; Sommer, M.O.A. 2014: MODEST: a web-based design tool for oligonucleotide-mediated genome engineering and recombineering. Nucleic Acids Research 42(Web Server Issue): W408-W415

Woźniak, M.ł; Tiuryn, J.; Dutkowski, J. 2010: MODEVO: exploring modularity and evolution of protein interaction networks. Bioinformatics 26(14): 1790-1791

Hughes, J.D.; Langevin, C.D.; White, J.T. 2015: MODFLOW-Based Coupled Surface Water Routing and Groundwater-Flow Simulation. Ground Water 53(3): 452-463

Peterson, L.J. 1946: Hyperparathyroidism. Surgical Staff Seminars. United States. Veterans Administration. Hospital Minneapolis 1(8): 114-129

Anonymous 1946: MODIFIED mosquito light trap. Bulletin of the U.S. Army Medical Department. United States. Army. Medical Department 5: 13

Samanta, A.; Ganguly, S.; Myneni, R.B. 2011: MODIS Enhanced Vegetation Index data do not show greening of Amazon forests during the 2005 drought. New Phytologist 189(1): 11-15

Di Nicolantonio, W.; Cacciari, A.; Petritoli, A.; Carnevale, C.; Pisoni, E.; Volta, M.L.; Stocchi, P.; Curci, G.; Bolzacchini, E.; Ferrero, L.; Ananasso, C.; Tomasi, C. 2009: MODIS and OMi satellite observations supporting air quality monitoring. Radiation Protection Dosimetry 137(3-4): 280-287

Vadrevu, K.P.; Ellicott, E.; Badarinath, K.V.S.; Vermote, E. 2011: MODIS derived fire characteristics and aerosol optical depth variations during the agricultural residue burning season, north India. Environmental Pollution 159(6): 1560-1569

Yoo, S.; Huang, T.; Campbell, J.D.; Lee, E.; Tu, Z.; Geraci, M.W.; Powell, C.A.; Schadt, E.E.; Spira, A.; Zhu, J. 2014: MODMatcher: multi-omics data matcher for integrative genomic analysis. Plos Computational Biology 10(8): E1003790

Machnicka, M.A.; Milanowska, K.; Osman Oglou, O.; Purta, E.; Kurkowska, M.; Olchowik, A.; Januszewski, W.; Kalinowski, S.; Dunin-Horkawicz, S.; Rother, K.M.; Helm, M.; Bujnicki, J.M.; Grosjean, H. 2013: MODOMICS: a database of RNA modification pathways--2013 update. Nucleic Acids Research 41(Database Issue): D262-D267

Czerwoniec, A.; Dunin-Horkawicz, S.; Purta, E.; Kaminska, K.H.; Kasprzak, J.M.; Bujnicki, J.M.; Grosjean, H.; Rother, K. 2009: MODOMICS: a database of RNA modification pathways. 2008 update. Nucleic Acids Research 37(Database Issue): D118-D121

Richey, R.H.; Craig, J.V.; Shah, U.U.; Nunn, A.J.; Turner, M.A.; Barker, C.E.; Ford, J.L.; Peak, M. 2013: MODRIC - Manipulation of drugs in children. International Journal of Pharmaceutics 457(1): 339-341

Coronel, J.; Roper, M.; Mitchell, S.; Castillo, E.; Gamarra, N.; Drobniewski, F.; Luna, G.; Mendoza, A.; Moore, D.A.J. 2010: MODS accreditation process for regional reference laboratories in Peru: validation by GenoType® MTBDRplus. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 14(11): 1475-1480

Horowitz, G.L.; Zaman, Z.; Blanckaert, N.J.C.; Chan, D.W.; Dubois, J.A.; Golaz, O.; Mensi, N.; Keller, F.; Stolz, H.; Klingler, K.; Marocchi, A.; Prencipe, L.; McLawhon, R.W.; Nilsen, O.L.; Oellerich, M.; Luthe, H.; Orsonneau, J.-L.; Richeux, G.ér.; Recio, F.; Roldan, E.; Rymo, L.; Wicktorsson, A.-C.; Welch, S.L.; Wieland, H.; Grawitz, A.B.; Mitsumaki, H.; McGovern, M.; Ng, K.; Stockmann, W. 2005: MODULAR ANALYTICS: a new Approach to Automation in the Clinical Laboratory. Journal of Automated Methods and Management in Chemistry 2005: 8-25

Ali, F.B.; Sohail, S.; Majid, Z. 2013: MODY (maturity onset diabetes of the young). JPMA. Journal of the Pakistan Medical Association 63(10): 1327

Mota, A.J.; Brüggemann, S.; Costa, F.íc.F. 2013: MODY 2: mutation identification and molecular ancestry in a Brazilian family. Gene 512(2): 486-491

Simonella, G.; Pianese, L.; Vichi, G.; Staffolani, P.; Morosini, P. 2011: MODY 3 correlations between the genotype and clinical manifestations of diabetes. Recenti Progressi in Medicina 102(10): 387-391

Miettinen, P.äi.J.; Tuomi, T. 2012: MODY diabetes--a monogenic developmental and functional disturbance of pancreatic beta cells. Duodecim; Laaketieteellinen Aikakauskirja 128(19): 1989-1998

Zung, A.; Petek, E.; Ben-Zeev, B.; Schwarzbraun, T.; Ben-Yehoshua, S.J. 2011: MODY type 2 in Greig cephalopolysyndactyly syndrome (GCPS) as part of a contiguous gene deletion syndrome. American Journal of Medical Genetics. Part a 155a (10): 2469-2472

Ben Khelifa, S.ïr.; Barboura, I.; Dandana, A.; Ferchichi, S.; Miled, A. 2011: MODY type diabetes: overview and recent findings. Annales de Biologie Clinique 69(5): 531-540

Iwasaki, N.; Ogata, M.; Takizawa, M.; Fujimaki, R. 2012: MODY(maturity onset diabetes of the young). Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 5): 199-204

Karlsson, E.; Groop, L. 2007: MODY--an autosomal dominant type of diabetes. Diagnosis via genetic testing results in better treatment. Lakartidningen 104(37): 2600-2602

Bhoj, E.J.; Romeo, S.; Baroni, M.G.; Bartov, G.; Schultz, R.A.; Zinn, A.R. 2009: MODY-like diabetes associated with an apparently balanced translocation: possible involvement of MPP7 gene and cell polarity in the pathogenesis of diabetes. Molecular Cytogenetics 2: 5

Pulst, K.; Arbo, T.; Kahre, T.; Peet, A.; Tillmann, V. 2012: MODY2 caused by a novel mutation of GCK gene. Journal of Pediatric Endocrinology and Metabolism: Jpem 25(7-8): 801-803

Fernandez-Zapico, M.E.; van Velkinburgh, J.C.; Gutiérrez-Aguilar, R.; Neve, B.; Froguel, P.; Urrutia, R.; Stein, R. 2009: MODY7 gene, KLF11, is a novel p300-dependent regulator of Pdx-1 (MODY4) transcription in pancreatic islet beta cells. Journal of Biological Chemistry 284(52): 36482-36490

Fajans, S.S.; Bell, G.I. 2011: MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care 34(8): 1878-1884

Qi, Y.; Ma, X.; Liu, F.; Jiao, L.; Sun, J.; Wu, J. 2014: MOEA/D with adaptive weight adjustment. Evolutionary Computation 22(2): 231-264

Ke, L.; Zhang, Q.; Battiti, R. 2013: MOEA/D-ACO: a multiobjective evolutionary algorithm using decomposition and AntColony. IEEE Transactions on Cybernetics 43(6): 1845-1859

Li, X.; Corsa, C.A.S.; Pan, P.W.; Wu, L.; Ferguson, D.; Yu, X.; Min, J.; Dou, Y. 2010: MOF and H4 K16 acetylation play important roles in DNA damage repair by modulating recruitment of DNA damage repair protein Mdc1. Molecular and Cellular Biology 30(22): 5335-5347

Sharma, G.G.; So, S.; Gupta, A.; Kumar, R.; Cayrou, C.; Avvakumov, N.; Bhadra, U.; Pandita, R.K.; Porteus, M.H.; Chen, D.J.; Cote, J.; Pandita, T.K. 2010: MOF and histone H4 acetylation at lysine 16 are critical for DNA damage response and double-strand break repair. Molecular and Cellular Biology 30(14): 3582-3595

Liu, Y.; Wang, N.; Diestel, L.; Steinbach, F.; Caro, J.ür. 2014: MOF membrane synthesis in the confined space of a vertically aligned LDH network. Chemical Communications 50(32): 4225-4227

Gupta, A.; Hunt, C.R.; Hegde, M.L.; Chakraborty, S.; Chakraborty, S.; Udayakumar, D.; Horikoshi, N.; Singh, M.; Ramnarain, D.B.; Hittelman, W.N.; Namjoshi, S.; Asaithamby, A.; Hazra, T.K.; Ludwig, T.; Pandita, R.K.; Tyler, J.K.; Pandita, T.K. 2014: MOF phosphorylation by ATM regulates 53BP1-mediated double-strand break repair pathway choice. Cell Reports 8(1): 177-189

Falcaro, P.; Ricco, R.; Doherty, C.M.; Liang, K.; Hill, A.J.; Styles, M.J. 2014: MOF positioning technology and device fabrication. Chemical Society Reviews 43(16): 5513-5560

Shekhah, O.; Liu, J.; Fischer, R.A.; Wöll, C. 2011: MOF thin films: existing and future applications. Chemical Society Reviews 40(2): 1081-1106

Gu, Z.-Y.; Wang, G.; Yan, X.-P. 2010: MOF-5 metal-organic framework as sorbent for in-field sampling and preconcentration in combination with thermal desorption GC/MS for determination of atmospheric formaldehyde. Analytical Chemistry 82(4): 1365-1370

Hughes, J.T.; Navrotsky, A. 2011: MOF-5: enthalpy of formation and energy landscape of porous materials. Journal of the American Chemical Society 133(24): 9184-9187

Yang, W.; Bai, Z.-Q.; Shi, W.-Q.; Yuan, L.-Y.; Tian, T.; Chai, Z.-F.; Wang, H.; Sun, Z.-M. 2013: MOF-76: from a luminescent probe to highly efficient U(VI) sorption material. Chemical Communications 49(88): 10415-10417

Chelmicki, T.; Dündar, F.; Turley, M.J.; Khanam, T.; Aktas, T.; Ramírez, F.; Gendrel, A.-V.; Wright, P.R.; Videm, P.; Backofen, R.; Heard, E.; Manke, T.; Akhtar, A. 2014: MOF-associated complexes ensure stem cell identity and Xist repression. Elife 3: E02024

Stavila, V.; Talin, A.A.; Allendorf, M.D. 2014: MOF-based electronic and opto-electronic devices. Chemical Society Reviews 43(16): 5994-6010

Yang, S.Jae.; Im, J.Hyuk.; Kim, T.; Lee, K.; Park, C.Rae. 2011: MOF-derived ZnO and ZnO@C composites with high photocatalytic activity and adsorption capacity. Journal of Hazardous Materials 186(1): 376-382

Yue, H.; Shi, Z.; Wang, Q.; Cao, Z.; Dong, H.; Qiao, Y.; Yin, Y.; Yang, S. 2014: MOF-derived cobalt-doped ZnO@C composites as a high-performance anode material for lithium-ion batteries. Acs Applied Materials and Interfaces 6(19): 17067-17074

Banerjee, A.; Upadhyay, K.K.; Puthusseri, D.; Aravindan, V.; Madhavi, S.; Ogale, S. 2014: MOF-derived crumpled-sheet-assembled perforated carbon cuboids as highly effective cathode active materials for ultra-high energy density Li-ion hybrid electrochemical capacitors (Li-HECs). Nanoscale 6(8): 4387-4394

Zou, F.; Hu, X.; Li, Z.; Qie, L.; Hu, C.; Zeng, R.; Jiang, Y.; Huang, Y. 2014: MOF-derived porous ZnO/ZnFe₂O₄/C octahedra with hollow interiors for high-rate lithium-ion batteries. Advanced Materials 26(38): 6622-6628

Shekhah, O.; Hirai, K.; Wang, H.; Uehara, H.; Kondo, M.; Diring, S.; Zacher, D.; Fischer, R.A.; Sakata, O.; Kitagawa, S.; Furukawa, S.; Wöll, C. 2011: MOF-on-MOF heteroepitaxy: perfectly oriented [Zn2(ndc)2(dabco)]n grown on [Cu2(ndc)2(dabco)]n thin films. Dalton Transactions 40(18): 4954-4958

Huo, J.; Marcello, M.; Garai, A.; Bradshaw, D. 2013: MOF-polymer composite microcapsules derived from Pickering emulsions. Advanced Materials 25(19): 2717-2722

Canivet, J.; Aguado, S.; Schuurman, Y.; Farrusseng, D. 2013: MOF-supported selective ethylene dimerization single-site catalysts through one-pot postsynthetic modification. Journal of the American Chemical Society 135(11): 4195-4198

Lü, Y.; Zhan, W.; He, Y.; Wang, Y.; Kong, X.; Kuang, Q.; Xie, Z.; Zheng, L. 2014: MOF-templated synthesis of porous Co(3)O(4) concave nanocubes with high specific surface area and their gas sensing properties. Acs Applied Materials and Interfaces 6(6): 4186-4195

Koh, K.; Wong-Foy, A.G.; Matzger, A.J. 2009: MOF@MOF: microporous core-shell architectures. Chemical Communications 2009(41): 6162-6164

de Oliveira, C.Alberto.Fernandes.; da Silva, F.Fred.; Jimenez, G.Chaves.; Neto, Jé.Ferreira.da.S.; de Souza, D.Maria.Bastos.; de Souza, I.Antônia.; Alves, S. 2013: MOF@activated carbon: a new material for adsorption of aldicarb in biological systems. Chemical Communications 49(58): 6486-6488

Henninger, S.K.; Habib, H.A.; Janiak, C. 2009: MOFs as adsorbents for low temperature heating and cooling applications. Journal of the American Chemical Society 131(8): 2776-2777

Cirujano, F.G.; Llabrés i Xamena, F.X.; Corma, A. 2012: MOFs as multifunctional catalysts: one-pot synthesis of menthol from citronellal over a bifunctional MIL-101 catalyst. Dalton Transactions 41(14): 4249-4254

Ramaswamy, P.; Wong, N.E.; Shimizu, G.K.H. 2014: MOFs as proton conductors--challenges and opportunities. Chemical Society Reviews 43(16): 5913-5932

Wang, C.; Wang, T.; Li, L.; Guo, B.; Zhang, Y.; Xiong, Z.; Li, G. 2013: MOFs constructed with the newly designed imidazole dicarboxylate bearing a 2-position aromatic substituent: hydro(solvo)thermal syntheses, crystal structures and properties. Dalton Transactions 42(5): 1715-1725

Zhang, Z.; Zhao, Y.; Gong, Q.; Li, Z.; Li, J. 2013: MOFs for CO2 capture and separation from flue gas mixtures: the effect of multifunctional sites on their adsorption capacity and selectivity. Chemical Communications 49(7): 653-661

Liu, C.; Zhang, G.; Zhao, C.; Li, X.; Li, M.; Na, H. 2014: MOFs synthesized by the ionothermal method addressing the leaching problem of IL-polymer composite membranes. Chemical Communications 50(91): 14121-14124

Gagnon, K.J.; Beavers, C.M.; Clearfield, A. 2013: MOFs under pressure: the reversible compression of a single crystal. Journal of the American Chemical Society 135(4): 1252-1255

Mony, J.T.; Khorooshi, R.; Owens, T. 2014: MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE. Multiple Sclerosis 20(10): 1312-1321

Varrin-Doyer, M.; Shetty, A.; Spencer, C.M.; Schulze-Topphoff, U.; Weber, M.S.; Bernard, C.C.A.; Forsthuber, T.; Cree, B.A.C.; Slavin, A.J.; Zamvil, S.S. 2014: MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS. Neurology (R) Neuroimmunology and Neuroinflammation 1(2): E20

Luppe, S.; Robertson, N.P. 2014: MOG-IgG in neuromyelitis optica. Journal of Neurology 261(3): 640-642

Misu, T.; Sato, D.K.; Nakashima, I.; Fujihara, K. 2015: MOG-IgG serological status matters in paediatric ADEM. Journal of Neurology Neurosurgery and Psychiatry 86(3): 242

Anonymous 1945: MOHAMMEDAN population. Human Fertility 10: 55

Ruymgaart, A.P.; Cardenas, A.E.; Elber, R. 2011: MOIL-opt: Energy-Conserving Molecular Dynamics on a GPU/CPU system. Journal of Chemical Theory and Computation 7(10): 3072-3082

Hasegawa, A.; Daub, C.; Carninci, P.; Hayashizaki, Y.; Lassmann, T. 2014: MOIRAI: a compact workflow system for CAGE analysis. Bmc Bioinformatics 15: 144

Dawson-Bowling, S.; Adimonye, A.; Cohen, A.; Cottam, H.; Ritchie, J.; Fordyce, M. 2012: MOJE ceramic metatarsophalangeal arthroplasty: disappointing clinical results at two to eight years. Foot and Ankle International 33(7): 560-564

Abreu, R.M.; Froufe, H.J.; Queiroz, M.J.ão.R.; Ferreira, I.C. 2010: MOLA: a bootable, self-configuring system for virtual screening using AutoDock4/Vina on computer clusters. Journal of Cheminformatics 2(1): 10

Aquilante, F.; De Vico, L.; Ferré, N.; Ghigo, G.; Malmqvist, P.-A.; Neogrády, P.; Pedersen, T.B.; Pitonák, M.; Reiher, M.; Roos, B.ör.O.; Serrano-Andrés, L.; Urban, M.; Veryazov, V.; Lindh, R. 2010: MOLCAS 7: the next generation. Journal of Computational Chemistry 31(1): 224-247

Church, M.B.; Thom, C. 1921: Mold Hyphae in Sugar and Soil Compared with Root Hairs. Science 54(1402): 470-471

Sehnal, D.; Svobodová Vařeková, R.; Berka, K.; Pravda, L.áš; Navrátilová, V.; Banáš, P.; Ionescu, C.-M.; Otyepka, M.; Koča, J. 2013: MOLE 2.0: advanced approach for analysis of biomacromolecular channels. Journal of Cheminformatics 5(1): 39

Sincell, M. 2000: MOLECULAR STRUCTURE: Physicists Glimpse how Quasicrystals Boogie. Science 289(5484): 1451

Naves, Y.R. 1946: Production of synthetic menthols. Manufacturing Chemist and Aerosol News 17(12): 525-528

Berka, K.; Hanák, O.; Sehnal, D.; Banás, P.; Navrátilová, V.; Jaiswal, D.; Ionescu, C.-M.; Svobodová Vareková, R.; Koca, J.; Otyepka, M. 2012: MOLEonline 2.0: interactive web-based analysis of biomacromolecular channels. Nucleic Acids Research 40(Web Server Issue): W222-W227

Hong, K.; Kim, D. 2014: MOLLi and AIR T1 mapping pulse sequences yield different myocardial T1 and ECV measurements. Nmr in Biomedicine 27(11): 1419-1426

Brown, J. 2012: MOM brings care, dignity to those most in need. Cds Review 105(4): 12-13

Bush, D.M. 2014: MOM is coming to Indiana. Journal 93(2): 8-9

Connolly, S. 2013: MOM volunteers give, but also receive. Pennsylvania Dental Journal 80(4): 9

Harman, N.L.; Bruce, I.A.; Callery, P.; Tierney, S.; Sharif, M.Owaise.; O'Brien, K.; Williamson, P.R. 2013: MOMENT--Management of Otitis Media with Effusion in Cleft Palate: protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Trials 14: 70

Wang, Y.; Li, H.-X.; Yen, G.G.; Song, W. 2015: MOMMOP: multiobjective optimization for locating multiple optimal solutions of multimodal optimization problems. IEEE Transactions on Cybernetics 45(4): 830-843

Sharda, S.; Panigrahi, I.; Marwaha, R.K. 2011: MOMO Syndrome with Holoprosencephaly and Cryptorchidism: Expanding the Spectrum of the new Obesity Syndrome. Case Reports in Genetics 2011: 839650

Giunco, C.T.; Moretti-Ferreira, D.; Silva, A.E.; Rocha, S.S.; Fett-Conte, A.C. 2008: MOMO syndrome associated with autism: a case report. Genetics and Molecular Research: Gmr 7(4): 1223-1225

Lorenzen, D.; Bracy, K. 2011: MOMS Plus: A public health program for substance using pregnant inmates in an urban jail. Journal of Correctional Health Care: the Official Journal of the National Commission on Correctional Health Care 17(3): 233-240

Davies, S.L.; Horton, T.V.; Williams, A.G.; Martin, M.Y.; Stewart, K.E. 2009: MOMS: formative evaluation and subsequent intervention for mothers living with HIV. Aids Care 21(5): 552-560

Blu, T.; Thévenaz, P.; Unser, M. 2001: MOMS: maximal-order interpolation of minimal support. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 10(7): 1069-1080

Hilbig, M.; Urbaczek, S.; Groth, I.; Heuser, S.; Rarey, M. 2013: MONA - Interactive manipulation of molecule collections. Journal of Cheminformatics 5(1): 38

Zhu, Y.; Jiang, H.; Zhang, C.; He, Q.-J.; Yang, B.; Li, L.-J.; Zhu, H. 2009: MONCPT exerts anti-cancer activities via inducing G2/M arrest and apoptosis in human bladder cancer. Die Pharmazie 64(12): 823-828

Castelar, S.L. 1946: Frequency of dental caries in schoolchildren in San Salvador. Salud y Vida 1(3): 16

Burgess, A. 1955: Child health and parental care. Journal of Tropical Pediatrics 1(3): 129-140

Xi, W.; Seidel, J.; Kakareka, J.W.; Pohida, T.J.; Milenic, D.E.; Proffitt, J.; Majewski, S.; Weisenberger, A.G.; Green, M.V.; Choyke, P.L. 2010: MONICA: a compact, portable dual gamma camera system for mouse whole-body imaging. Nuclear Medicine and Biology 37(3): 245-253

De Sousa, T.F.; Fonseca, S.A.; José, H.P.M.ó; Nahas, M.V. 2012: MONISA study: characteristics and methodological aspects. Revista Brasileira de Epidemiologia 15(4): 904-907

Oh, S.-J.; Hwang, S.J.; Jung, J.; Yu, K.; Kim, J.; Choi, J.Y.; Hartzell, H.C.; Roh, E.J.; Lee, C.J. 2013: MONNA, a potent and selective blocker for transmembrane protein with unknown function 16/anoctamin-1. Molecular Pharmacology 84(5): 726-735

Konishi, M.; Donner, T.J.; Scarpella, E.; Yanagisawa, S. 2015: MONOPTEROS directly activates the auxin-inducible promoter of the Dof5.8 transcription factor gene in Arabidopsis thaliana leaf provascular cells. Journal of Experimental Botany 66(1): 283-291

Sam-Wobo, S.O.; Mafiana, C.F.; Onashoga, S.A.; Vincent, O.R. 2007: MONRATE: a descriptive tool for calculation and prediction of re-infection of Ascaris lumbricoides (Ascaridida: Ascarididae). Revista de Biologia Tropical 55(3-4): 755-760

Cooper, R.J.; Magee, E.; Everdell, N.; Magazov, S.; Varela, M.; Airantzis, D.; Gibson, A.P.; Hebden, J.C. 2014: MONSTIR II: a 32-channel, multispectral, time-resolved optical tomography system for neonatal brain imaging. Review of Scientific Instruments 85(5): 053105

Anonymous 1946: MONTAIGNE'S essay on drunkenness. Quarterly journal of studies on alcohol 7: 297-304

Anonymous 1947: MONTANA summary of vital statistics, 1945. Vital Statistics Special Reports 26: 321-331